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ABSTRACT
Metal-catalyzed nucleophilic substitution reactions of aryl halides have become one of
the most valuable and useful classes of reactions developed in the last 30 years. Foremost among
these processes are the classes of palladium- and copper-catalyzed reactions, which employ
heteroatom-based nucleophiles. Herein, newly designed catalyst systems are presented for the
palladium- and/or copper-catalyzed nucleophilic substitution reactions of aryl halides with a
variety of nucleophiles, including (benz)imidazoles, oxindoles, 2-, 3- and 4-hydroxypyridines,
anilines, and aliphatic, benzylic, allylic and propargylic alcohols. In many cases, catalyst
optimization and ligand structure are discussed and evaluated. Where applicable, the palladium-
and copper-based catalyst systems are contrasted to demonstrate the complementary
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Introduction
Preparations of Aromatic Amines
Aryl amines are a common motif in many biologically active compounds including those
with potential therapeutic applications.' These structures are also found in conducting and
photographic materials as well as electroluminecent devices.2 Further, N-aryl amines serve as
intermediates for the synthesis of heterocycles,3 and for the chemical synthesis of interesting
molecules."4
Non-metal-mediated routes for the preparation of N-substituted anilines involve benzyne
chemistry,5 by reductive amination,6 by an arene nitration/reduction sequence,6 and by
nucleophilic aromatic substitution of an activated aryl halide (Figure 1).7
Figure 1. Non-metal-catalyzed Preparations of Aromatic Amines
Benzyne R LNR2R3  1) Amination
X = halide 2) [H]
R3
NR2R3
LiNR2R3  1) HNO/H 2SO4
X = halide 2) reduction
R' = EWG R2, R3 = H
Aromatic R1 R Nitration/AromaticR-
Substitution n- • Reduction
The stringent conditions required by these methods (strong acid or base, high reaction
temperatures, use of stoichiometric metal reagents) and the inherent problems in achieving high
regioselectivity render these methods ill-suited for preparing certain targets. Additionally,
employing these strategies makes it difficult to rapidly and directly assemble multiple analogs of
a given target (core structure) in a simple fashion using mild conditions."
A classical transition-metal mediated approach to form C-heteroatom bonds developed
by Ullmann'o and Goldberg,11 involves Cu-mediated reactions of amines, phenols or amides with
aryl iodides (eq. 1). However, these reactions are severely limited by the harsh conditions often
required-exposure of substrates to high temperatures, typically 150-200 'C, for extended periods
of time using super-stoichiometric quantities of a copper compound.'2
Ullmann x CuX N(R2)2
Coupling R1  + HN(R 2)2  150- R- N (1)
These limitations have led to the development of new complementary methods based on
metal-catalyzed cross-coupling reactions between amines and aryl halides. The newer Cu-9 and
Pd-8 based methodologies allow for the rapid, direct and efficient preparation of a wide variety of
N-aryl compounds under conditions that are mild enough to tolerate sensitive functional groups.
Palladium-catalyzed Aryl-Heteroatom Bond Formation
Early reports of Ni-'3 and Pd-catalyzed' 4 C-heteroatom bond formation using aryl halides
and sulfonate esters remained dormant for decades until extensive work by the groups of
Buchwald8 and Hartwig'5 significantly improved the reliability, generality, functional group
tolerance, and substrate scope of these reactions. Currently, these reactions are practiced on a
regular basis in industrial'6 and academic laboratories (eq. 2).3-4
X1  "Pd(O)" Phosphine Ligand 
. X2R2(R3)
HX2R2(R3) Base, Solvent, (Heat) (2)
X1 = I, Br, CI, OTs, OTf X2 = N, O, P, S
Both groups have contributed to the elucidation of the mechanism of Pd-catalyzed C-
heteroatom bond-forming reactions.81"5" 7For the Pd-catalyzed amination of aryl halides using the
dialkyl biarylmonophosphine ligands developed in our laboratory (Figure 2), oxidative addition
of an aryl halide to an LPd(O) complex affords the LIPd(II)(Ar)(X) complex (Figure 3). A two-
step transmetallation reaction occurs, involving coordination of an amine to the metal followed
by deprotonation of the acidified N-H bond, to generate an LIPd(II)(Ar)(NR'R") species.
Subsequently, reductive elimination provides the N-aryl amine, and regenerates the active
LPd(O) species.
Figure 2. Bulky Dialkyl Biarylmonophosphine Ligands
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Several properties of dialkylbiarylmonophosphine compounds make this class of ligand
attractive for practical use. In general, the crystalline state of the pure compounds and their high
stability towards oxidation" make them easy for users to manipulate under ambient conditions.
Catalytically, when employing bulky biarylmonophosphine ligands, both the oxidative addition,
and reductive elimination steps of the catalytic cycle are accelerated due to the electron-donating
ability and steric bulk of the ligands, respectively. The size of the ligand encourages formation of
the active LPd(O) complex, as opposed to an L2Pd(O) complex, which resides outside of the
catalytic cycle. Further, certain pathways of catalyst decomposition are retarded when employing
this class of ligand."9
Computational analyses of the metal complexes at various stages of the catalytic cycle
have further detailed the participation of the biarylmonophosphine ligands over the course of the
reaction. 2 -2 1 Specifically, rotation of the ligand about the P-Ca, bond facilitates the various
fundamental organometallic reactions within the catalytic cycle (Scheme 1). First, the LPd(O)
species (I) and the L,Pd(Ar)(X) oxidative addition product (IIa) are likely stabilized by
interactions between the Pd atom and at-electrons from the lower ring of the biaryl moiety (e.g.
XPhos), or a substituent on the lower ring (e.g. SPhos).20 Second, the coordination and
deprotonation events of the transmetallation (IIb-lII-IV) reaction likely occur after the P-Cy,
bond rotates so that the metal is distal to the lower biaryl ring, thus preventing the ligand from
sterically shielding the electrophilic metal from the nucleophile during the transmetallation
step.2 1 Most likely, rotation of the P-Caryl bond occurs prior to the reductive elimination step,
repositioning the metal above the lower biaryl ring (V). This event forces the amine and aryl
ligands into a cis-relationship, and encourages C-N bond-formation through steric
compression. 21
Scheme 1. Rotation about the P-C., Bond at Various Stages of the Catalytic Cycle
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While the preceding discussion considered an amine as the nucleophile, the catalytic
cycle is analogous for other substrates, such as alcohols. However, for other nucleophiles, the
rate-determining step might be the reductive elimination, as opposed to transmetallation.22
Copper-catalyzed Aryl-Heteroatom Bond Formation
Recent work initiated by Lam, Chan and Evans has employed various stoichiometric
reagents as electrophilic components for Cu-mediated heteroatom-arylation reactions including,
aryllead triacetates, arylboronic acids, 4 triarylbismuths,2 5 hypervalent aryl siloxanes, 26 diaryl
iodonium salts,27 and arylstannanes (eq. 3).8 While these reactions generally operate at room
temperature, as opposed to the high temperatures normally employed in traditional Ullmann
reactions, they typically require stoichiometric quantities of copper. A second major drawback of
kI
M -rl ml·a ; MI; . 1.
U%.fi LVD lVG CIIIIIOtuIV I
these methods is the required use of toxic and/or unstable reagents that are generally accessed
from aryl iodides or bromides. Furthermore, in some cases, only one of multiple aryl groups is
transferred to the nucleophile. The direct use of aryl halides as the electrophilic coupling partner
resolves many of these drawbacks.
R1- + HNR 2R3  CU R1R- (3)
X = -B(OR)2 , -SiR3, -SnR 3, -Pb(OAc) 3, -BiAr2 , -IPh
A plethora of new hard-chelating ligands has been reported in the last decade, which
allow the Ullmann and Goldberg reactions to be run under significantly milder conditions-
typically rt-120 'C using weak inorganic bases. This development has greatly improved the
substrate scope, functional group tolerance and selectivity of these reactions (eq. 4).9
+ HX2R2(R3) RI- (4)Rl-~ x , + HX2R2(Rs Cat. "Cu(l)" Hard Chelating Ligand " R'• ] 'X2R2(R3)
+' HX 2R (R) Base, Solvent, 80-120 *C I'll (4)
X'= I, Br X2 = N, O, P, S
Despite the progress in this field, the development of newer, more stable and more active
Cu-catalyzed C-heteroatom bond forming reactions has been limited by the poor understanding
of the catalytic cycle. Although the Ullmann Reaction is over 100 years old, few formal studies
of have shed light into its mechanism.9' 12 The following discussion will consider the arylation of
N-H-containing nucleophiles. At this point, it will be assumed that the mechanism is the same
for other nucleophiles.
Historically, one reason why Cu-catalyzed arylation reactions of amines with aryl halides
have historically been difficult to study is that Cu(0), Cu(I) and Cu(II) salts and complexes all
provide active catalysts.9 Although the crystal structure of an isolated ligated Cu(II) complex,
suggests that a Cu(II) species is the catalytically active precursor,29 more compelling evidence
involving electron paramagnetic resonance (EPR) studies and detailed
heterogeneous/homogenous studies run with Cu precursors at 0, +1 and +2 oxidation states
suggest that Cu(I) is the active precatalyst. 30 31
Although mechanisms involving addition-elimination mechanism via a Meisenheimer
complex have been proposed,32 the strong trend observed in leaving group reactivity of I > Br >>
Cl >> F for Cu-catalyzed processes indicates that the rate limiting step involves the C-halogen
bond cleavage, as opposed to rate-limiting addition of the nucleophile. 33
One plausible proposal has drawn similarities between the Pd(0)/Pd(II)-based catalyst
system and a potential Cu(I)/Cu(III)-based catalysts systems-both involving metals with d'0 /d8
electronic configurations-and suggested that the individual steps of the Cu catalytic cycle mimic
those of the Pd-catalyzed mechanism, that is, oxidative addition, followed by transmetallation
and reductive elimination.34 However, this mechanism is unlikely to occur, as kinetic evidence
obtained from catalytic and stoichiometric Cu(I)-catalyzed amidation reactions of aryl iodides
indicates that transmetallation precedes aryl halide activation (Figure 4).35
Figure 4. Proposed Cu(I)-Cu(III) Based Mechanism for Amination of Aryl Halides
(R2)R'N R3





Several potential mechanisms have been proposed for the aryl halide activation event
(Figure 5). After transmetallation, rate-limiting oxidative insertion of Cu(I) into the C-halogen
bound could potentially generate a Cu(III) intermediate (VII), which would reductively eliminate
the C-N bond to regenerate the L2Cu(I)X species (VI).36 Critics of this mechanism argue that the
existence of an instable Cu(III) intermediate within the catalytic cycle is unlikely. However,
Cu(III) complexes have been isolated, characterized and reported, thus reinforcing the possibility
of a short-lived, high-energy Cu(III) species.37 Although the oxidative addition/reductive
elimination pathway has been computationally supported,38 this mechanistic proposal neglects
the existence of the Cu(II) and organic radical species that have been observed by EPR in
Goldberg reactions."3 4
Figure 5. Potential Mechanisms for Aryl Halide Activation During Cu-Catalyzed Amination
Reactions
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Reasonable mechanisms, which account for this observation, invoke electron transfer and
atom transfer processes, which would generate Cu(II) intermediates (IX, X). An atom transfer
reaction between the aryl halide and VII would provide a Cu(II) species and an aryl radical (X),
which can decompose to provide the product by solvolytic, anion transfer, or oxidative
substitution (XI-VIII) mechanisms.41 Electron transfer from VII to an aryl halide would
generate Cu(II) and an anionic radical halide (IX).4 From complex IX, a sequential electron
transfer could generate VIII. This sequence of reactions would constitute an oxidative addition,
and generate a Cu(III) intermediate, albeit by a radical mechanism as opposed to an insertion
reaction. Alternatively, decomposition of IX into an aryl radical and a halide anion would form
IX, which could then provide the product.41-42
According to these potential mechanisms, the hard-chelating ligands employed for these
reactions help control the coordination sphere about the metal throughout the catalytic cycle and
provide high concentrations of complex VII prior to the rate-determining aryl halide activation
step.43 Further, the electron-donating ability of the ligands drastically lowers the oxidation
potential of the Cu(I)-Cu(II) couple, thus, stabilizing higher-oxidation state intermediates, and
accelerating the aryl halide activation process.3 5'44
Complementary Pd- and Cu-Based Catalyst Systems
Mechanistically, Pd- and Cu-based catalyst systems can be differentiated by the order of
the steps in the catalytic cycle; while oxidative addition is the first step for Pd-catalyzed process,
transmetallation precedes the aryl halide activation step for Cu. This suggests that the ideal
substrate scopes for the nucleophilic substitution reactions of catalysts derived from each metal
might be complementary. For instance, Pd-based catalysts have proven highly efficient in the N-
arylation of anilines under generally mild conditions.8 In contrast, more limited success has been
achieved for the N-arylation of N-containing heterocycles. 45 On the other hand, Cu-catalysts
typically provide inefficient systems for the N-arylation of anilines with aryl iodides and
bromides,9' while they are highly active for the reactions of N-H heterocycles with aryl iodides
and bromides. 7
Foreword
The following thesis will attempt to compare and contrast both Pd- and Cu-based catalyst
systems for C-heteroatom bond formation by highlighting the inherent differences in reactivity.
In Chapter 1, Pd-based catalyst systems for the N-arylation of imidazoles with aryl halides will
be discussed, as well as a newly designed Cu-based catalyst system that provides a highly active
and stable system for this transformation. In Chapter 2, the orthogonal chemoselectivity of Pd-
and Cu-based catalyst systems in reactions of oxindoles with aryl halides is explored, which
generate either the C3- or N1-aryl products, respectively. Chapter 3 details a series of three Cu-
based catalysts systems that successfully cross-couple 2-, 3-, and 4-hydroxypyridines and related
compounds. Pd-based catalyst systems have historically proven unsuccessful in accomplishing
these reactions. In Chapter 4, a general Cu-based catalyst system is developed for the cross-
coupling of anilines with aryl iodides and bromides, a reaction that has been dominated by Pd-
based catalyst systems for the last 10 years. In Chapter 5, an improved catalyst system is
developed for the Cu-catalyzed cross-coupling of aliphatic, benzylic, allylic alcohols with aryl
halides, reactions that typically provide high quantities of reduced arene when employing Pd-
based catalysts. By studying the following pages, the reader should gain insight into the
complementary relationship between Pd- and Cu-based catalyst systems for C-heteroatom bond-
forming reactions.
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Chapter One
Palladium and Copper-catalyzed Reactions of Imidazoles
and Benzimidazoles with Aryl Halides
2.5% Pd2dba 3, 10% Me4t-BuXPhos
K3PO 4, toluene
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1.1 Introduction
N-Aryl imidazoles and benzimidazoles are found in many biologically active
compounds.1 Although traditional methods for their preparation (nucleophilic aromatic
substitution of an activated aryl halide and Cu-mediated coupling of the heterocycle with an aryl
iodide) can give access to a wide variety of N-arylated products, these methods suffer from
significant limitations. In the former case, the scope of the reaction is confined to the use of aryl
halides possessing strongly electron-withdrawing substituents. In the latter case, the range of
functional groups tolerated by the long-established Ullmann reaction is severely restricted by the
harsh conditions often required (exposure of substrates to high temperatures, typically 150-200
'C, for extended periods of time using stoichiometric quantities of a copper compound). 2
In recent years, mild transition metal-catalyzed cross coupling reactions of aryl halides
with N-H heterocycles 3" have complemented the traditional preparations of these structures.
Despite the continued development of hindered biaryl monophosphines 5 and other ligands3 for
improved Pd-catalyzed C-N bond-forming reactions, only two examples of Pd-catalyzed
reactions of imidazoles with aryl halides can be found in the literature (Scheme 1).-7 Both
examples require the use of activated electrophiles for C-N bond-formation to occur. Thus, Cu-
based catalysts have continued to provide the most effective systems for the N-arylation of
imidazoles. 4
Scheme 1. Literature Reports of Pd-Catalyzed N-Arylation Reactions of Imidazole6-7
MeO N HN- 2% Pd(OAc)2, 2% L N  r
MeO1 N C +  N NaOt-Bu, THF, rt, 12 h MeO N NN L=•76% ,N i-Pr i-Pr
NC
NC HN 51% Pd(OAc) 2, 5% dppf
+ B 4N DMF, 180 *C, mw N
B84% KN
Although the Cu-mediated N-arylation of imidazoles and benzimidazoles has been
accomplished using aryllead triacetate,8 arylboronic acid,9 triarylbismuth,'0 hypervalent aryl
siloxane," diaryl iodonium salt,'2 and arylstannane' 3 reagents, these methods generally require
the use of toxic and/or unstable reagents that can be difficult to prepare. Furthermore, in many
cases, only one of multiple aryl groups is transferred to the heterocycle. In contrast, the use of
more stable and readily available aryl halides as the electrophilic coupling partner resolves these
issues.
In an early report, 5 mol% bis-[copper(I) triflate] benzene [(CuOTf)2.PhH] facilitated the
coupling of imidazole with aryl iodides under moderate conditions [100% 1,10-phenanthroline,
(Lla)/10% dba/Cs2CO3/xylenes/1 10-125 *C/24-48 h, eq. 1].14 However, the scope of the catalyst
system was limited to the coupling of unhindered imidazoles with unhindered aryl iodides. The
use of the air-sensitive (CuOTf)2.PhH as the precatalyst required the use of inconvenient glove
box techniques for reaction set-up. The need for stoichiometric quantities of 1,10-phenanthroline
ligand and long reaction times were also undesirable.
5% (CuOTf)2 .PhH R'
R1 X R2  100% dba, 100% Lla /-1 R2/1 + N > /N (1)N/NH A Cs2CO3 , xylenes
110-125 "C
X = Br, I
Subsequently, we developed effective ligands and catalyst systems for the Cu-catalyzed
coupling of aryl iodides and bromides with a variety of N-H containing azoles; however, little
progress was made with respect to the N-arylation of imidazoles.' 5 While reports by other groups
have disclosed the use of salicylaldoxime derivatives,'6" amino acid derivatives, 16b-c NN'-
dimethylethylenediamine derivatives (DMEDA),'•" ligands first reported for C-N couplings by
us,' 6c-e 4,7-dichloro-1,10-phenanthroline,' 6- 8-hydroxyquinoline, T' aminoarenethiol, 6g oxime-
phosphine oxides, 16h  phosphoramidites,'6  1,10-phenanthroline,' 6j  fluoroapetite, 6k 2-
aminopyrimidinediols, 161 3-ketoesters, 16m and pyrrolidinylmethylimidazole"'6 as supporting ligands
in the Cu-catalyzed N-arylation of imidazoles with aryl iodides, very few examples of the
coupling of imidazoles with aryl bromides or of even moderately hindered substrates (e.g. a 2-
substituted imidazole or a 2-substituted aryl halide) were disclosed until our communication
(Figure 1)."7 Furthermore, the use of heteroaryl halides and 4(5)-substituted imidazoles have not
been reported.
Figure 1. Reported Ligands for the Cu-Catalyzed N-Arylation Reactions of Imidazole and
Benzimidazole
R' X R2 Cat. Cu(I)IL 2== R2
NNH 80-160 °C N
18-30 h
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1.2 Results and Discussion
12.1 Palladium Catalysis
Imidazole itself acts a catalyst poison for Pd-based C-heteroatom bond-forming
reactions. A catalytic amount of this molecule can completely inhibit a simple amination reaction
of an aryl halide (Table 1, entries 1-2). Since the replacement of the N-H with an N-Me group
provides a more active catalyst (entry 4), the source of catalyst poisoning likely involves the free
N-H bond. Therefore, the development of a Pd-based catalyst system to cross-couple imidazole
with an aryl halide provides a significant challenge.
Table 1. Imidazoles as Catalyst Poisons and Catalyst Enhancers
o--
O /l !P, 0.5% Pd2dba3, 4% t-BuXPhos 0 N





Additive (0.2 ea) GC Cony. (%) GC Yield (%)
None 49 48 t-uXPhosPd(Ar)
Imidazole 0 0 N/H(Me)
N
2-Methyl imidazole 0 0 Catalytically Inactive
1-Methyl imidazole 97 98
Due to the size and structure of pyrrole relative to imidazole (rigid, flat, 5-member ring),
insight into the challenge of coupling imidazole with aryl halides using a Pd-based catalyst
system can be obtained from Hartwig's studies of the Pd-catalyzed reaction of pyrroles with aryl
halides.'8 According to this work, due to the small size of the nucleophile, the slow reductive
elimination of the C-N bond from a (PPh3)Pd(Ar)(Pyrrole) intermediate allowed for the addition
of a second equivalent of pyrrole to occur to generate a Na[PPh3Pd(Ar)(Pyrrole)2] intermediate
(A), which resisted reductive elimination (Figure 2). By employing a bidentate ligand (dppf), the
authors were able to control the coordination sphere about the metal, inhibiting the formation of
the inactive intermediate A', and allow reductive elimination to occur. By analogy, the reductive
elimination of an LPd(Ar)(Imidazole) intermediate (B) should also be slow. However, the
formation of the analogous [LPd(Ar)(Imidazole)2]- intermediate (C) should be faster, since
addition of a second imidazole molecule to B involves the sp2-hybridized lone pair electrons,
compared to the reaction of pyrrole with L Pd(Ar)(Pyrrole) intermediate, where coordination of
the p-hybridized lone pair electrons, prior to deprotonation, results in a loss of aromaticity. Thus,
in order to successfully couple imidazole with an aryl halide the slow reductive elimination of
complexes complex B must be over come, and the formation of complexes of the type C must be
inhibited.
Figure 2. Potential Formation of Inactive Catalyst
Reductive N Pyrrole N Reductive












Early attempts to employ a Pd-based catalyst system to cross-couple imidazole with a
simple aryl bromide provided no conversion of aryl halide or yield of product (eq. 1). A wide
variety of ligands including dialkyl biarylmonophosphino-, bis-phosphinobinaphthyl-,
ferrocenyl-, Xantphos-type trialkyl- and triaryl-phosphino-based ligands all provided inactive
catalysts for this transformation (Figure 3). In addition to the use of the N-H heterocycle, the
reaction of polymeric tri-n-butylstannyl imidazole and sodium tetra(imidazoyl) borate provided




M = H, SnBu3, NaB(Imidazole)3
Figure 3. Summary of Unsuccessfully
Reactions of Imidazole
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Z = PPh 2, NMe2 , OCH 2(1-naphthyl) R = Ph, o-Tol, Cy, i-Pr, t-Bu
The first success for this methodology came when employing the extremely hindered
dialkyl biarylmonophosphine ligand, Me4t-BuXPhos (Table 2). With a catalyst derived from this
ligand, unactivated aryl bromides and chlorides could be coupled with benzimidazoles (2a-c), as
well as unactivated aryl bromides with imidazole (2d). The catalyst system was not very tolerant
of steric hindrance, as neither 2-methyl imidazole nor 2-chlorotoluene were not efficiently
coupled with simple partners.
Table 2. Pd-Catalyzed N-Arylation of Imidazoles Using Me4t-BuXPhosa
Me
Me Me
N X 2.5% Pd2dba, 10% Me4t-BuXPhos " N Me Pt-Bu2




II \> I\•> I \--Me I \>
NNN NM Me
Me MMe
2a 91% 2b 95% 2c 95% 2d 70% < 15% <10%(X = Br) (X = Br) (X = CI) (X = Br, Me2 NPh) Conversion Conversion
a General Reaction Conditions: 1.2 mmol (benz)imidazole, 1.0 mmol ArX, 0.025 mmol Pd2dba 3,
0.10 mmol Me4t-BuXPhos, 2.0 mmol K3PO4, 1.0 mL toluene under Ar atmosphere at 100 "C for
24 h.
The fact that only Me 4t-BuXPhos serves as an appropriate ligand for this transformation
is intriguing. For Me4t-BuXPhos, the methyl substituent ortho to the phosphorous atom on the
biaryl ring resides directly between the t-butyl groups on the phosphine. This simple methyl
group impedes the rotation about the P-Cal bond, and thus controls the geometry around the
metal center and the coordination of the nucleophile to Pd.'9 For the Pd-catalyzed reaction of
imidazole with aryl halides, this phenomenon might have significant implications regarding the
formation of the presumed complex C (Scheme 2). For dialkyl biarylmonophosphine ligands that
lack the methyl-substituted top ring (R = H), transmetallation generally occurs after rotation
around the P-Caryl bond places Pd distil to the lower ring of the biaryl system (D-)E).20 This, in
turn, opens up a free binding site on Pd for a second equivalent of imidazole to coordinate to and
form inactive 16 e- complex C. When employing Me4t-BuXPhos as a ligand (R = Me), the metal
is locked directly above the lower biaryl ring, which impedes the transmetallation of a second
equivalent of imidazole due to the steric bulk about Pd (G-H). This should inhibit the
formation of inactive complex C. Thus, from the L1Pd(Ar)(Im) intermediate C, reductive
elimination should be the lowest energy pathway (H-I).
Scheme 2. Proposed Significance of Methylated Upper
For t-BuXPhos Ar Im
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Due to the poor generality of this catalyst system, we sought to develop a more efficient
Cu-based catalyst system for the reactions of imidazoles with aryl halides.
122 Copper Catalysis
1.2.2.1 Method Development and Mechanistic Considerations. Our initial investigations
involving the coupling of 2-iodotoluene with imidazole demonstrated that 4,7-dimethoxy-1,10-
phenanthroline (L1c, Scheme 3)21 in combination with (CuOTf)2"PhH and Cs2CO3 in CH3CN
provided an improved catalyst system for this transformation relative to those previously
reported. Compared to that derived from Lla, the enhanced reactivity of the catalyst system
based on Cu(I)-Llc can be attributed to the increased sigma-donating ability of the ligand, as
evidenced by the difference in acidities of the corresponding conjugate acids of the free
phenanthrolines (pka Lla-H' = 4.86, pka Llc-H÷ = 6.45).22 The more electron-rich ligand should
further stabilize a higher oxidation state intermediate (Scheme 3, III-)I) and lower the oxidation
potential for the Cu(I)-Cu(II) or Cu(I)-Cu(III) redox pairs, thus accelerating rate limiting aryl
halide activation process.23

















Recent reports have also demonstrated that increasing the solubility of the base can
accelerate metal-catalyzed amination reactions of aryl halides. Specifically,
cetyltrimethylammonium bromide has been used as a phase transfer catalyst (PTC) in Pd-
catalyzed amination reactions24 and as tetraethylammonium carbonate (TEAC) has been used as
a base in the Cu-catalyzed amination reactions"' of aryl halides. Therefore, we attempted to
employ tetraalkylammonium salts in our own system to increase the solubility of the base. While
the use of these reagents did provide increased reaction rates, product yields were low due to
alkylation of the starting material and products. Further, TEAC decomposed under the reaction
MeO
conditions to give NEt3 and CO2, which were detected by GCMS and by bubbling the gas
produced through IM HCl, respectively. The problems associated with TEAC could be
alleviated while maintaining faster reaction rates by employing non-tetraalkylammonium solid-
liquid phase transfer catalysts in combination with Cs2CO3.25 The key choice of poly(ethylene
glycol) (PEG) as an additive allowed for the use of inexpensive and stable copper salts (e.g.,
Cu20, CuI) as precatalysts, as opposed to air- and moisture-sensitive copper complexes, such as
[CuOTf]2"PhH.26
The use of PEG as a solid-liquid phase transfer catalyst increased the solubility of the
carbonate in organic media, increasing the rate of reaction by 10-30%.27 Without added PEG, the
observed reactivity of our system in nitrile solvents decreased in the order MeCN > EtCN > n-
PrCN at 110 °C-opposite the trend of their boiling points in the same series-suggesting that the
relative insolubility of the Cs2CO3 , or a polar Cu-complex (Scheme 3), in less polar solvents
retards the reaction. Reactions carried out in these three solvents in the presence of PEG proceed
at comparable rates at 110 OC.2 However, using PEG as a solvent was less effective, possibly
due to poor mass transport in the highly viscous solvent. While most of the chemistry described
herein generally uses either n-PrCN or NMP, it is also important to note that reactions using the
PEG/Cs2CO3 combination also show rate enhancements in solvents such as MeCN, EtCN, DMF,
DMA and DMSO; however, reactions ducted in these other solvents tend to be slower than those
conducted in butyronitrile or NMP. In addition, this imidazole N-arylation process is moderately
tolerant of water, as evidenced by the fact that our typical procedure involved weighing out a
hygroscopic base (Cs 2CO3) in the air with no protection from ambient moisture. Moreover, by
using 2.5-10% Cu20 as the precatalyst, water is necessarily produced.29
1.2.2.2 Substrate Scope. Using the catalyst system based on Lic, we explored the scope
of the reaction with unhindered aryl iodides (Table 3). Using a catalyst loading of only 0.05% Cu
we were able to N-arylate imidazole with iodobenzene in 48h at 110 OC (3a). To the best of our
knowledge, no Cu-based system for C-N bond formation has previously been reported to achieve
as many as 2000 turnovers. The reactions of aryl iodides possessing ester and nitrile groups were
inefficient under the standard conditions, due to the partial hydrolysis of the ester to benzoic
acid, and of the nitrile to benzamide. However, by lowering the reaction temperatures to 80-90
'C, excellent yields of the N-arylated products could be obtained (3b, 3d). Aryl iodides were
selectively coupled in the presence of substrates containing aryl bromides, chlorides and
fluorides (3e, 3j and 3k). Electron-rich, -neutral, and -deficient aryl iodides all provided products
in good to excellent yields. The coupling of hindered substrate combinations could also be
accomplished using this catalyst system; 2-alkyl and 2-aryl imidazoles (3j-1) and ortho-
substituted aryl iodides (3f-i) were effectively converted to product. The coupling of more
hindered substrate combinations (31-m) could be accomplished at higher reaction temperatures
(150 °C). When reacting imidazole with mesityl iodide, mesitylene from the reduction of the aryl
iodide was the major side-product.
Table 3. Coupling of Imidazoles with Aryl lodidesa
R1  1 R2 2.5% Cu20, 7.5% Lic R2
N,,NH Cs2CO, PEG, n-PrCN, 110 "CON
N VN HON N/N02
NCN N NCO2Et NN Br NN
3a, 95,
b 92 c 3b, 95d 3c, 92
e  3d, 87' 3e, 8 2g 3f, 94
i-Pr Ph Me Me/ _y=N•, N F .-"\
N-NA 
Ny NoN
NNO NN NN Me NPh _F N I N N I  Me
CI Me Me/
3g, 94 3h, 82h  3i, 93i  3j, 84 3k, 85 31, 86i 3m, 44k
a General Reaction Conditions: 1.2 mmol Imidazole, 1.0 mmol ArX, 0.025 mmol Cu2O, 0.075
mmol Llc, 1.4 mmol Cs2CO3, 200 mg PEG, 0.25-1.0 mL n-PrCN under Ar or N2 atmosphere at
110 "C for 24-48 h. b 12 mmol Imidazole, 10 mmol Arl, 14 mmol Cs2CO3, 0.0025 mmol Cu2O,
0.0075 mmol Liec, 2.0 g PEG, 2.5 mL n-PrCN. c Reaction run in NMP for 3 h. d Reaction run at
80 *C in MeCN. e Reaction run at 90 *C.I Reaction run at 80 *C in MeCN with 3 A mol. sieves. g
1.2 mmol Arl, 1.0 mmol Imidazole. 6 : 1 ratio of iodo- : bromo-substituted arene. h 0.05 mmol
Cu20, 0.15 mmol Lic, 120 "C. ' Reaction run in NMP with no PEG. j Reaction run in NMP at
150 "C. k Reaction run in DMSO at 150 *C.
Aryl bromides were also successfully coupled under our reaction conditions (Table 4).
However, higher quantities of catalyst and longer reaction times were often necessary to provide
good yields of product. The combination of 2-substituted imidazoles with aryl bromides
provided N-arylated products in good yields (4d-e). Additionally, the coupling of imidazole and
2-bromotoluene can be successfully accomplished (4f). Further, imidazole can be selectively
arylated in the presence of a free -OH or -NH 2 group (4b-c). This selectivity is particularly
interesting, as 1,10-phenanthroline derivatives have also been reported as ligands in the Cu-
catalyzed syntheses of aryl ethers and aryl amines from aryl halides.30
Table 4. Couplings of Imidazoles with Aryl Bromidesa
R Br 2  5% Cu20, 15% LIc /-h R
2
N/NH r~ Cs2CO3, PEG, n-PrCN
110 °C, 12-48 h
\ 1 \ -\ NH2
t-Bu NOH Ph
5a, 93 5b, 84 5c, 92 5d, 81b
SMe /
NMe t-Bu NN"N NN N•,NNMe
5e, 95 5f, 85C 5g, 90 5h, 97
c.d
a Reaction Conditions: 1.2 mmol imidazole, 1.0 mmol ArX, 0.05 mmol Cu20, 0.15 mmol
L1c, 1.4 mmol Cs2CO3, 200 mg PEG, 0.25-1.0 mL n-PrCN under Ar at 110 "C for 24-48 hr. b
0.10 mmol Cu20, 0.30 mmol Lic at 120 "C. c Reaction run in NMP. d 1.0 eq. ArBr and 2.4 eq.
imidazole with 2.8 eq. Cs2CO3.
For many of the reactions described, butyronitrile was employed as a solvent, since it is
relatively volatile, non-polar and easy to remove from products compared to the higher boiling
point solvents such as DMF, DMSO and NMP. However, in some cases, the use of NMP as the
solvent provided faster reactions. For example, we found that we were able to arylate imidazole
with iodobenzene in excellent yields in 3 hours with 5% Cu in NMP (3a), while the same
reaction required 4 hours using n-PrCN. More difficult cases, such as reactions of hindered aryl
halides and 2-substituted imidazoles, also reacted more efficiently using NMP as the solvent (3i,
31, 4f, 4h and 6d). The rate enhancement using NMP will be revisited in Figures 5-8.
Despite the many reports of Cu-catalyzed methods for the N-arylation of heterocycles
with aryl iodides and aryl bromides,1 6 the inability of Cu(I) to activate the aryl chlorides has
traditionally been a major limitation.4 Since the Cu-catalyzed coupling of N-H-containing
heterocycles with activated aryl chlorides has been described,31 it seemed natural to extend the
scope of this reaction to unactivated aryl chlorides. Although 4-chlorotoluene was an unreactive
substrate when employing the general conditions described with aryl bromides and iodides, Cu20O
in combination with 4,7-dihydroxy-1,10-phenanthroline (Lib) and LIc catalyzed the amination
in good yield at 150 "C using a two-fold excess of aryl chloride (Table 5). Due to the high
temperatures, O-arylation from residual water in the base was a competing process. Therefore, it
was crucial to use anhydrous Cs2CO3, and minimize the exposure time of the base to moisture in
the air. As previously observed with iodides and bromides, reactions of hindered substrates were
significantly slower. Still, due to the commercial availability and relatively low cost compared to
iodides and bromides, the use of aryl chlorides in Cu-catalyzed cross-coupling reactions of aryl
halides remains a worthy goal.
Table 5. Coupling of Imidazoles with Aryl Chloridesa
CI N 5% Cu20, 15% Ligand
NFN\H up N -NMe CS2C03, NMP, 150 C, 24 h Me
2.0 equiv
Entry Ligand Equiv ArCI Consumed GC Yield (%)
1 _b 0.02 0
2 0.34 11
3 Llc 0.72 60
4 L1b 1.36 86
5 Llbc 1.10 87
6 Llcd 1.49 78
Me
NMe n- Bu
22 % GC Yielda  15 % GC Yielda
a Reaction Conditions: 1.0 mmol Imidazole, 2.0 mmol ArX, 0.05 mmol Cu20, 0.15 mmol L, 2.0
mmol Cs2CO3, 0.25 ml NMP under Ar at 150 "C for 24 h. b No Cu. c Run with K2CO 3 as base. d
Reaction run in microwave (250 W) with Powermax function for 2 h at 150 OC.
The reactions of 4(5)-substituted imidazoles with aryl halides showed varying degrees of
regioselectivity, with the preferential formation of 4-substituted imidazoles (Table 6).32 With 4-
phenyl imidazole, the 1,4-diarylimidazole was the exclusive product observed (6a). Reactions of
4-methyl imidazoles with aryl bromides lacking an ortho-substituent showed similar selectivity
for formation of 1-aryl-4-alkyl imidazoles similar to that previously observed (6b-c). 14 As in the
study conducted by Collman on the coupling of 4-substituted imidazoles with aryl boronic
acids,32 the preferential selectivity for the 4-regioisomer over the 5-regioisomer is likely due to
the greater steric interactions when substituent R' resides at the 5-position compared to the 4-
position either prior to aryl halide activation (Scheme 4, V-VI) or upon activation of the aryl
halide (VII-VIII). In contrast, reactions of 4(5)-methylimidazole with ortho-substituted aryl
halides provided the 4-regioisomer with significantly better selectivity (6d-f). This increase in
regioselectivity when using a hindered aryl halide likely arises due to the additional unfavorable
steric interaction between the group ortho to the halide (R2) and R' when R' is situated in the 5-
position (IX) as opposed to the 4-position (X). The reaction of 4-bromo-2-methylimidazole with
4-iodoanisole provided 4-bromo-l-(4-methoxyphenyl)-2-methyl-1H-imidazole as the major
product (6g). Formation of the 5-bromo-1-(4-methoxyphenyl)-2-methyl-isomer was not detected
by GC or 'H NMR techniques. In this case, the selectivity is likely dictated by the increased
steric effects that exist on a high-oxidation state intermediate when the large bromide-substituent
resides at the 5-position (XI) relative to the 4-position (XII).
Table 6. Coupling of 4(5)-Substituted Imidazolesa' b
R Br R2  2.5-5 CU20, 7.5-15% L1c R2
R•-_ R 2 
R 2
N ,NH N Cs2CO3, PEG, n-PrCN, 110 'C N N
4-R' 5-R'
Ph Me Me Me
N9N0 SSMe NN SMe N"pN-8 F N N
i-Pr
6a, 96 (99 :1)b 6b, 97 (4.4 : 1)b 6c, 93 (5.1: 1)b 6d, 82 (44 : 1)c,d
Me Me Br
N ,N.N NN eN , N.N
Me CIe
6e, 91 (16: 1)c 6f, 96 (15 : 1)c 6g, 76 e
a 4-R' : 5-R' Selectivity is reported in parentheses and was determined by GC analyses of the
crude reaction mixtures and/or 'H NMR spectra of the pure products. b Reaction Conditions for
ArBr: 1.2 mmol imidazole, 1.0 mmol ArBr, 0.05 mmol Cu20O, 0.15 mmol L1ci, 1.4 mmol
Cs2CO3, 200 mg PEG, 0.25-1.0 mL n-PrCN under Ar atmosphere at 110 *C for 24-30 h. Isolated
yields reported. c Reaction Conditions for ArI: 1.2 mmol imidazole, 1.0 mmol ArI, 0.025 mmol
Cu20, 0.075 mmol L1ci, with ArI. d NMP used as solvent. GC yield reported. e 1.2 mmol Arl, 1.0
mmol Imidazole, No PEG, 0.05 mmol Cul, 0.075 mmol Llc in 0.5 mL MeCN. Only one
regioisomer was detected by GC and 1H NMR.
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Since N-heteroaryl imidazoles are interesting targets in drug discovery and medicinal
chemistry,33 the coupling of imidazoles with unactivated heteroaryl bromides and iodides was
examined (Table 7). An interesting result was observed in the reaction of imidazole with 2-
chloro-5-iodopyridine, a substrate activated at the 2-position for uncatalyzed SnAr. In this case,
the Cu-catalyzed substitution occurred predominantly at the iodide to provide 7a in good yield.
In the coupling of 5-iodoindole with imidazole (7b), the N-heteroaryl imidazole was isolated in
good yield, with trace amounts of N-aryl indole formed as a side product.34 This selectivity likely
arises from the more rapid transmetallation of imidazole with Cu(I) through the sp2-hybridized
lone pair electrons compared to the case of indole, where coordination of the p-hybridized lone
pair electrons results in a partial loss of aromaticity. Imidazoles were also successfully combined
with a variety of heteroaryl halides including 3-bromofuran (7c), 3-bromoisoquinoline (7d), 2-
iodothiophene (7e, 7g),35 and 3-bromobenzothiophene (7g).
Table 7. Couplings of Heteroaryl Halidesa
R
R 2.5-5% Cu20, 7.5-15% Llc R
F':J + Het-X N N, HetN NH Cs2CO 3, PEG, DMSO NpN.Het
110 'C, 24-48 h
NcN CN NH N"N - O  NN.N NN N PN N N
Me N -Me
7a, 76 (X = I)a 7b, 83 (X = I) 7c, 60 (X = Br)b 7d, 85 (X = Br)b 7e, 70 (X = I)a 7f, 79 (X = Br)b 7g, 83 (X = I)a
a Reaction Conditions (ArI): 1.0 mmol imidazole, 1.2 mmol Arl, 0.025 mmol Cu20, 0.075 mmol
Liec, 1.4 mmol Cs2CO3, 200 mg PEG, 0.5 mL DMSO under Ar at 110 "C for 12-24 h. b Reaction
Conditions (ArBr): 1.0 mmol imidazole, 1.2 mmol ArBr, 0.05 mmol Cu20O, 0.15 mmol LIc, 1.4
mmol Cs2CO3, 200 mg PEG, 0.5 mL DMSO under Ar at 110 *C for 24-48 h. c 1.2 mmol
imidazole, 1.0 mmol Arl, 0.025 mmol Cu20, 0.075 mmol Lci, 1.4 mmol Cs 2CO3, 0.5 mL n-
PrCN under Ar at 110 *C for 16 h.
Generally, isolated yields for reactions of imidazoles with heteroaryl iodides and
bromides were slightly lower than those with simple aryl halides due to formation of the reduced
heteroarene as a byproduct.36 The use of DMSO as a solvent caused an increase in the yield of
the desired product and decreased the quantity of the dehalogenated by-product. Although the
Cu(I)-catalyzed reduction of aryl halides has been reported,37 the lack of an obvious hydride
source suggests an alternative pathway for the formation of the reduced arene. Since alkali
metals have long been known to reduce aryl halides by a radical anionic mechanism,"3 it is
plausible that a similar sequence involving the Cu(I)-Cu(II) redox pair might occur (Scheme 5).
Single electron transfer (SET) from Cu(I) to the aryl halide, would generate the radical anion,
which could homolytically cleave to generate an aryl radical and halogen anion. Abstraction of
H- from the solvent39 would then produce the dehalogenated arene. The observation that more
reduction is detected with N-containing heteroaryl halides than with aryl halides is consistent
with previous reports that SET to halo pyridines is faster than to halobenzenes due to the
electron-accepting nature of the imine-like C-N bond." Further, our observation that formation
of the reduced arene can be suppressed by using DMSO as a solvent in place of n-PrCN agrees
with the relative rates of radical anionic aryl halide cleavage in acetonitrile and DMSO.4 1
However, the mechanism of the reduction, like the mechanism for the amination itself has yet to
be properly elucidated.
Scheme 5. Possible Reduction Pathway in Cu-Catalyzed Amination Reactions
Cu' Cull X SH S.
ArX [ArX Ar * ArH
The use of DMSO and Lic also permits the successful coupling of benzimidazoles to
unactivated aryl bromides (Table 8), which until recently'"' had been limited to aryl iodides, and
unhindered aryl bromides using Cu-catalyzed methodology.14' 15g,' 6 As seen previously, substrates
containing a free anilino-NH2 groups (8e) were good substrates under our conditions. Ortho-
substituted aryl bromides, as well as 2-substituted benzimidazoles were successfully used as
partners (8a, 8c, 8e-f). In some cases, the use of 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene
(MTBD) as base provided better yields than the Cs2CO3/PEG combination (8a, 8c).42
Table 8. Coupling of Benzimidazoles with Aryl Bromidesa
Br 2  5-10% Cu20, 7.5-20-/% L1C R2
N NH + Cs2CO3/PEG or MTBD N N
R1  DMSO, 110-130 "C, 6-24 h R
NNN NyN--F1 .8V N-NýV N V
NNNF Nt-Bu t-BuMe e Bu N•-, H2N Me
8a, 8 2 b,c 8b, 81 8c, 8 2b,c 8d, 98 8e, 71 8f, 7 8 c,d
" General Reaction Conditions: 1.2 mmol benzimidazole, 1.0 mmol ArBr, 0.10 mmol Cu2O, 0.20
mmol Lci, 1.4 mmol Cs2CO3, 200 mg PEG, 0.5 mL DMSO under Ar or N2 atmosphere at 110
"C for 24 h. b MTBD used as base. c Reaction run at 130 "C for 24 h. d 0.05 mmol Cu20, 0.15
mmol LIc.
1.2.2.3 Evaluation of the Ligands Commonly Employed for the N-Arylation of Imidazoles.
After most of our work for on this topic was finished, several catalyst systems were reported for
the N-arylation of imidazoles and benzimidazoles (Figure 1)."'16 To evaluate our new catalyst
system in light of those previously published, we decided to undertake a study in order to
compare our system with those that had been previously reported for this coupling in addition to
other 1,10-phenanthroline derivatives (Figures 4-7). While ligands Lla, Lib, Lci, L2-L6 and
L10 are commercially available, L7-9 are only accessible through multiple step sequences.
Furthermore, the harsh conditions necessary for the use of L9-10 (145-160 "C) suggest that at the
time of the report these ligands were useful only in specific circumstances. For this reason, we
focused the following study on L1-L6. L11 was also examined to assess the significance of
44
ligand rigidity for this transformation. Importantly, no reaction was observed for control
reactions in which no ligand or PEG was added.
Figure 4. Reaction of Imidazole with 4-t-Butylbromobenzene
5% Cu20, 20% L
CS2CO3, PEG, n-PrCN
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Figure 5. Reaction of 2-Methylimidazole with 4-n-Butyliodobenzene
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Figure 7. Reaction of 4-Methylimidazole with 2-Isopropyliodobenzene
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Case 1-Non-hindered aryl bromide: To examine a process in which steric hindrance was
not a significant factor, the reaction of 4-t-butylbromobenzene with imidazole was conducted
(Figure 4). Of the catalysts examined, only systems derived from the 4,7-disubstituted- 1,10-
phenanthrolines and L6 (with PEG/Cs2CO3 instead of TEAC) provided reasonable results (>
60% GC yield). Of these, the use of Llc provided nearly quantitative yield of N-aryl product,
followed by Lie, and Lib (86% and 76% GC yields, respectively).
Case 2-Aryl iodide, 2-substituted imidazole: The efficient N-arylation of 2-substituted
imidazoles had not been achieved prior to our earlier communication.17 '43 The reaction of 4-n-
butyliodobenzene with 2-methylimidazole was chosen to probe the sensitivity of each catalytic
system to substitution on the nucleophile (Figure 5). Only catalyst systems based on 4,7-
disubstituted-l1,10-phenanthrolines (Llb-e), L6 and L11 were effective for this transformation.
Of those mentioned, Lib, Liec, and L6b provided slightly better yields (> 95% GC yield) of
product than did Lie (86-88% GC yield). All other ligands were ineffective for this
transformation within a reasonable time period (< 20% GC yield).
Case 3-Hindered aryl bromide with imidazole: The very few examples of Cu-catalyzed
reactions of ortho-substituted aryl bromides with imidazole require high temperatures and/or
long reaction times.16bf. We, therefore, chose to examine the reaction of 2-bromotoluene with
imidazole (Figure 6). The majority of the ligands screened provided similarly efficacious
catalysts (40-60% GC yield). The use of Lie provided a slightly higher yield of product (66%).
Only the use of dimethoxy Lic and L6 as ligands provided synthetically useful yields (83-85 %
GC yield respectively) using PEG/Cs2CO3. However, using L6 and TEAC as the base, 15% of
the aryl bromide was lost.
Case 4-Hindered aryl iodide with 4(5)-substituted imidazole: To explore the effect of the
ligand employed on the regioselectivity of the coupling process, 4-methylimidazole was
combined with 2-isopropyliodobenzene (Figure 7). Systems based on most ligands provided low
catalytic activity (< 40% GC yield) and moderate selectivity in favor of the 4-regioisomer.
Reactions utilizing Llb and Lie provided reasonable reaction efficiencies (51 - 62% GC yield)
with excellent selectivity for the 4-alkyl imidazole (30 - 42 : 1). Once again, the use of Lic
provided the best result, giving an 82% GC yield with a selectivity of 37 : 1 in favor of the 4-
methyl regioisomer.
Summary of Ligand Comparisons Screens: In general, Lic outperformed other 1,10-
phenanthroline ligands lacking heteroatoms in the 4- and 7-positions (LMa and Llf). The catalyst
derived from anionic 4,7-dihydroxy derivative Lib showed higher reactivity than unsubstituted
Lia, but was generally less active than that with Lic. This may be due to the relative insolubility
of Llb in the solvents employed. Interestingly, Lic outperformed 4,7-dibutoxy-1,10-
phenanthroline (Lld)," which we had postulated might be a better ligand due to its increased
solubility. Reactions using chlorinated Lie as a ligand demonstrated good conversion to product,
which we found surprising considering the electron-deficient nature of the ligand compared to
the methoxy counterpart. However using Lie, re-isolation of the ligand at the end of the reaction
showed that the chlorides had been displaced at the 4- and 7-positions by a mixture of both the
residual water and imidazole. Thus, using the Cu/Lle combination, it is unclear as to the nature
of the actual ligand in the active catalyst. The increased efficiency of catalysts based on LIc
relative to L11, demonstrated the significance of the rigid phenanthroline backbone over the
2,2'-bipyridine structure, which contains conformational freedom about the biaryl bond. While
catalysts using ligands L3-L5 demonstrated sluggish reactivity with more challenging
imidazole/aryl halide substrate combinations under the reported conditions, 16 a-d their use with the
PEG/Cs2CO3 conditions described here provided higher conversions and yields. The effect of
PEG can be further seen as the Cu20/PEG combination, L2, (without a N-containing ligand)
which provided similar reactivity as when unsubstituted 1,10-phenantholine (Lla) was used as
the ligand. The use of L6 as ligand for these reactions provided high reactivity; however, the use
of TEAC as a base provided low yields as previously mentioned in this text. Using L6, the use of
PEG/Cs2CO3 instead of TEAC as the base provided higher yields of N-aryl imidazoles due to the
suppression of three side reactions: 1) reduction of the aryl halide, 2) O-arylation of the ligand,
3) N-alkylation of imidazole by the tetraalkylammonium cation. Due to their low cost, many of
these systems might still be attractive for the coupling of more facile substrate combinations;
however, there are significant limitations to the scope of imidazoles and aryl halides that can be
effectively coupled by these systems compared with Lic.
1.3 Conclusion
We have developed the first Pd-based catalyst system for the N-arylation of imidazoles
and benzimidazoles using unactivated aryl halides. Due to the poor substrate scope of this
catalyst system, a superior Cu-based catalyst system was developed. 4,7-Dimethoxy-1,10-
phenanthroline was revealed as an excellent ligand for the Cu-catalyzed arylation of imidazoles
and benzimidazoles with aryl and heteroaryl iodides and bromides in combination with PEG and
Cs 2CO3 . Not only is this system the most general reported to date, it also allows for the cross-
coupling of hindered substrate combinations. The mild conditions employed also manifest a high
functional group tolerance.
1.4 Experimental Procedures
All reactions were carried out in resealable test tubes with teflon septa and run under a
dry argon or nitrogen atmosphere. Copper (I) oxide (97%) was purchased from Aldrich as a red
powder. Pd2dba3 was obtained from Strem, Inc. and stored in a vacuum desiccator filled with
anhydrous calcium sulfate. Anhydrous Cs2CO3 (99.9%) was purchased from Alfa Aesar. K3PO4
(finely milled) was purchased from Fluka. The bulk of the bases were stored under nitrogen in a
Vacuum Atmospheres glovebox. Small portions (-5 g) were removed from the glovebox in glass
vials, stored in the air in a desiccator filled with anhydrous calcium sulfate, and weighed in the
air. Poly(ethylene glycol) (Mn 3,400) was purchased from Aldrich. Generally, aryl halides and
imidazoles were purchased from commercial sources and used without further purification.
When necessary, aryl halides were filtered through neutral alumina, or distilled. Butyronitrile (_
99%) was purchased from Aldrich and used without further purification. Anhydrous solvents
(NMP, DMSO, and Acetonitrile) were purchased from Aldrich in Sure-Seal ® bottles. Flash
column chromatography was performed with EM Science silica gel 60 (230-400 mesh). In all
cases, dichloromethane was used to load the crude reaction material onto a silica gel column. A
gradient elution technique was used for column chromatography, beginning with hexane and
continuing to the specified concentration of ethyl acetate in hexane.
Yields reported in the publication are isolated (except where noted) and represent an
average of at least two independent runs. Yields reported in the supporting information refer to a
single experiment. Compounds described in the literature were characterized by comparing their
'H NMR, and melting point (m.p.) to the previously reported data; their purity was confirmed by
gas chromatographic analyses (GC). For known compounds prepared using the new method
(conditions) described, a copy of the 'H NMR spectrum, of each, is included. GC analyses were
performed on a Hewlett Packard 6890 instrument with an FID detector and a Hewlett Packard 10
m x 0.2 mm i.d. HP-1 capillary column using dodecane as an internal standard. Previously
unknown compounds were synthesized, purified and analyzed from a single run and were then
repeated to determine an average yield. They were characterized by 'H NMR, 3C NMR, m.p., IR
and elemental analysis. Elemental analyses were performed by Atlantic Microlabs, Inc.,
Norcross, GA. For those compounds that did not give a satisfactory elemental analysis, a copy of
their 'H NMR spectrum is included. 'H NMR and '3C NMR were recorded on Varian 300 MHz
and 500 MHz instruments with chemical shifts reported relative to the deuterated solvent or
TMS. IR spectra were recorded on a Perkin-Elmer System 2000 FT-IR instrument for all
previously unknown compounds (KBr disc). Melting points (uncorrected) were obtained on a
Mel-Temp II capillary melting point apparatus.
Synthesis of Ligands
Lla, Llf, L3, L4, L5, L7 and L8 were purchased from commercial sources. L3 was
purified by recrystallization from hexane. Lld45 and complex L64 were prepared according to
literature precedent. The synthesis of Llb, Llc and Lle was adapted from literature precedent.47
A larger scale preparation of Llb, Llc and Lle can be preformed as described in the following







MeOH, 65'C, 24 hN 74 % Over 2 Steps
Lic L1e
1,2-Bis-[(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidenemethyl)amino]benzene (1). An oven-
dried 2 L 2-neck flask equipped with a mechanical stirrer was charged with trimethyl
orthoformate (850 mL, 7.8 mol) and Meldrum's acid (101 g, 0.700 mmol). The flask was fitted
with a reflux condenser; the contents were flushed with N2 and brought to a gentle reflux for 2 h.
The resulting red solution was cooled (~ 80 'C) and phenylene diamine (32.4 g, 300 mmol) was
added portionwise (exothermic reaction) resulting in the formation of a yellow solid. The
mixture was heated to reflux, stirred vigorously for an additional hour and then cooled to room
temperature. The resulting solid was filtered, washed with cold acetone (slightly soluble) and
dried to afforded 95 g (77%) of product as a flaky light-yellow solid. 'H NMR (CDCl3 , 400
MHz) 8 11.34 (br d, 2H), 8.50 (d, 2H), 7.41 (m, 4H), 1.74 (s, 12H). m.p. 208-210 °C, decomp.
(Lit. 209, decomp.).47a
4,7-Dihydroxy-1,10-phenanthroline (LMb). A 5 L 3-neck flask equipped with a mechanical
stirrer and a large air-cooled reflux condenser was charged with 3 L of diphenyl ether and was
heated to 240 *C using a heating mantle. Precursor 1 was added in small portions resulting in
vigorous gas evolution. When the addition was complete, the mixture was brought to reflux (260
aC) for 30 min. The mixture was allowed to cool to 80 *C, and the precipitate was isolated by
vacuum filtration and washed with acetone until the filtrate was colorless. The product was
further washed with excess hexane and diethyl ether. Drying by vacuum filtration, then under hi-
vac at 60 *C, afforded 41.5 g (86%) of a fine dark-brown powder. Although the title compound
was essentially insoluble in common NMR solvents, a spectrum could be obtained using NaOH
in D20. 1H NMR (D20, NaOH, 400 MHz) 8 8.17 (d, 2H, J = 5.6 Hz), 7.75 (s, 2H), 6.43 (d, 2H J
= 5.6 Hz). Anal Calc. for C12H8N2: C 67.92, H 3.80. Found: C 67.60, H 3.59. m.p. stable up to
250 oC (Lit. 471-474, decomp.).4
4,7-Dichloro-1,10-phenanthroline (Lie). A 1 L 2-neck round bottom flask equipped with a stir
bar, reflux condenser, and distillation apparatus was flame-dried and allowed to cool under an
atmosphere of N2. Phosphorous oxychloride (400 mL) and Lib (20.0 g, 94.3 mmol) were added
to the flask under a N2 purge. The apparatus was immersed in an oil bath and heated at reflux for
2 h (the condenser for the distillation apparatus was not filled with water at this time). After this
period, the circulation of water for the distillation apparatus was turned on and roughly half of
the excess phosphorous oxychloride was removed by gentle vacuum distillation. The solution
was cooled to room temperature and crushed ice was slowly added to the reaction mixture (very
exothermic!) while keeping the temperature below 30 *C with an ice bath. When HCI gas
evolution ceased, the acidic solution was stirred for one hour at room temperature to dissolve the
black solids that formed. The resulting dark cloudy solution was filtered through activated
charcoal (Darco®) to give a translucent-beige solution, which was brought to pH 13 by the slow
addition of 20% KOH solution while maintaining the temperature below 25 oC. The white
precipitate that formed was collected by suction filtration, washed with excess H20, and dried
under vacuum overnight at 60 oC affording Lle as a white solid. The product was used in the
subsequent step without further purification. 'H NMR (DMSO, 400 MHz) 6 9.09 (d, 2H, J = 4.8
Hz), 8.41 (s, 2H), 8.08 (d, 2H, J = 4.8 Hz). m.p. 245-247 (Lit. 249-250).47c
4,7-Dimethoxy-1,10-phenanthroline (Lic). An oven-dried 3-neck round bottom flask was
cooled under a stream of nitrogen. Anhydrous methanol (1.2 L) was added, and purged with N2
for 10 min. Sodium metal (9.20 g, 400 mmol) was slowly added in small pieces while the
solution was stirred. A reflux condenser was attached, and Lie (all that was produced in the
previous step) was added. The flask was heated to reflux for 24 hours under an atmosphere of N2.
Concentration of the resulting solution to -30 mL and addition of cold water (250 mL) resulted
in the precipitation of a tan solid. The flask was stored overnight in a refrigerator to allow
complete precipitation of the solid. The product was collected by filtration, washed with excess
water, and dried under vacuum overnight at 60 oC affording 16.7 g (74% over 2 steps) of a tan
solid, which can be recrystallized from benzene. 'H NMR (CDCl3, 300 MHz) 6 8.93 (d, 2H, J =
5.3 Hz), 8.18 (s, 2H), 7.03 (d, 2H, J = 5.3 Hz), 4.09 (s, 6H). m.p. 210-212 (Lit. 209-210) 47e
General procedure for the Pd/Me4t-BuXPhos N-arylation of imidazoles and
benzimidazoles.
An oven-dried Schlenk tube was charged with a magnetic stir bar, Pd2dba3 (0.025 mmol, 5 % Pd),
Me4t-BuXPhos (0.10 mmol), imidazole/benzimidazole (1.2 mmol) and K3PO4 (2.0 mmol). The
tube was evacuated and backfilled with argon, and this sequence was two additional times. Aryl
halide (1.00 mmol) and solvent (1.0 mL) were then added successively. The reaction tube was
sealed, and stirred in a pre-heated oil bath for the designated time period. The reaction mixture was
cooled to room temperature, diluted with ethyl acetate (10 mL), and filtered through a plug of celite,
eluting with additional ethyl acetate (50 mL). The filtrate was concentrated and the resulting residue
was purified by flash chromatography (100 % CH2CI2  - hexanes : ethyl acetate 3 : 1 - 1 : 3) to
provide the desired product.
N~-
3-benzoimidazol-1-yl-quinoline (2b)
The general procedure was followed using Pd2dba3 (23 mg, 0.025 mmol), Me4t-BuXPhos (48 mg,
0.10 mmol), K3PO4 (0.42 g, 2.0 mmol), 3-bromoquinoline (136 [L, 1.0 mmol), and benzimidazole
(165 mg, 1.2 mmol) with toluene (1.0 mL) as solvent for 24 h at 100 *C. Chromatographic
purification provided the title compound (white crystals, 232 mg, 95 %). 1'H NMR (500 MHz,
CDCl3) 8 9.02-9.01 (d, 1H, J = 2.3 Hz), 8.20-8.11 (m, 3H), 7.90-7.81 (m, 2H), 7.77-7.71 (m, 1H),
7.63-7.57 (m, 1H), 7.51-7.45 (m, 1H), 7.35-7.27 (m, 2H). 13C NMR (126 MHz, CDC13) 8 147.2,
146.3, 144.0, 142.1, 133.6, 130.3, 129.7, 129.6, 129.5, 128.1, 127.8, 127.7, 124.2, 123.2, 120.8,
110.0. m.p. 139-141 °C. (Lit. 136-137). 49
Me
1-p-tolyl-1H-benzoimidazole (2c)
The general procedure was followed using Pd2dba3 (23 mg, 0.025 mmol), Me4t-BuXPhos (48 mg,
0.10 mmol), K3PO4 (0.42 g, 2.0 mmol), 4-chlorotoluene (120 RL, 1.0 mmol), and benzimidazole
(165 mg, 1.2 mmol) with toluene (1.0 mL) as solvent for 24 h at 100 *C. Chromatographic
purification provided the title compound (yellow oil, 197 mg, 95 %). 1'H NMR (500 MHz, CDCl3)
6 8.15-8.11 (m, 1H), 7.91-7.88 (m, 1H), 7.54-7.51 (m, 1H), 7.43-7.32 (m, 6H), 2.48 (s, 3H). 13C
NMR (126 MHz, CDCl3) 8 142.4, 138.1,130.6, 123.9, 123.6, 122.7, 120.5, 110.5, 21.2.-
Me
1-p-tolyl-1H-imidazole (2d)
The general procedure was followed using Pd2dba3 (23 mg, 0.025 mmol), Me 4t-BuXPhos (48 mg,
0.10 mmol), K3PO4 (0.42 g, 2.0 mmol), 4-bromotoluene (171 mg, 1.0 mmol), and imidazole (82
mg, 1.2 mmol) with N,N-dimethylaniline (1.0 mL) as solvent for 24 h at 100 *C. Chromatographic
purification provided the title compound (white crystals, 108 mg, 68 %). 'H NMR (500 MHz,
CDCl3) 8 7.80 (bs, 1H), 7.28-7.22 (m, 511H), 7.18 (bs, 1H), 2.40 (s, 3H). 13C NMR (126 MHz,
CDCl3) 8 137.5, 135.7, 130.5, 130.3, 121.5, 118.5, 21.1. m.p. 48-49 *C. (Lit. 49-50).5'
Procedure for screening of the coupling of aryl iodides with imidazoles (Figures 6 and 8)
To a screw-cap test tube, was added copper precatalyst (0.025 mmol), ligand (0.05 mmol, solid),
imidazole (0.6 mmol), poly(ethylene glycol) (100 mg), Cs2CO3 (0.7 mmol), and a magnetic stir
bar. The reaction vessel was fitted with a rubber septum. The vessel was evacuated and back-
filled with argon or nitrogen. This was repeated two additional times. Aryl iodide (0.5 mmol),
ligand (0.375 mmol, liquid) and solvent (0.25 mL) were added. The reaction tube was sealed and
the contents were stirred in a pre-heated oil bath at 110 OC for the designated time period. The
reaction mixture was cooled to room temperature, and 113 mL dodecane and dichloromethane (5
mL) were added. This mixture was stirred, then filtered through a small plug of celite into a vial
for GC analysis. The average of two experiments is reported.
2.5% Cu20, 10% L
N NH + n-Bu Cs2CO3, PEG, n-PrCN 
-n-BuMe 110 "C, 20 h Me


































































































i-Pr Me MeMe H 2.5% Cu20, 10% L r--
N NH CS2C0 3 , PEG, n-PrCN N +
110 "C, 22h i-Pr i-Pr
4-Me 5-Me
Copper GC Conv. GC Yield Ratio
Ligand Solvent Additive Temperature(oC) (4 Me 5Source (%) (%) Me)
Lla Cu20 PrCN PEG 110 32 31 11
Lib Cu20 PrCN PEG 110 56 51 42
Liec Cu20 PrCN PEG 110 68 61 41
Liec Cu20 PrCN - 110 64 53 30
Liec Cu20 NMP - 110 91 81 37
Lid Cu20 PrCN PEG 110 41 39 12
Lie Cu 20 PrCN PEG 110 43 37 11
Lie Cu20O NMP 110 77 62 32
Llf Cu2O PrCN PEG 110 39 35 19
L2 Cu20 PrCN PEG 110 31 30 15
L3a Cu20 CH3CN - 82 12 12 n. d.
L3b Cul PrCN PEG 110 34 29 8
















































Procedure for screening the coupling of aryl bromides with imidazoles (Figures 5 and 7)
To a screw-cap test tube, was added copper precatalyst (0.05 mmol), ligand (0.01 mmol, solid),
imidazole (0.6 mmol), poly(ethylene glycol) (100 mg), Cs2CO3 (0.7 mmol), and a magnetic stir
bar. The reaction vessel was fitted with a rubber septum. The vessel was evacuated and back-
filled with argon or nitrogen. This procedure was repeated two times. Aryl bromide (0.5 mmol),
ligand (0.01 mmol, liquid) and solvent (0.25 mL) were then added successively. The reaction
tube was sealed and the contents were stirred in a pre-heated oil bath at 110 'C for the designated
time period. The reaction mixture was cooled to room temperature and 113 mL dodecane and
dichloromethane (5 mL) were added. This mixture was stirred, then filtered through a small plug
of celite into a vial for GC analysis. The average of two experiments is reported.
5% Cu20, 20% L
CS2CO 3, PEG, n-PrCN110 "C, 12h N / IN 't-Bu
Ligand Copper Source Solvent Additive Temperature GC Cony. (%) GC Yield (%)(oC) G y G
Lla Cu 20 PrCN PEG 110 30 28
Llb Cu 20 PrCN PEG 110 74 75
Lic Cu 20 PrCN PEG 110 97 97
Lic Cu2 0 PrCN - 110 68 67
Lic Cu 20 NMP 110 100 95
Lid Cu20 PrCN PEG 110 60 61
Lie Cu20 PrCN PEG 110 51 51
Lie Cu2 0 NMP 110 87 82
Llf Cu20 PrCN PEG 110 47 41
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iBr- 5% Cu2O, 20% L /--
NNNH + N, NM Cs 2CO, PEG, n-PrCN
110 -C, 24 h Me
TemperatureLigand Copper Source Solvent Additive Temperature GC Cony. (%) GC Yield (%)
_Lla Cu20 PrCN PEG 110 43 42
Lla Cu2 O PrCN PEG 110 43 42
Lib Cu20 PrCN PEG 110 42 40
Llcl Cu 20 PrCN PEG 110 76 78
Llc2 Cu 20 PrCN 110 56 53
L1c3 Cu2O NMP 110 89 83
Lld Cu20 PrCN PEG 110 52 50
LMel Cu20 PrCN PEG 110 49 47
L1e2 Cu20 NMP 110 71 66
Lif Cu20 PrCN PEG 110 42 41
L2 Cu20 PrCN PEG 110 43 41
L3a Cu20 CH3CN 82 16 14
L3b Cul PrCN PEG 110 51 52
L4a Cul DMSO 82 17 6
L4b Cul DMSO - 110 56 42
L5 Cul PrCN PEG 110 37 27
L6a Cul DMF/H20(10:1) - 110 93 61
L6b Cul PrCN PEG 110 100 85
L10 CuI PrCN PEG 110 48 47
General procedure for the N-arylation of imidazoles with aryl iodides
An oven-dried screw-cap test tube was charged with Cu2O (0.025 mmol), Lic (0.075 mmol),
imidazole (1.2 mmol), aryl iodide (1.00 mmol, if solid), poly(ethylene glycol) (200 mg), Cs2CO3
(1.4 mmol), and a magnetic stir bar. The reaction vessel was fitted with a rubber septum. The
CH3CNCu20
vessel was evacuated and back-filled with argon or nitrogen, and this sequence was repeated an
additional time. Aryl iodide (1.00 mmol, if liquid) and solvent (0.5 mL) were then added
successively. The reaction tube was sealed, and stirred in a pre-heated oil bath for the designated
time period. The reaction mixture was cooled to room temperature, diluted with dichloromethane
(10 mL), and filtered through a plug of celite, eluting with additional dichloromethane (50 mL).
The filtrate was concentrated and the resulting residue was purified by flash chromatography to
provide the desired product.
General procedure for the N-arylation of imidazoles with aryl bromides
An oven-dried screw-cap test tube was charged with Cu20 (0.05 mmol), Llc (0.15 mmol),
imidazole (1.2 mmol), aryl bromide (1.00 mmol, if solid), poly(ethylene glycol) (200 mg),
Cs2CO3 (1.4 mmol), and a magnetic stir bar. The reaction vessel was fitted with a rubber septum.
The vessel was evacuated and back-filled with argon or nitrogen, and this sequence was repeated
an additional time. Aryl bromide (1.00 mmol, if liquid), and solvent (0.5 mL) were then added
successively. The reaction tube was sealed, immersed, and stirred in a preheated oil bath for the
designated time period. The reaction mixture was cooled to room temperature, diluted with
dichloromethane (10 mL), filtered through a plug of celite, and eluted with additional
dichloromethane (50 mL). The filtrate was concentrated and the resulting residue was purified by
flash chromatography to provide the desired product.
Experimental procedures for all compounds contained in Table 1
1-phenyl-1H-imidazole (3a)
The general procedure was followed using Cu20 (3.6 mg, 0.025 mmol), Lci (18 mg, 0.075
mmol), PEG (200 mg), Cs 2CO 3 (0.45 g, 1.4 mmol), iodobenzene (112 tL, 1.00 mmol), and
imidazole (82 mg, 1.2 mmol), with NMP (0.5 mL) as solvent for 3 h at 110 OC. Chromatographic
purification (hexane / ethyl acetate 1 : 3) afforded 1-phenyl-1H-imidazole (slightly yellow oil,
131 mg, 92%). The low catalyst loading experiment was preformed using the general procedure
with Cu20 (0.4 mg, 0.0025 mmol), Lic (1.8 mg, 0.0075 mmol), PEG (2.0 g), Cs2CO 3 (4.50 g, 14
mmol), iodobenzene (1.12 mL, 10 mmol), and imidazole (820 mg, 12 mmol), in butyronitrile
(2.0 mL) as solvent for 48 h at 110 OC. Chromatographic purification (hexane / ethyl acetate 1 :
3) provided 1-phenyl-1H-imidazole (slightly yellow oil, 1.34 g, 93%). 'H NMR (300 MHz,
CDCI3) 67.82 (s, 1H), 7.47-7.41 (m, 2H), 7.36-7.29 (m, 3H), 7.25 (bs, 1H), 7.18 (bs, 1H). 52
f~ ---
CN
3-imidazol- I -yl-benzonitrile (3b)
The general procedure was followed using Cu20O (3.6 mg, 0.025 mmol), Llc (18 mg, 0.075
mmol), PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 3-iodobenzonitrile (229 mg, 1.00 mmol), and
imidazole (82 mg, 1.2 mmol), with butyronitrile (0.5 mL) as solvent for 24 h at 90 OC.
Chromatographic purification (hexane / ethyl acetate 1 : 3) 3-imidazol-1-yl-benzonitrile (white
needles, 158 mg, 94%). 'H NMR (500 MHz, CDC13) 6 7.89 (s, 1H), 7.71-7.60 (m, 4H), 7.30 (bs,
1H), 7.25 (bs, 1H). m.p. 151-154 °C (Lit. 156-157 oC). 53
r- NO 2SN \
1-(3-nitro-phenyl)-1H-imidazole (3c)
The general procedure was followed using Cu20 (3.6 mg, 0.025 mmol), Lci (18 mg, 0.075
mmol), PEG (200 mg), Cs2CO 3 (0.45 g, 1.4 mmol), 3-nitroiodobenzene (249 mg, 1.00 mmol),
and imidazole (83 mg, 1.2 mmol) with acetonitrile (0.5 mL) as solvent for 29 h at 80 *C.
Chromatographic purification (hexane / ethyl acetate 1 : 3) 1-(3-nitro-phenyl)-IH-imidazole
(white solid, 177 mg, 93%). ' H NMR (500 MHz, CDCl3) 8 8.25 (t, 1H, J = 1.9), 8.19 (ddd, 1H, J
= 1.1, 1.9, 7.9 Hz), 7.94 (s, 1H), 7.75 (ddd, 1H, J = 1.4, 2.2, 8.1 Hz), 7.69 (t, 1H, J = 8.0 Hz),
7.36 (s, 1H), 7.23 (s, 1H). 13C NMR (100 MHz, CDCI3) 8 149.1, 138.3, 125.5, 131.5, 131.2,
126.9, 122.1, 118.0, 116.2. m.p. 109-110 *C (Lit. 109-110 *C).54
N4ýýN " COEt
4-imidazol- 1 -yl-benzoic acid ethyl ester (3d)
The general procedure was followed using Cu2O (3.6 mg, 0.025 mmol), Lic (18 mg, 0.075
mmol), PEG (200 mg), Cs2 CO3 (0.45 g, 1.4 mmol), ethyl-4-iodobenzoate (168 [pL, 1.00 mmol),
and imidazole (82 mg, 1.2 mmol), 3 A molecular sieves (200 mg, powdered, flame activated)
with acetonitrile (0.5 mL) as solvent for 23 h at 80 *C. Chromatographic purification (hexane /
ethyl acetate 1 : 3) 4-imidazol-1-yl-benzoic acid ethyl ester (white crystals, 184 mg, 84%). 1H
NMR (500 MHz, CDCl3) 8 8.18 (td, 2H, J = 1.8, 8.5 Hz), 7.96 (s, 1H), 7.48 (td, 2H, J = 1.8, 8.8),
7.37 (s, 1H), 7.26 (s, 1H), 4.43 (q, 2H, J = 7.1 Hz), 1.44 (t, 3H, J = 7.0 Hz). m.p. 101-103 *C
(Lit. 100-102 °C).55
1-(4-bromo-phenyl)-1H-imidazole" (3e)
The general procedure was followed using Cu20 (3.6 mg, 0.025 mmol), Lie (18 mg, 0.075
mmol), PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 1-bromo-4-iodobenzene (340 mg, 1.20
mmol), and imidazole (68 mg, 1.0 mmol) with butyronitrile (0.5 mL) as solvent for 24 h at 90
OC. Chromatographic purification (hexane / ethyl acetate 1 : 1) provided 1-(4-bromo-phenyl)-1H-
imidazole (white crystals, 171 mg, 78%). 1H NMR (300 MHz, CDCl3) 6 7.83 (bs, 1H), 7.63 (m,
2H), 7.32-7.20 (m, 4H). m.p. 120-122 "C. GC/MS of the crude material showed an 6.1 : 1
mixture of 1-(4-bromo-phenyl)-1H-imidazole to 1-(4-iodo-phenyl)-1H-imidazole.
HO
(2-imidazol- 1-yl-phenyl)-methanol (3f)
The general procedure was followed using Cu2O (3.6 mg, 0.025 mmol), Llc (18 mg, 0.075
mmol), PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 2-iodobenzylalcohol (234 mg, 1.00 mmol),
and imidazole (82 mg, 1.2 mmol) with butyronitrile (0.3 mL) as solvent for 24 h at 110 *C.
Chromatographic purification (hexane / ethyl acetate 1 : 1) provided (2-imidazol-1-yl-phenyl)-
methanol (clear crystals, 165 mg, 95%). 'H NMR (300 MHz, CDCl3) 8 7.62 (dd, 2H, J = 1.7, 7.6
Hz), 7.45 (td, 1H, J = 1.4, 7.5 Hz ), 7.38 (td, 1H, J = 1.4, 7.4 Hz), 7.23 (dd, 1H, J = 1.1, 7.7 Hz),
7.13 (s, 1H), 7.08 (s, 1H), 4.90 (bs, 1H), 4.46 (s, 1H). m.p. 102-104 *C (Lit. 100.5-102.5 aC).57
i-Pr
1-(2-isopropyl-phenyl)-1H-imidazole (3g)
The general procedure was followed using Cu2O (3.6 mg, 0.025 mmol), Lci (18 mg, 0.075
mmol), PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 2-isopropyl iodobenzene (246 mg, 1.00
mmol), and imidazole (82 mg, 1.2 mmol) with butyronitrile (0.5 mL) as solvent for 48 h at 110
'C. Chromatographic purification (hexane / ethyl acetate 1 : 1) provided 1-(2-isopropyl-phenyl)-
1H-imidazole (white crystals, 171 mg, 92%). 'H NMR (300 MHz, CDCl3) 8 7.57 (bs, 1H), 7.46-
7.42 (m, 2H), 7.31-7.11 (m, 3H), 7.05 (m, bs), 2.74 (heptet, 1H, J = 6.9 Hz), 1.16 (d, 6H, J = 6.9
Hz). 13C NMR (100 MHz, CDCl3) 8 145.0, 135.1, 129.4, 129.2, 127.0, 126.7, 126.4, 121.1,27.4,




The general procedure was followed using Cu20 (7.2 mg, 0.05 mmol), LIe (36 mg, 0.15 mmol),
PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 2-iodobiphenyl (176 [L, 1.00 mmol), and imidazole
(82 mg, 1.2 mmol) with butyronitrile (0.6 mL) as solvent for 72 h at 120 *C. Chromatographic
purification (hexane / ethyl acetate 1 : 1) provided 1-biphenyl-2-yl-1H-imidazole (slightly yellow
crystals, 179 mg, 81%). 'H NMR (300 MHz, CDC13) 8 7.50-7.33 (m, 5H), 7.30-7.24 (m, 3H),
7.02 (bs, 1H), 6.82 (bs, 1H). 13C NMR (100 MHz, CDC13) 8 137.8, 137.5, 135.2, 131.5, 128.7,
128.7, 128.6, 128.3, 127.8, 126.3. Anal. Calc. for C,5H,2N2: C 81.79, H 5.49. Found: C 81.50, H
5.46. m.p. 93-95 *C.
1-naphthalen-1-yl- 1H-imidazole (3i)
The general procedure was followed using Cu20 (7.2 mg, 0.05 mmol), Liec (36 mg, 0.15 mmol),
PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 1-iodonaphthalene (146 [LL, 1.00 mmol), and
imidazole (82 mg, 1.2 mmol) with NMP (0.3 mL) as solvent for 24 h at 110 *C. The crude
reaction mixture was dissolved in 20 mL of water, and extracted with dichloromethane (5 x 30
mL). The combined organic layers were dried with MgSO 4, and the solvent was removed in
vacuo. Chromatographic purification (hexane / ethyl acetate 1 : 1) provided 1-naphthalen-1-yl-
1H-imidazole (yellow-white solid, 179 mg, 92%). 'H NMR (300 MHz, CDCI3) 8 7.94-7.92 (m,
2H), 7.76, (bs, 1H), 7.61-7.48 (m, 4 H), 7.43 (d, 1H, J = 7.0 Hz), 7.30 (bs, 1H), 7.25 (bs, 1H).





The general procedure was followed using Cu20O (7.2 mg, 0.05 mmol), Llc (36 mg, 0.15 mmol),
PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 1,3-dichloro-5-iodobenzene (273 mg, 1.00 mmol), 2-
methylimidazole (100 mg, 1.2 mmol) with butyronitrile (0.5 mL) as solvent for 24 h at 110 *C.
Chromatographic purification (hexane / ethyl acetate 1 : 3) provided 1-(3,5-dichloro-phenyl)-2-
methyl- 1H-imidazole (white needles, 194 mg, 86%). IH NMR (300 MHz, CDCI3) 8 7.44 (t, 1H, J
= 1.8), 7.23 (d, 2H, J = 1.9), 7.05 (d, 1H, J = 1.2), 6.99, (d, 1H, J = 1.2), 2.40 (s, 3H). 13C NMR
(100 MHz, CDC13) 8 139.8, 135.8, 128.5, 128.4, 124.1, 14.0. IR (KBr disc, cmnf) 1534, 1501,
1463, 1451, 1405, 1305, 1176, 1143, 1115, 1099, 985, 850, 781. Anal. Calc. for CloH8 N2CI2: C




The general procedure was followed using Cu20 (3.6 mg, 0.025 mmol), Llc (18 mg, 0.075
mmol), PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 4-fluoroiodobenzene (222 mg, 1.00 mmol),
2-phenylimidazole (173 mg, 1.2 mmol) with butyronitrile (0.3 mL) as solvent for 24 h at 110 *C.
Chromatographic purification (hexane / ethyl acetate 3 : .1) provided 1-(4-fluoro-phenyl)-2-
phenyl-1H-imidazole (white solid, 211 mg, 89%). 'H NMR (300 MHz, CDCl3) 6 7.36-7.30 (m,
2H), 7.24-7.16 (m, 4H), 7.15-7.09 (m, 2H), 7.06 (s, 1H), 7.03-6.96 (m, 2H). 13C NMR (100
MHz, CDCl3) 8 163.5, 160.2, 134.5, 129.0, 128.5, 128.4, 128.2, 127.6, 127.5, 116.5, 116.2. IR
(KBr disc, cm') 1509, 1501, 1466, 1414, 1303, 1285, 1233, 1212, 1151, 1128, 1091, 1068, 970,
915, 840, 775, 747, 715, 697. Anal. Calc. for C15H1-N 2F: C 75.62, H 4.65. Found: C 75.39, H




2-methyl- 1-o-tolyl- 1H-imidazole (31)
The general procedure was followed using Cul (19 mg, 0.10 mmol), Lie (36 mg, 0.15 mmol),
PEG (200 mg), Cs2CO 3 (0.45 g, 1.4 mmol), 2-iodotoluene (127 gLL, 1.00 mmol), and imidazole
(82 mg, 1.2 mmol) except NMP (0.5 mL) was used as solvent and the reaction was carried out
for 48 h at 140 *C. Chromatographic purification (hexane / ethyl acetate 1 : 3) afforded 2-
methyl-l-o-tolyl-IH-imidazole (yellow oil, 149 mg, 86%). 'H NMR (300 MHz, CDCI3) 8 7.34-
7.09 (m, 4H), 6.99 (bs, 1H), 6.81 (bs, 1H), 2.12 (s, 3H), 1.99 (s, 3H). 13C NMR (100 MHz,
CDC13) 8 138.9, 137.6, 135.5, 133.5, 129.6, 129.1, 120.1, 21.1, 17.4. IR (KBr disc, cm-') 1524,






The general procedure was followed using Cu20 (7.2 mg, 0.05 mmol), Lic (36 mg, 0.15 mmol),
PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 2-iodotoluene (127 [LL, 1.00 mmol), 2-
methylimidazole (100 mg, 1.2 mmol) except that DMSO (0.5 mL) was used as solvent and the
reaction was carried out for 48 h at 150 *C. Chromatographic purification (hexane / ethyl acetate
1 : 3) afforded 1-(2,4,6-trimethyl-phenyl)-1H-imidazole (yellow oil, 96 mg, 51%). 'H NMR (300
MHz, CDCl3) 8 7.42 (s, 1H), 7.21 (s, 1H), 6.95 (s, 2H), 6.87 (s, 1H), 2.32 (s, 3H), 1.97, (s, 6H).
'
3C NMR (100 MHz, CDCl3) 8 145.1, 1r36.9, 135.3, 131.1, 129.1, 127.7, 127.4, 126.9, 120.4,
17.2, 13.1. m.p. 107-109 *C (Lit. 107-108 °C)."
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Experimental procedures for all compounds contained in Table 2
1-(4-tert-butyl-phenyl)- lH-imidazole61 (4a)
The general procedure was followed using Cu2O (7.2 mg, 0.05 mmol), Llc (36 mg, 0.175
mmol), PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 4-t-butylbromobenzene (173 [iL, 1.00
mmol), and imidazole (82 mg, 1.2 mmol) with butyronitrile (0.25 mL) as solvent for 15 h at 110
*C. Chromatographic purification (hexane / ethyl acetate 1 : 3) afforded 1-(4-tert-butyl-phenyl)-
1H-imidazole (white crystals, 174 mg, 87%). 'H NMR (300 MHz, CDCl3) 8 7.78 (s, 1H), 7.3 (m,
2H), 7.25 (m, 2H), 7.20 (s, 1H), 7.15 (s, 1H), 1.30 (s, 9H). 13C NMR (100 MHz, CDCI3) 6 150.6,
135.6, 134.8, 130.2, 126.7, 121.1, 118.3, 34.6, 31.3. IR (KBr disc, cm-') 1525, 1462, 1365, 1302,
1266, 1243, 1120, 1106, 1061, 903. Anal Calc. for C13H,6N2: C 77.96, H 8.05. Found: 77.56, H




The general procedure was followed using Cu2O (7.2 mg, 0. 05 mmol), LIc (36 mg, 0.15 mmol),
PEG (400 mg), Cs2CO3 (1.0 g, 3.0 mmol), 4-bromophenol (172 mg, 1.00 mmol), and imidazole
(82 mg, 1.2 mmol) with butyronitrile (0.5 mL) as solvent for 15 h at 110 *C. After cooling to
ambient temperature, the crude reaction mixture was dissolved in 20 mL 2M HCl(q), and washed
once with diethyl ether. The aqueous layer was brought to pH 8 with Na 2CO 3 , and extracted
repeatedly with CH2CI2 . The combined organic layers were dried with anhydrous MgSO 4, and
concentrated. Chromatographic purification (1% ethanol in ethyl acetate, dry pack) afforded 4-
imidazol-1-yl-phenol (white crystals, 198 mg, 90%). 1H NMR (300 MHz, CD3OD) 6 7.95 (bs,
1H), 7.41 (bs, 1H), 7.35-7.30 (m, 2H), 7.01 (bs, 1H), 6.92-6.87 (m, 2H). 13C NMR (100 MHz,




The general procedure was followed using Cu20O (7.2 mg, 0.05 mmol), Lci (36 mg, 0.15 mmol),
PEG (200 mg), Cs2 CO3 (0.45 g, 1.4 mmol), 3-bromoaniline (109 FtL, 1.00 mmol), and imidazole
(82 mg, 1.2 mmol) with butyronitrile (0.25 mL) as solvent for 20 h at 110 *C. Chromatographic
purification (ethyl acetate) afforded 3-imidazol-1-yl-phenylamine (white powder, 141 mg, 88%).
'H NMR (300 MHz, CDCI3) 8 7.79 (bs, 1H), 7.21-7.15 (m, 3H), 6.72-6.68 (m, 1H), 6.64-6.60
(m, 2H). 4.01 (bs, 2H). 13C NMR (100 MHz, CDC13) 8 148.2, 138.4, 135.6, 130.7, 130.1, 118.4,
114.0, 111.1, 107.7. m.p. 112-114 *C (Lit. 111-113 *C).63
1,2-diphenyl-1H-imidazole (4d)
The general procedure was followed using Cu20O (14.4 mg, 0.10 mmol), Lic (72 mg, 0.30
mmol), PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 4-t-butylbromobenzene (173 [tL, 1.00
mmol), and imidazole (82 mg, 1.2 mmol) with butyronitrile (0.6 mL) as solvent for 72 h at 120
*C. Chromatographic purification (hexane / ethyl acetate 1 : 1) afforded 1,2-diphenyl-lH-
imidazole (white crystals, 198 mg, 90%). 'H NMR (300 MHz, CDCl3) 8 7.42-7.32 (m, 5H), 7.28-
7.16 (m, 6H), 7.14 (d, 1H, J = 1.1 Hz). 13C NMR (100 MHz, CDCl3) 8 138.6, 130.4, 129.5,
129.1, 128.6, 128.4, 128.2, 128.2, 125.9, 123.0. m.p. 88-89 *C (Lit. 90 *C).4
1-(4-tert-butyl-phenyl)-2-methyl- 1H-imidazole (4e)
The general procedure was followed using Cu2O (7.2 mg, 0.05 mmol), LIc (36 mg, 0.15 mmol),
PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 4-t-butylbromobenzene (173 [L, 1.00 mmol), 2-
methylimidazole (100 mg, 1.2 mmol) with butyronitrile (0.25 mL) as solvent for 48 h at 110 *C.
Chromatographic purification (hexane / ethyl acetate 1 : 3) afforded 1-(4-tert-butyl-phenyl)-2-
methyl-1H-imidazole (yellow oil, 207 mg, 97%). 'H NMR (300 MHz, CDCl3) 8 7.41 (m, 2H),
7.12 (m, 1H), 6.94 (bs, 1H), 6.91 (bs, 1H), 2.28 (s, 3H), 1.29 (s, 9H). 13C NMR (100 MHz,
CDCl3) 8 151.1, 135.3, 127.5, 126.3, 124.9, 12.7, 34.6, 31.3, 13.8. IR (KBr Disc, cm -) 2962,




The general procedure was followed using Cu20O (7.2 mg, 0.05 mmol), Lic (36 mg, 0.15 mmol),
PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 2-bromotoluene (120 giL, 1.00 mmol), and imidazole
(82 mg, 1.2 mmol) with butyronitrile (0.3 mL) as solvent for 28 h at 110 *C. Chromatographic
purification (hexane / ethyl acetate 1 : 1) afforded 1-ortho-tolyl-1H-imidazole (yellow oil, 140
mg, 89%). 'H NMR (300 MHz, CDCl3) G 7.59 (bs, 1H), 7.37-7.28 (m, 3H), 7.23-7.20 (m, 2H),
7.06 (bs, 1H), 2.19 ( s, 3H). 13C NMR (100 MHz, CDCI3) 8 148.2, 138.4, 135.6, 130.7, 130.1,
118.4, 114.0, 111.1, 107.7.5
o
1-(4-imidazol- 1-yl-phenyl)-ethanone (4g)
The general procedure was followed using Cu20 (7.2 mg, 0.05 mmol), Llc (36 mg, 0.15 mmol),
PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 4-bromoacetophenone (199 mg, 1.00 mmol), and
imidazole (82 mg, 1.2 mmol) with butyronitrile (0.4 mL) as solvent for 48 h at 110 *C.
Chromatographic purification (hexane / ethyl acetate 1 : 3) afforded 1-(4-imidazol-1-yl-phenyl)-
ethanone (white solid, 159 mg, 86%). 1'H NMR (300 MHz, CDCl3) 8 8.04, (m, 2H), 7.92 (bs,
1H), 7.46 (m, 2H), 7.33 (bs, 1H), 7.19 (bs, 1H), 2.59 (s, 3H). '3C NMR (100 MHz, CDC13) 6
196.6, 140.7, 135.7, 135.4, 131.2, 130.4, 120.7, 117.8, 26.7. m.p. 112-114 *C (Lit. 110-112 *C).66
1,4-bis(imidazol- 1-yl)-benzene67 (4h)
The general procedure was followed using Cu2O (7.2 mg, 0.05 mmol), Llc (36 mg, 0.15 mmol),
Cs2CO3 (0.90 g, 2.8 mmol), 1,4-dibromobenzene (236 mg, 1.00 mmol), and imidazole (164 mg,
2.4 mmol) with NMP (0.5 mL) as solvent for 30 h at 110 *C. The crude reaction mixture was
diluted in excess CH 2Cl2, and filtered through a celite plug. After removal of the solvent in
vacuo, the product was crystallized from EtOAc and stored in a freezer at -23 oC overnight, to
afford 1,4-bis(imidazol-1-yl)-benzene (white solid, 200 mg, 95%). 'H NMR (500 MHz, CDC13)
7.90 (bs, 2H), 7.54 (s, 4H), 7.32 (bs, 1H), 7.26 (bs, 1H). m.p. 190 *C (dec.). IR (KBr disc, cmn')
1534, 1485, 1304, 1248, 1105, 1059. Anal Calc. for C12H,0N4: C 68.56, H 4.79. Found C 68.49,
H 4.90.
Experimental procedures for all compounds contained in Table 5
An oven-dried screw-cap test tube was charged with Cu20 (0.05 mmol), ligand (0.15 mmol),
imidazole (1.0 mmol), Cs2CO3 (1.4 mmol), and a magnetic stir bar. The reaction vessel was fitted
with a rubber septum. The vessel was evacuated and back-filled with argon, and this sequence was
repeated an additional time. Aryl chloride (1.00 mmol, liquid) and NMP (0.25 mL) were then added
successively by syringe. The reaction tube was sealed, and stirred in a pre-heated oil bath at 150 °C
for 24. The reaction mixture was cooled to room temperature. Dichloromethane (10 mL), and 225
ýtL dodecane were stirred into the reaction mixture, which was subsequently filtered through a short
celite plug for GC Analysis.




The general procedure was followed using Cu20 (7.2 mg, 0.05 mmol), Llc (36 mg, 0.15 mmol),
PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 4-bromothioanisole (203 mg, 1.00 mmol), 4-
phenylimidazole (173 mg, 1.2 mmol) with butyronitrile (0.4 mL) as solvent for 17 h at 110 OC.
Chromatographic purification (hexane / ethyl acetate 1 : 1) afforded 1-(4-methylsulfanyl-
phenyl)-4-phenyl-IH-imidazole (white crystals, 254 mg, 95%). GC analysis and 'H NMR
showed no trace of a second regioisomer. 'H NMR (300 MHz, CDCI3) 8 7.87-7.83 (m, 3H), 7.54
(d, 1H, 1.4 Hz), 7.44-7.34 (m, 6H), 7.32-7.26 (m, 2H), 2.53 (s, 3H). 13C NMR (75.5 MHz,
CDCl3) 8 143.3, 138.4, 135.8, 134.5, 133.8, 128.8, 127.8, 127.3, 125.1, 122.0, 113.9, 16.1. IR
(KBr disc, cm -') 1550, 1508, 1443, 1420, 1313, 1252, 1070, 957, 936, 920, 828, 817, 758, 703.
Anal. Calc. for C16H,4N2S: C 72.15, H 5.30. Found: C 71.98, H 5.34. m.p. 122-124°C.
Me Me




The general procedure was followed using Cu20 (7.2 mg, 0.05 mmol), Llc (36 mg, 0.15 mmol),
PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 4-bromothioanisole (203 mg, 1.00 mmol), 4-
methylimidazole (100 mg, 1.2 mmol) with butyronitrile (0.3 mL) as solvent for 48 h at 110 *C.
Chromatographic purification (hexane / ethyl acetate 1 : 1) afforded 4-methyl-1-(4-
methylsulfanyl-phenyl)-lH-imidazole (yellow oil, 203 mg, 100%). 'HNMR showed a 3.0 : 1
mixture of A : B. 'H NMR (300 MHz, CDCl3) 6 7.65 (bs, 1H), 7.28-7.11 (m, 4H), 6.90 (bs, 1H),
2.46 (s, minor regioisomer), 2.43 (s, major regioisomer). 13 C NMR (100 MHz, CDCI3) 6 138.5,
135.9, 134.6, 133.9, 128.9, 127.9, 125.1, 122.0, 113.9, 16.7, 15.6.. Anal. Calc. for C1 H1 2N 2S: C
64.67, H 5.92. Found: C 64.29, H 5.93.
Me Me
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1-(4-fluoro-phenyl)-4-methyl-1H-imidazole (6c)
The general procedure was followed using Cu20O (7.2 mg, 0.05 mmol), Lci (36 mg, 0.15 mmol),
PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 1-bromo-4-fluorobenzene (109 [tL, 1.00 mmol), 4-
phenylimidazole (173 mg, 1.2 mmol) with butyronitrile (0.5 mL) as solvent for 15 h at 110 *C.
Chromatographic purification (hexane / ethyl acetate 1 : 1) afforded 1-(4-Fluoro-phenyl)-4-
methyl-1H-imidazole (yellow solid/liquid, 161 mg, 92%). 'HNMR showed a 5.0 : 1 mixture of
regioisomers. By GC, the ratio of A : B was determined to be 5.7 : 1. 'H NMR (300 MHz,
CDCl3) 8 7.65 (bs, 1H), 7.31-7.24 (m, 2H), 7.15-7.07 (m, 2H), 6.92 (bs, 1H), 2.26 (s, 1H, major
regioisomer), 2.12 (s, 1H, minor regioisomer). 13C NMR (100 MHz, CDCl3) 8 162.5, 160.5,
139.8, 134.9, 133.9, 123.1, 116.8, 13.7. IR (KBr disc, cm'i ) 1519, 1449, 1324, 1293, 1227, 1160,
1101, 1071, 1007, 974, 926, 816. Anal. Calc. for CIoH 9N2F: C 68.17, H 5.15. Found: C 68.30, H





The general procedure was followed using Cu2O (3.6 mg, 0.025 mmol), Lic (18 mg, 0.075
mmol), PEG (200 mg), Cs 2CO 3 (0.45 g, 1.4 mmol), 2-isopropyliodobenzene (160 LtL, 1.00
mmol), 4-methylimidazole (100 mg, 1.2 mmol) with butyronitrile (0.3 mL) as solvent for 20 h at
110 OC. GC and GC/MS analysis of the crude material showed an 82% yield and 41 : 1 ratio of A
: B. (See GC screens on p. S8) 'H NMR of the purified material showed a 16 : 1 ratio of A : B.
'H NMR (300 MHz, CDCl3) 8 7.48-7.40 (m, 3H), 7.28-7.15 (m, 2H), 6.75 (t, 1H, J = 0.9 Hz),




4-methyl- 1-o-tolyl- IH-imidazole 68 (6e)
The general procedure was followed using Cu20 (3.6 mg, 0.025 mmol), Lic (18 mg, 0.075
mmol), PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 2-iodotoluene (127 ýtL, 1.00 mmol), 4-
methylimidazole (100 mg, 1.2 mmol), with butyronitrile (0.3 mL) as solvent for 24 h at 110 OC.
GC Analysis showed a 23 : 1 ratio of regioisomers. Chromatographic purification (hexane / ethyl
acetate 1 : 3) provided 4-methyl-1-o-tolyl-1H-imidazole (yellow oil, 154 mg, 87%). 'H NMR of
the purified material showed a 16 : 1 ratio of A : B. 1H NMR (300 MHz, CDCl3) 8 7.44 (bs, 1H),
7.35-7.14 (m, 4H), 6.75 (bs, 1H), 2.28 (s, 3H, major isomer), 2.17 (s, 3H, major isomer), 2.11 (s,
minor isomer), 1.97 (s, minor regioisomer). (KBr disc, cm -') 1507, 1448, 1386, 1364, 1294,
1269, 1231, 1191, 1122, 1073. 1002,971.
Me Me




The general procedure was followed using Cu20 (3.6 mg, 0.025 mmol), Liec (18 mg, 0.075
mmol), PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 2-chloroiodobenzene (122 tL, 1.00 mmol),
4-methylimidazole (100 mg, 1.2 mmol) with butyronitrile (0.3 mL) as solvent for 15 h at 110 OC.
Chromatographic purification (hexane / ethyl acetate 1 : 1) afforded 1-(2-chloro-phenyl)-4-
methyl-1H-imidazole (yellow oil, 191 mg, 99%). 1HNMR showed a 12.1 : 1 mixture of A : B.
By GC, the ratio was determined to be 19 : 1. 'H NMR (300 MHz, CDCl3) 8 7.49 (bs, 1H), 7.47-
7.39 (m, 1H), 7.29-7.18 (m, 3H), 6.78 (bs, 1H), 2.21 (s, major regioisomer), 2.06 (d, minor
regioisomer). 13C NMR (100 MHz, CDC13) 8 135.1, 130.7, 129.4, 129.2, 127.7, 127.4, 13.6. IR
(KBr disc, cm -') 1593, 1570, 1503, 1447, 1392, 1369, 1290, 1232, 1202, 1131, 1084, 1059, 1035,





4-bromo- 1-(4-methoxy-phenyl)-2-methyl- 1H-imidazole (6g)
The general procedure was followed using Cul (9.5 mg, 0.05 mmol), Lci (18 mg, 0.075 mmol),
Cs2 CO3 (0.45 g, 1.4 mmol), 4-iodoanisole (280 mg, 1.2 mmol), 4-bromo-2-methylimidazole (161
mg, 1.00 mmol) with acetonitrile (1.0 mL) as solvent for 24 h at 110 OC. Chromatographic
purification (hexane / ethyl acetate 3 : 1) provided 4-bromo- 1-(4-methoxy-phenyl)-2-methyl-1H-
imidazole (white crystalline solid, 218 mg, 82%). 'H NMR (300 MHz, CDCI3) 8 7.09 (m, 2H),
6.89, (m, 2H), 6.82 (s, 1H), 3.79, (s, 3H), 2.12 (s, 3H) ' 3C NMR (100 MHz, CDCl3) 8 159.6,
145.1, 129.6, 126.7, 119.7, 114.6, 113.8, 55.53, 13.4. IR (KBr disc, cm -') 1559, 1507, 1457,
1437, 1419, 1299, 1239, 1181, 1167, 1135, 1108, 1032, 1020, 949, 668. Anal. Calc. for
C,1 H,lBrN20: C 49.46, H 4.15. Found: C 49.51, H 4.03. m.p. 136-137 *C.




The general procedure was followed using Cu20 (3.6 mg, 0.025 mmol), Llc (18 mg, 0.075
mmol), PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 5-iodo-2-chloropyridine (239 mg, 1.00
mmol), 2-methylimidazole (100 mg, 1.2 mmol) with butyronitrile (1.0 mL) as solvent for 24 h at
110 *C. Chromatographic purification (ethyl acetate) provided 2-chloro-5-(2-methyl-imidazol-1-
yl)-pyridine (white solid, 143 mg, 74%). 1H NMR (300 MHz, CDCl3) 8 8.33, (d, 1H, J = 2.9 Hz),
7.59 (dd, 1H, J = 2.9, 8.7 Hz), 7.43 (d, 1H, 8.7, Hz), 6.99 (d, 1H, 1.2 Hz), 6.95 (d, 1H, J = 1.6
Hz), 2.31 (s, 3H). 13C NMR (100 MHz, CDC13) 8 139.9, 136.0, 128.7, 128.5, 124.4, 124.2, 120.5,





The general procedure was followed using Cu20O (3.6 mg, 0.025 mmol), Llc (18 mg, 0.075
mmol), PEG (200 mg), CsCO3 (0.45 g, 1.4 mmol), 5-iodoindole (243 mg, 1.00 mmol), and
imidazole (82 mg, 1.2 mmol) with butyronitrile (0.3 mL) as solvent for 13 h at 110 *C.
Chromatographic purification (ethyl acetate) provided 5-imidazol-1-yl-1H-indole (white solid,
152 mg, 83%). 1H NMR (300 MHz, CDCI3/CD3CN) 8 10.0 (bs, 1H), 7.9 (1H), 7.79-7.65 (lH),
7.60-7.48 (1H), 7.44-7.43 (2H), 7.28 (s, 1H), 7.21 (dd, 1H), 6.68-6.60 (m, 1H). 13C NMR (100
MHz, CDCI3) 8 202.2, 136.5, 135.4, 129.6 128.4, 126.8, 119.9, 116.8, 114.3, 112.3, 102.6. IR
(KBr disc, cm'-1) 1541, 1498, 1457, 1436, 1346, 1309, 1268, 1241, 1110, 1055, 916, 870, 725.
Anal. Calc. for C1tH9N3: C 72.11, H 4.95. Found: C 72.43, H 4.95. m.p. 144-146 *C.
1-furan-3-yl-1H-imidazole (7c)
The general procedure was followed using Cu20 (7.2 mg, 0.05 mmol), Llc (36 mg, 0.15 mmol),
PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 2-bromofuran (108 [tL, 1.2 mmol), and imidazole
(68 mg, 1.00 mmol) with DMSO (0.5 mL) as solvent for 24 h at 110 *C. Chromatographic
purification (ethyl acetate / hexane 3 : 1) provided 1-furan-3-yl-1H-imidazole (white solid, 89
mg, 67%). 1H NMR (300 MHz, CDCI3) 8 7.71 (bs, 1H), 7.62 (dd, 1H, J = 0.8, 1.7 Hz), 7.42 (dd,
1H, J = 1.7, 1.9 Hz), 7.22-7.06 (bs, 2H), 6.54 (dd, 1H, J = 0.8, 1.9 Hz). 13C NMR (100 MHz,
CDCl3) 8 143.9, 133.0, 126.0, 106.2. IR (neat, cm ') 2092, 1523, 1489, 1406, 1317, 1252, 1173,
1025. m.p. 39-41 *C.
N
4-imidazol-1-yl-isoquinoline (7d)
The general procedure was followed using Cu20O (7.2 mg, 0.05 mmol), Lie (36 mg, 0.15 mmol),
PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 4-bromoisoquinoline (250 mg, 1.2 mmol), and
imidazole (68 mg, 1.00 mmol) with DMSO (0.5 mL) as solvent for 24 h at 110 *C.
Chromatographic purification (ethyl acetate / hexane 3 : 1) provided the title compound (clear
crystals, 165 mg, 85%). 1H NMR (300 MHz, CDCI3) 8 9.27 (d, 1H, 0.9 Hz), 8.48 (s, 1H), 8.08
(m, 1H), 7.78-7.62, (m, 4H), 7.30 (bs, 1H), 7.25 (bs, 1H). 13C NMR (100 MHz, CDCI3) 8 153.3,
139.6, 138.2, 132.1, 131.9, 130.2, 129.2, 128.8, 128.4, 127.9, 121.5, 121.2. IR (KBr disc, cmf')
1589, 1508, 1491, 1406, 1382, 1307, 1260, 1250, 1194, 1107, 1078, 1038, 942, 913, 782, 756,
660, 589. Anal. Calc. for CI2H9N3: C 73.43 H 4.65. Found: C 73.43, H 4.63. m.p. 67-71 *C.
Me
2-methyl- 1-thiophen-2-yl- 1H-imidazole (7e)
The general procedure was followed using Cu2O (3.6 mg, 0.025 mmol), LIe (18 mg, 0.075
mmol), PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 2-iodothiophene (132 Rg, 1.2 mmol), 2-
methylimidazole (83 mg, 1.00 mmol) with DMSO (0.3 mL) as solvent for 24 h at 110 *C.
Workup was performed under an atmosphere of N2. Chromatographic purification (ethyl acetate /
hexane 3 : 1) provided 2-methyl-l-thiophen-2-yl-1H-imidazole (yellow oil, 90 mg, 55%). 'H
NMR (500 MHz, CDCl3) 6 7.25 (dd, 1H, J = 1.4, 5.5 Hz), 7.03-6.99 (m, 3H), 6.96 (dd, 1H, 1.5,
3.7 Hz), 2.39 (s, 3H). 13C NMR (100 MHz, CDC13) 6 128.0, 126.2, 124.1, 123.5, 122.3, 100.0,
13.7. IR (neat, cm -') IR (KBr disc, cm-') 1555, 1496, 1451, 1406, 1305, 1287, 1172, 1137, 987,
941. This compound turns dark brown upon exposure to air or after standing for 2-3 of days as
room temperature under an argon atmosphere.
1-benzo[b]thiophen-3-yl- 1H-imidazole (7f)
The general procedure was followed using Cu20O (7.2 mg, 0.05 mmol), Lie (36 mg, 0.05 mmol),
PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 3-bromothianaphthene (131 iL, 1.00 mmol), and
imidazole (82 mg, 1.2 mmol) with DMSO (0.5 mL) as solvent for 48 h at 110 *C. The crude
reaction mixture was dissolved in 20 mL H20, and the organic material was extracted repeatedly
with CH2Cl 2. The combined organic extracts were washed once with brine, then dried over
MgSO 4 and concentrated to an oil. Chromatographic purification (ethyl acetate / hexane 3 : 1) 1-
benzo[b]thiophen-3-yl-1H-imidazole (yellow oil, 188 mg, 94%). 1H NMR (300 MHz, CDCI3)
7.89-7.85 (m, 1H), 7.80 (bs, 1H), 7.68-7.63 (m, 1H), 7.46-7.38 (m, 3H), 7.26 (bs, 2H). 13C NMR
(75 MHz, CDCl3) 6 139.0, 133.8, 130.5, 130.0, 125.8, 125.3, 123.44, 121.0, 119.7. IR (KBr Disc,
cm -') 3114, 1570, 1539, 1509, 1486, 1431, 1385, 1332, 1267, 1254, 1228, 1106, 1081, 1061,
1035, 912, 821, 731, 757, 659. After 2-3 days at room temperature under an argon atmosphere,
the compound turned dark brown in color.
s
1-thiophen-2-yl-1H-imidazole (7g)
The general procedure was followed using Cu2O (3.6 mg, 0.025 mmol), Lic (18 mg, 0.075
mmol), PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 2-iodothiophene (132 mg, 1.2 mmol),
imidazole (68 mg, 1.00 mmol) with DMSO (0.3 mL) as solvent for 24 h at 110 *C.
Chromatographic purification (ethyl acetate / hexane 3 : 1) provided 1-thiophen-2-yl-1H-
imidazole (yellow oil, 125 mg, 83%). 1H NMR (300 MHz, CDCl3) 8 7.71 (bs, 1H), 7.15 (bs, 1H),
7.11 (bs, 1H), 7.09 (dd, 1H, J = 2.0, 5.2 Hz), 6.96-6.92 (m, 2H). '3C NMR (100 MHz, CDCl3)
139.0, 137.0, 130.2, 126.4, 121.8, 120.3, 119.0. This oil turned dark brown after 2-3 days as
room temperature under an argon atmosphere.
Experimental procedures for all compounds contained in Table 8
&YOMe
1-(3-methoxyphenyl)-2-methyl- 1H-benzo[d]imidazole (8a)
The general procedure was followed using Cu2O (14.3 mg, 0.10 mmol), Lic (48 mg, 0.20
mmol), MTBD (200 IL, 1.4mmol), 3-bromoanisole (126 [tL, 1.00 mmol), and 2-
methylbenzimidazole (159 mg, 1.2 mmol) with DMSO (0.5 mL) as solvent for 24 h at 130 *C.
The crude reaction mixture was dissolved in 20 mL of ammonium hydroxide and extracted with
dichloromethane (3 x 30 mL). The combined organic layers were then extracted with 20 mL of
brine. The resulting aqueous phase was extracted with dichloromethane (3 x 30 mL). The
combined organic layers were dried with anhydrous MgSO 4, and the solvent was removed in
vacuo. Chromatographic purification (hexane / ethyl acetate 1 : 1) afforded 1-(3-
methoxyphenyl)-1H-benzo[dlimidazole (white solid, 192 mg, 81%). 'H NMR (300 MHz,
CDCl3) 8 7.64 (d, 1H, J = 8.0), 7.37 (t, 1H, J = 8.1 Hz), 7.19-7.05 (m, 3H), 6.95 (ddd, 1H, J =
0.9, 2.5, 8.5 Hz), 6.80-6.87 (m, 2H), 3.75 (s, IH), 2.40 (s, 1H). 1'3C NMR (125 MHz, CDCI3) 8
160.7, 151.6, 142.6, 137.2, 136.4, 130.7, 122.6, 122.4, 119.3, 119.0, 114.4, 112.9, 110.1, 55.6,
14.5. IR (KBr disc, cm-') 1601, 1516, 1492, 1464, 1392, 1322, 1288, 1255, 1222, 1165, 1054,
1024, 928, 879, 830, 786, 751, 697, 435. Anal. Calc. for C15H14N20: C 75.61, H 5.92. Found C
75.22, H 5.79. m.p. 132.5-133.5 *C.
F
1-(4-fluroropheyl)-1H-benzop[dlimidazole (8b)
The general procedure was followed using Cu20 (14.3 mg, 0.10 mmol), Lic (48 mg, 0.20
mmol), PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 1-bromo-4-fluorobenze (109 [L, 1.00
mmol), and benzimidazole (142 mg, 1.2 mmol) with DMSO (0.5 mL) as solvent for 9 h at 110
*C. The crude reaction mixture was dissolved in 20 mL of ammonium hydroxide and extracted
with dichloromethane (3 x 30 mL). The combined organic layers were then extracted with 20 mL
of brine. The resulting aqueous phase was extracted with dichloromethane (3 x 30 mL). The
combined organic layers were dried with anhydrous MgSO 4, and the solvent was removed in
vacuo. Chromatographic purification (hexane / ethyl acetate 1 : 2) afforded 1-(4-fluroropheyl)-
1H-benzop[d]imidazole (white solid, 180 mg, 85%). 'H NMR (300 MHz, CDCl3) 6 7.92 (s, 1H),
7.76-7.72 (m, 1H), 7.34-7.30 (m, 3H), 7.30-7.09 (m, 4H). 13C NMR (125 MHz, CDCl3) 6 162.9,
160.9, 143.9, 142.3, 133.8, 132.3, 126.0, 125.9, 123.8, 122.9, 120.6. 117.1, 116.9, 110.2. IR
(KBr disc, cm -') 3416, 3061, 1911, 1781, 1734, 1666, 1614, 1511, 1486, 1458, 1317, 1289, 1235,
1217, 1148, 1094, 1010, 980, 936, 887, 868, 845, 823, 815, 783, 766, 750, 716, 668, 647, 619,
589, 567, 531,483, 436, 411. Anal. Calc. for C, 3H9FN2: C 73.57, H 4.27. Found C 73.37, H 4.24.
m.p. 118.5-119.5 *C (Lit. 114-115 'C). 69
t-Bu
1-(4-tert-butylphenyl)2-methyl- 1H-benzo[dlimidazole (8c)
The general procedure was followed using Cu20 (14.3 mg, 0.10 mmol), Llc (48 mg, 0.20
mmol), MTBD (200 ixL, 1.4mmol), 1-bromo-4-t-butylbenzene (173 [L, 1.00 mmol), and 2-
methylbenzimidazole (159 mg, 1.2 mmol) with DMSO (0.5 mL) as solvent for 24 h at 130 *C.
The crude reaction mixture was dissolved in 20 mL of ammonium hydroxide and extracted with
dichloromethane (3 x 30 mL). The combined organic layers were then extracted with 20 mL of
brine. The resulting aqueous phase was extracted with dichloromethane (3 x 30 mL). The
combined organic layers were dried with anhydrous MgSO 4, and the solvent was removed in
vacuo. Chromatographic purification (hexane / ethyl acetate 1 : 1) afforded 1-(4-tert-
butylphenyl)2-methyl-1H-benzo[d]imidazole (white solid, 191 mg, 72%). 'H NMR (300 MHz,
CDCl3) 8 7.63 (d, 1H, J=7.9Hz), 7.44 (d, 2H, J=8.4), 8 7.15-7.13 (m, 3H), 7.05-7.03 (m, 2H),
2.39 (s, 3H), 1.29 (s, 9H). 13C NMR (125 MHz, CDCI3) 8 151.9, 151.7, 142.6, 136.6, 133.3,
126.8, 126.5, 122.4, 122.2, 118.9, 110.1, 34.9, 31.4, 14.5. IR (KBr disc, cm-1) 3399, 3050, 3038,
2964, 2868, 2717, 2320, 1924, 1883, 1847, 1806, 1766, 1664, 1612, 1587, 1518, 1477, 1456,
1397, 1367, 1324, 1314, 1285, 1269, 1248, 1204, 1186, 1145, 1122, 1108, 1033, 1011,998, 973,
942, 875, 860, 842, 764, 741, 704, 678, 644, 633, 593, 566, 534, 497, 429, 406. Anal. Calc. for
C18H2oN2: C 81.78, H 7.63. Found C 81.69, H 7.62. m.p. 132-133 *C.
t-Bu
1-(4-tert-butylphenyl)- H-benzo[dJimidazole (8d)
The general procedure was followed using Cu20 (14.3 mg, 0.10 mmol), Llc (48 mg, 0.20
mmol), PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 1-bromo-4-t-butylbeneze (173 [IL, 1.00
mmol), and benzimidazole (142 mg, 1.2 mmol) with DMSO (0.5 mL) as solvent for 6 h at 110
*C. The crude reaction mixture was dissolved in 20 mL of ammonium hydroxide and extracted
with dichloromethane (3 x 30 mL). The combined organic layers were then extracted with 20 mL
of brine. The resulting aqueous phase was extracted with dichloromethane (3 x 30 mL). The
combined organic layers were dried with anhydrous MgSO 4, and the solvent was removed in
vacuo. Chromatographic purification (hexane / ethyl acetate 1 : 1) afforded 1-(4-tert-
butylphenyl)-1H-benzo[d]imidazole (white crystals, 240 mg, 96%). 1'H NMR (300 MHz, CDCI3)
8 7.94 (s, 1H), 7.77-7.74 (dd, 1H, J = 2.9, 6.2 Hz), 7.43-7.37 (m, 3H), 7.27-7.15 (m, 4H), 1.25 (s,
9H). 13C NMR (125 MHz, CDCl3) 8 151.2, 144.0, 142.3, 133.8, 133.7, 126.9, 123.6, 123.6,
123.5, 122.6, 120.5, 110.5, 34.7, 31.3. IR (KBr disc, cm-1) 3429, 3112, 3055, 2959, 2902, 2867,
1736, 1609, 1520, 1488, 1461, 1416, 1369, 1361, 1323, 1303, 1267, 1232, 1212, 1162, 1142,
1123, 1107, 1026, 1009, 977, 932, 890, 871, 846, 827, 783, 765, 741, 645, 621, 589, 565, 548,
500, 431. Anal. Calc. for C,7HisN 2: C 81.56, H 7.25. Found C 81.12, H 7.23. m.p. 150-151.5 *C.
NH2
2-(1H-benzo[d]imidzol- 1-yl)aniline (8e)
The general procedure was followed using Cu20O (14.3 mg, 0.10 mmol), Lie (48 mg, 0.20
mmol), PEG (200 mg), Cs2CO3 (0.45 g, 1.4 mmol), 2-bromoaniline (109 [LL, 1.00 mmol), and
benzimidazole (142 mg, 1.2 mmol) with DMSO (0.5 mL) as solvent for 15 h at 110 *C. The
crude reaction mixture was dissolved in 20 mL of ammonium hydroxide and extracted with
dichloromethane (3 x 30 mL). The combined organic layers were then extracted with 20 mL of
brine. The resulting aqueous phase was extracted with dichloromethane (3 x 30 mL). The
combined organic layers were dried with anhydrous MgSO4, and the solvent was removed in
vacuo. Chromatographic purification (with Biotage system with gradient of pure hexane to pure
ethyl acetate to hexane / ethyl acetate 1 : 1) afforded 2-(1H-benzo[d]imidzol-1-yl)aniline (orange
crystals, 157 mg, 75%). 'H NMR (300 MHz, CDC13) 8 7.83 (s, 1H), 7.73 (dd, 1H, J = 2.2, 6.3
Hz), 7.20-7.11 (m, 4H), 7.03 (dd, 1H, J = 1.4, 7.7 Hz), 6.80-6.71 (m, 2H), 3.67 (s, 2H) '3C NMR
(125 MHz, CDC 3) 8 143.5, 143.3, 142.9, 133.9, 130.3, 128.2, 123.6, 122.8, 121.1, 120.4, 118.6,
116.6, 110.9. IR (KBr disc, cm1') 3227, 3202, 1625, 1507, 1486, 1454, 1308, 1288, 1227, 1157,
977, 890, 785, 744, 503, 442, 428. Anal. Calc. for C13HIlN 3: C 74.62, H 5.30. Found C 74.45, H
5.25. m.p. 115-116 *C (Lit. 112.5-113 *C).70
1-o-tolyl- 1H-benzo[dJimidazole7 ' (8f)
The general procedure was followed using Cu20 (7.2 mg, 0.05 mmol), LIe (36 mg, 0.15 mmol),
PEG (200 mg), Cs 2CO3 (0.45 g, 1.4 mmol), 2-bromotoluene (120 IiL, 1.00 mmol), and
benzimidazole (142 mg, 1.2 mmol) with DMSO (0.5 mL) as solvent for 24 h at 130 *C. The
crude reaction mixture was dissolved in 20 mL of ammonium hydroxide and extracted with
dichloromethane (3 x 30 mL). The combined organic layers were then extracted with 20 mL of
brine. The resulting aqueous phase was extracted with dichloromethane (3 x 30 mL). The
combined organic layers were dried with anhydrous MgSO 4, and the solvent was removed in
vacuo. Chromatographic purification (with Biotage system with gradient of pure hexane to
hexane / ethyl acetate 1 : 1) afforded 1-o-tolyl-1H-benzo[d]imidazole (yellow oil, 186 mg, 78%).
'
1H NMR (300 MHz, CDCI3) 6 7.88 (s, 1H), 7.81 (d, 1H, J = 7.9 Hz), 7.95-7.18 (m, 6H), 7.05
(dd, J = 7.9, 0.6 Hz), 2.01 (s, 3H). 13C NMR (125 MHz, CDCl3) 6 143.5, 143.1, 135.5, 134.9,
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Chapter Two
Orthogonal Selectivity in Palladium- and Copper-catalyzed
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2.1 Introduction
In recent years, Pd- 1 and Cu-2 catalyzed nucleophilic substitution reactions of aryl halides
have been areas of intensive research. Our laboratory has been intimately involved in designing
and developing highly-efficient and user-friendly Pd- and Cu-based catalyst systems to cross-
couple aryl halides with a wide variety of nucleophiles, including amides3-4 and ketone enolate
derivatives.5-6
Generally, the Cu- and Pd-catalyzed arylation reactions of both linear and cyclic aliphatic
amides react at the more acidic N-H moiety as opposed to the less acidic C-H, position. For
instance, when reacting 2-pyrrolidinone with aryl halides, both Cu-diamine- and Pd-
biarylmonophosphine-based catalyst systems provide the N-aryl amide in excellent yield
(Scheme 1).34 Ongoing work in our and other laboratories7 has identified oxindole as a unique
substrate for chemoselective metal-catalyzed cross-coupling reactions with aryl halides. Due to
the identical acidities of the protons in positions C3 and NI (pKa = 18.5),8 the cross-coupling
reactions of oxindole with aryl halides might provide either the C-aryl or N-aryl products.
Scheme 1. Pd- and Cu-Catalyzed C- and N-Arylation of 2-Pyrrolidinone and Oxindole
pKa ~ 35 -
H
X-- -- + Cu or Pd Cat.
NH HJ X = I, Br (Cu)
pKa = 24 X = OTf, Br, CI, OTs (Pd)
pKa = 18.5
H
Pd Cat. X Cu Cat.
I 0 R
SNH C-Arylation H N-Arylation
pKa = 18.5 NR
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Importantly, NJ-aryl and C3-aryl oxindole products of the type generated from the
reactions described in this manuscript display interesting biological activities with therapeutic
applications (Figure 1).' In addition, the amide of the N-aryl oxindole can be cleaved to provide
access to a variety of derivatives of 2-(2-phenylamino)-phenyl)ethanoic acid non-steroidal anti-
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Herein, we describe improved reaction conditions for the Cu-catalyzed NI-arylation
reaction with aryl iodides and bromides, and general reaction conditions for the Pd-catalyzed C3-
arylation reaction of unprotected oxindoles with aryl chlorides and tosylates. Further, we report
computational studies that suggest reasonable explanations for the observed selectivity.








2.2 Results and Discussion
2.2.1 Palladium-Catalyzed C3-Arylation of Oxindole
The use of 1% Pd2(dba)3 and 5% XPhos (Figure 2) was found to facilitate the cross-
coupling of aryl chlorides with oxindoles unsubstituted at C3 using K2CO3 as the base in THF or
1,4-dioxane at temperatures ranging between 80 and 100 'C (Table 1). The use of bidentate or
other dialkylbiarylmonophosphine ligands provided low conversion of starting material and yield
of products. The Pd-catalyzed C3-arylation reaction of oxindoles with aryl chlorides tolerated a
variety of functional groups on the meta- and para-positions of the electrophile (entries 1-10);
however, ortho-substituted aryl chlorides provided low conversion of reactants (> 5%) even at
slightly elevated temperatures (up to 120 OC) with a variety of biarylmonophosphine ligands.
Under the standard reaction conditions, the use of 3-chlorobenzonitrile provided low yields of
coupled product due to partial hydrolysis of the nitrile functional group to an amide (entry 4).
This side reaction could be partially impeded by the addition of activated 4 A molecular sieves to
the reaction vessel. Using t-BuOH as a solvent, an unactivated aryl benzenesulfonate could be
successfully cross-coupled to provide the C-aryl product in modest yield (entry 5). Substrates
possessing substituents on the benzannulated backbone as well as on the nitrogen atom provided
more highly substituted products (entries 6-10). Using XPhos as a ligand, the reaction of a 3-
substituted oxindole was unsuccessful;7b however, using re-optimized reaction conditions
(RuPhos/NaOt-Bu/toluene), the cross-coupling reactions of 3-methyl- and 3-benzyl-oxindole
were successfully accomplished to generate quaternary stereocenters at the C3 positions to
produce racemic products (entries 11-12). In contrast to the previously reported catalyst systems
for the C3-vinylation of unprotected oxindoles and -arylation of protected oxindoles, which
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required strong bases such as KHMDS and LHMDS, respectively, for the reactions to proceed,7b-
C K2CO3 and NaOt-Bu were found to be suitable bases with our catalyst system.
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-1.0 mmol ArCI, 2.0 mmol K2CO3, 0.010
in a sealed tube under an Ar atmosphere.
Yields reported are an average of at least two runs determined to be > 95% pure by elemental
analysis or 1H NMR. b 3.0 mmol K2C0 3 . c 4 A mol Sieves. d From ArOSO 2Ph. ' K3PO4 used as
base. f From ArBr. RuPhos and NaOt-Bu employed as ligand and base. 9 h reaction time. g From
ArBr. RuPhos and NaOt-Bu employed as ligand and base. 20 h reaction time.
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222 Copper-Catalyzed N1-Arylation of Oxindole
The Cu-catalyzed N-arylation reactions of meta- and para-substituted aryl iodides
generally proceeded smoothly at temperatures ranging from 80 to 100 OC using 1-5% catalyst
loading, 4-10% CyDMEDA (Figure 2) as the ligand, K2CO3 as the base, and 1,4-dioxane as the
solvent (Table 2, entries 1-8). In these reactions, the C3-aryl product was not detected by GCMS
analysis of the crude reaction mixtures. Using this catalyst system, ortho-substituted aryl iodides
were unreactive, even at temperatures up to 150 °C in high boiling-point solvents. This serves to
reinforce the notion that ortho-substituted aryl halides can be quite difficult to activate in Cu-
catalyzed C-heteroatom bond-forming reactions. At 60-100 'C, the cross-coupling reaction of 1-
bromo-4-iodobenzene with oxindole provided a complex mixture of products; however, by
lowering the reaction temperature to 40 OC, the iodo-substituted product could be isolated in
acceptable yield (entry 3). The addition of activated 4 A molecular sieves to the reaction
mixtures was necessary for substrates containing hydroxide- or water-sensitive functional groups
(entries 4 and 7). As anticipated, substituents on the nucleophile were also tolerated (entries 6-7).
Aryl bromides also proved to be reactive in the Cu-catalyzed cross-coupling reactions
with oxindoles (entries 8-11), though higher catalyst loadings were necessary to ensure full
conversion of the substrates within a 24 h time period. Although the C3-aryl oxindole product
was not observed, up to 5% of the N1,C3-bis-arylated product (10% of aryl halide consumption)
was isolated in the reaction of 5-bromo-m-xylene (entry 9). A second common side product,
when using aryl bromides, was the reduced arene.
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Table 2. Cu-Catalyzed N -Arylation of Oxindolesa
Y% Cul, Z% L
K2C0 3 , 1,4-dioxane
40-100 "C, 8-24 h
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5 I 10 80 87b
10 Br 20 100 62
10 Br 20 100 71
10 Br 20 100 77
10 Br 20 100 72
5 I 10 80 69
1.0-1.2 mmol oxindole, 1.2-1.0 mmol ArI, 2.0 mmol K2CO3, 1.0 mL 1,4-
dioxane, in a sealed tube under an Ar atmosphere. Yields reported are an average of at least two
runs determined to be > 95% pure by elemental analysis or 'H NMR. b 4 A mol Sieves.
2.23 Computational Studies of Palladium- and Copper-Catalyzed Reactions
The catalytic cycle of Pd-catalyzed nucleophilic substitution reactions of aryl halides







Scheme 2. Mechanisms of Pd- and Cu-Catalyzed Nucleophilic Substitution Reactions of Aryl
Halides
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Since oxindole does not participate in the oxidative addition step of the cycle, the
selectivity-controlling feature for the Pd-based catalyst system must involve either the
transmetallation or reductive-elimination steps. To gain further insight into the observed
selectivity, the relative energies and structures of various LPd(Ph)(oxindolate) complexes were
calculated by DFT methods.
In light of the experimental findings that catalysts derived from XPhos were the only
ones that produced high yields of the C3-arylation of oxindole product, it was critical to model
structures that contained the entire ligand without any approximations. The geometry of the
XPhos-Pd(Ph)(oxindolate) complex formed following transmetallation was minimized with the
Pd bound to either the nitrogen or a-carbon of the oxindole (Figure 3). This minimization was
performed with structures in which the Pd points towards or away from the lower biaryl ring.
Consistent with previous computational studies from our group,12 three-coordinate
Pd(II)/dialkylbiarylmonophosphine intermediates prefer the orientation shown in structures 1 and
2 with the Pd sitting above the lower biaryl ring. In both cases, the C-bound oxindolate was
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significantly higher in energy than the N-bound complex. This energy difference was 4.8
kcal/mol between 1 and 2 and 7.0 kcal/mol between 3 and 4.
Figure 3. Calculated Geometries
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We then determined the energies of the K2-amidate (5,9), O-bound amidate and enolate
(6-7, 10-11), and q3-oxyallyl (8,12) structures as, they may be intermediates in the N to C
isomerization process (Figure 4). As expected, the three-coordinate O-bound enolate and amidate
structures are lower in energy when the Pd is pointing towards the lower ring. However, the four-
coordinate K2-amidate and r13-oxyallyl bound structures are lower in energy when the Pd is distal




Figure 4. Calculated Geometries and Energies of the K2- 0- and q 3-oxyallyl-bound
XPhos-Pd(Ph)(oxindolate) Complexes with B3LYP.a,b
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2.2 kcallmol 19.0 kcal/mol 18.4 kcal/mol 7.8 kcal/mol
a Calculated at 298 K in THF. b AEre, values are relative to complex 1 in Figure 3.
If the N-bound and C-bound structures exist in rapid equilibrium, then the barriers for
reductive elimination should be product determining. Thus, transition states for both C-C and C-
N reductive elimination processes were calculated. The mechanism for reductive elimination
from Pd-bound enolates has not been well studied, and could occur by different mechanisms
involving O-bound, C-bound, or rl3-oxyallyl Pd intermediates. Hartwig and Culkin 13 have put
forth circumstantial evidence in support of a simple reductive-elimination between an Yr-bound
enolate and the arene. However, these studies were primarily performed using bidentate ligands,
which may prevent q3-bound intermediates and relevant transition states. Several reports have
appeared, which indicate rl3-oxyallyl Pd intermediates may be involved in some Pd-enolate
based processes.14
Reasonable starting geometries for the transition states of enolate C-C reductive




reductive elimination from Pd.15 A prior publication by our group on the mechanism of aryl
amination provided us with reasonable starting geometries for amidate C-N reductive-
elimination. 12 We were then able to quickly find transition states for both C-C and C-N
reductive elimination towards and away from the lower biaryl ring (Figure 5). The AE* for 1-1-
TS was calculated to be 21.7 kcal/mol while the AE* for 2-.2-TS was significantly less at 14.5
kcal/mol. For the structures with the Pd swung away, the AE* of 3-m3-TS was calculated to be
20.9 kcal/mol and the AE* of 4-.4-TS was 12.6 kcal/mol. Although these barriers are lower than
when the Pd is pointed towards the lower biaryl ring, their absolute energies are much higher.
Therefore, it is unlikely that 3-TS and 4-TS contribute to the reaction course. We also attempted
to find a transition state for C-C reductive elimination, which proceeds through an r3 pathway,
but one could not be located.
Figure 5. Calculated Reductive-Elimination Transition States for XPhos-Pd(Ph)(oxindolate) with
B3LYPa,b
i rPd ,Lv 7  iPPr Pd,.
Pr ': iPr
i PrO r DPr
1-TS 2-TS 3-TS 4-TS
AEre = 21.7 kcal/mol 19.3 kcal/mol 26.8 kcal/mol 25.6 kcal/mol
a Calculated at 298 K in THF. b AEre, values are relative to complex 1 in Figure 3.
Cu-catalyzed amidation reactions of aryl halides initiate by addition of the nucleophile to
a L2Cu(I)X complex to provide an L2Cu(I)amidate, followed by aryl halide activation and
subsequent product formation (Scheme 2, Cycle B).l -17 Although the Guo group has recently
published a computational study that calculates the transition states and intermediates of the
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catalytic cycle for the Goldberg reaction,18 this study only considered a mechanism based on an
insertion reaction between an L2Cu(I)(amidate) and an aryl halide to generate an L2Cu(III)
(Ar)(X)(amidate) species, and neglects to evaluate evidence that an electron-transfer mechanism
might be occurring, as suggested by Hida.19 Therefore, we will assume that the mechanism of the
rate-limiting aryl halide activation step is yet to be fully elucidated. According to this paradigm,
reaction of a molecule of oxindole with the CyDMEDA-CuI complex and base may provide
multiple regioisomeric products, which could react with aryl halides to provide the N-aryl and
C3-aryl products, respectively. In order to gain insight into the features that control the
selectivity of the reaction, the energies of relevant CyDMEDA-Cu(I)(oxindolate) complexes
were examined (Figure 6).
Figure 6. Calculated Geometries and Energies of CyDMEDA-Cu(Oxindolate) Complexes with
B3LYPa
-CNH CH3.,H
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AEre= 0 kcal/mol 14.1 kcallmol 9.7 kcal/mol 19.6 kcal/mol
a Calculated at 298 K.
As observed with the Pd-based catalyst system, the N-bound
(CyDMEDA)-Cu(oxindolate) 13 was found to be significantly lower in energy than both C3-
bound and O-bound structures. In this structure, the geometry around Cu is a distorted T-shape,
consistent with known neutral tricoordinate Cu(I) structures. 20 Interestingly, the calculation
predicts a hydrogen-bonding interaction between the carbonyl and one hydrogen of the amine
(O-H distance of 1.9 A). The C3-bound oxindolate 14 is significantly higher in energy by 14.1
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kcal/mol. It is noteworthy that the geometry about Cu is no longer planar but trigonal pyramidal
and equidistant to both nitrogen atoms. There also appears to be a hydrogen bond between the
carbonyl oxygen and amine hydrogen (O-H distance of 2.0 A). The O-bound amidate 15 and
enolate 16 are 9.3 kcal/mol and 19.2 kcal/mol higher in energy respectively than the N-bound
structure. We also optimized K2-amidate and r 3-oxyallyl bound structures but no reasonable
stationary points could be found.
2.2.4 Synthesis and Isolation of Diamine-Cu(I)-Oxindolate Complex
Although ligated-Cu(I)-amidate complexes relevant to the Goldberg reaction have been
generated and studied in situ, these species have not been isolated and characterized."2' Our
initial attempt to prepare the computationally predicted CyDMEDA-Cu-oxindolate complex (7)
involved reacting Cul with stoichiometric quantities of CyDMEDA, oxindole and K2CO3 (eq. 1).
Under these conditions, transmetallation did not occur, and a diamine-Cul dimer was formed.22
Even with the use of Ag 2CO 3 as a base to facilitate the removal of the halogen atom from copper,
13' was not observed. Complex 13' was successfully prepared by mixing equimolar quantities of
(Cu-mesityl) 5,, oxindole and CyDMEDA in toluene (eq. 2). The 'H NMR spectrum of this
species in both toluene-d8 shows a two-proton singlet signal at 3.20 ppm corresponding to the
C3-protons. No amide N-H peak was detected near 9 ppm. This complex proved to be sensitive
to oxygen, changing colors from off-white to blue upon exposure to the air.
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Scheme 3. Synthesis and Reactions of CyDMEDA-Cu(I)-Oxindolate Complex 13'
Me(H)N ,• K2CO3 or Ag2C0 3









10 equiv 89% (GC) OMe
The reactivity of 13' was examined to evaluate the competency of this species in
amidation reactions of aryl halides. Complex 13' was reacted with an excess of 4-iodoanisole at
room temperature to provide the N-aryl oxindole in 89% yield (eq. 3). The catalytic activity of
13' was compared to the activity of the CuI/CyDMEDA combination generally employed in
amidation reactions of aryl halides3 by monitoring the formation of the N-aryl product using in-
situ IR spectroscopy. A graphical plot of product formation vs. time for the cross-coupling
reaction of 4-iodoanisole with oxindole in 1,4-dioxane at 80 OC at 5% catalyst loading (1:1,
metal:ligand) using 13' or CuI/CyDMEDA demonstrated that both catalyst precursors were
equally efficient at promoting the amidation process (Figure 7).
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Figure 7. Catalytic Competence of 13' Compared to CuI/CyDMEDAa
I , 5% Cu, 5% CyDMEDA O
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Time (h)
" Reaction Conditions: 1.0 mmol Oxindole, 2.0 mmol 4-iodoanisole, 2.0 mmol K2CO 3 , and 1.0
mL 1,4-dioxane, under Ar at 80 *C. (0) 0.050 mmol 13'. (*) 0.050 mmol Cul and 0.050 mmol
CyDMEDA. Reactions monitored by in situ IR spectroscopy. Product observed at 1514 nm'.
Data recorded at 2 min intervals.
Complex 13' proved difficult to recrystallize, due to the propensity of the complex to
disproportionate into Cu(0) and Cu(II) under a variety of standard recrystallization techniques.24
However, crystals of 13', suitable for X-Ray analysis, were obtained by recrystallizing the
material from a saturated solution of acetonitrile, layered with pentane at -15 OC in the glovebox.
The material obtained in this fashion provided an unexpected dinuclear Cu-complex, with
disproportionated ligands (Figure 8). While to CyDMEDA ligands were bound to Cu(1) in a
pseudo-tetrahedral arrangement (CyDMEDA bite angle = 85.0 *, average bond length = 2.05 and
2.12 A), two anionic oxindole ligands were bound to Cu(2) in a nearly linear geometry (bond
angle = 176.3 0, average bond length = 1.85 A). No hydrogen-bonding interactions were present
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in the complex. The methyl groups on each diamine ligand were arranged in a trans fashion,
presumably to minimize steric interactions.
Figure 8. ORTEP Diagrama and Rendition of Crystallized 13'a
" ORTEP Diagram with thermal ellipsoids at 30% probability
2.2.5 Discussion
In metal-catalyzed amidation reactions of aliphatic amides, such as 2-pyrrolidinone,
coordination and deprotonation of the nucleophile during the transmetallation step of the
catalytic cycle occur at the more acidic N-H position as opposed to the less acidic C-H, position
(Scheme 1). In the case of oxindole, both the N-H and the C-H, protons are significantly
acidified due to the conjugation of the deprotonated anion with the aromatic ring. Further, the
predisposition for the anion to reside on the more electronegative nitrogen atom is overcome by
the aromatic stabilization gained from isomerization of the anion to generate an enolate.8 Thus, a
1:1 ratio of amidate:enolate exists in solution. As such, the difference in reactivity between
typical aliphatic amides and oxindole demonstrated by Cu- and Pd-based catalyst systems might
not be entirely unexpected.
Since a weak base was employed (K2CO3), the large pKa difference (~5) between
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oxindole and the base indicates that appreciable quantities of an anionic amidate species do not
exist in solution; thus, an intermolecular ligand exchange between an oxindolate anion and
XPhos-Pd(Ar)(C1) 17 is unlikely. As such, it is likely that the oxindole is further acidified by
reversible coordination of Pd(II) intermediate 17 to the oxindole carbonyl to form 18 (Scheme
4). Deprotonation of the acidified oxindole should occur at N as opposed to C3, since
deprotonation is kinetically faster from N-H than from C-H bonds, in which rehybridization
must occur at the carbon atom."5 Thus, deprotonation of 18 would initially lead to 6, followed by
an intramolecular migration of Pd from O to either N or C. If intramolecular isomerization is the
preferred pathway, then a plausible reaction sequence to form a C-bound Pd enolate that does not
involve formation a Pd-N bond may be 17-18-6-*7--8-'2. If a Pd-N bond does transiently
form, then the reaction pathway might proceed as such, 17-18--6--55-1-5 67--8--2.






For the Pd-catalyzed C-arylation reaction of oxindole with aryl halides, transmetallation
of a molecule of oxindole to the LtPd(Ar)(X) complex can provide multiple isomeric species.
Two of these isomers, namely 1 and 2, would reductively eliminate to provide the N-aryl and C3-
aryl oxindole products, respectively. The energy profile illustrating the reaction course with the
relative energies of the key intermediates and transition states is shown in Figure 9. The C3-aryl
product, which is exclusively observed in the Pd-catalyzed reaction, must result from a rapid
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reductive elimination from the higher-energy Pd-C-bound enolate, 2, as opposed to the more-
stable Pd-N-bound amidate, 1. Therefore, the selectivity demonstrated by the Pd-catalyzed
reaction is kinetically governed according to the Curtin-Hammett principle? 6 The 2.4 kcal/mol
difference in energy between 1-TS and 2-TS is consistent with the observed selectivity of the
catalytic reaction. This difference in energy is likely a reflection of the relative
electronegativities of nitrogen and carbon and the overlap of the relevant molecular orbitals with
those of Pd?7















For the Cu-catalyzed N-arylation reaction, the computational studies of the relevant
CyDMEDA-Cu(oxindolate) species suggest that N-bound species 13 is favored by 14.1 kcal/mol
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over the C-bound isomer 14 (Scheme 5). Therefore, the selectivity observed for the Cu-catalyzed
N-arylation of oxindole might be governed by two different factors: (1) aryl halide activation
from 13 proceeds faster than from 14, or (2) aryl halide activation proceeds faster than the
isomerization process. If the first factor is selectivity-determining, there could be a dynamic
equilibrium in solution between 13 and 14. The nature of the aryl halide activation step in Cu-
catalyzed C-heteroatom bond-forming substitution reactions of aryl halides is not well
understood."7-19 Kinetic studies for the reaction of 2-pyrrolidinone with 4-iodo-m-xylene estimate
AG* to be 19.4 kcal/mol.' 7 Therefore, it is plausible that the C-bound enolate does exist in small
portions in solution, and that the selectivity is governed by the aryl halide activation processes
(k3 > k4). If the second factor is selectivity-determining, then the absence of a low energy
pathway for the interconversion of 13 and 14 determines the reaction's outcome. A better
understanding of the mechanism of aryl halide activation is required to properly estimate the
transition state energies to gain a full understanding for the observed chemoselectivity of the Cu-
catalyzed reaction.
Scheme 5. Mechanistic Considerations for the Cu-Catalyzed N-Arylation of Oxindole.





ArX k3  ArX k4
H Ar
Ar H
N-Aryl Product C-Aryl Product
Observed Not Observed
The stoichiometric (eq. 3) and catalytic (Figure 7) reactions of 4-iodoanisole with
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isolated complex 13' confirm that 13' is an active coupling agent possessing the nucleophilic
component to react with an aryl halide, thus providing evidence that 13 may be a possible
intermediate of the catalytic cycle.
Although the crystal structure of 13' does not match the computationally predicted
complex 13, several interesting features of 13' are worth considering. The linear geometry of the
Cu(2)(oxindolate) 2 species is consistent with a previously reported crystal structure of a linear
anionic [Cu{N(SiMePh2)2}2]- bis-amide complex containing tetrahedral-ligated Li-based cation, 28
and suggests that Cu(2) in 13' exist in the +1 oxidation state. However, the "cation" of 13'
contains a transition metal-based species, and thus allows for speculation as to the oxidation
states of each Cu atom of the complex. Although disproportionation of the Cu atoms could
generate a Cu(O)(CyDMEDA) 2 complex and the corresponding Cu(II)(oxindolate) 2 species, the
linear geometry of the Cu-bis-oxindolate species suggest that Cu(2) is a Cu(I) species.28 Further,
disproportionation of the Cu atoms is unlikely, as the tetrahedral Cu(O)(CyDMEDA) 2 complex
would possess 19 valence shell electrons.
The crystal structure obtained for 13' may be misleading, and likely does not accurately
represent the structure of the active complex. While Cu-catalyzed amination reactions of aryl
halides using diamine ligands are 1" order in Cu,17 a reaction based on a bimetallic Cu-complex
would involve a reaction that is 2nd order in Cu. Therefore, an active species based on the
structure of 13 is more likely. At a bare minimum, the crystallization of 13' reconfirms the
understanding of the lability of the amide and diamine ligands in solution,2' and reminds us that




In summary, we have reported efficient and complementary Pd- and Cu-based catalyst
systems for the C3- and N-arylation reactions of unprotected oxindoles using aryl halides. The
use of a weak base allows for the presence of a wide variety of functional groups and substitution
patterns that are not tolerated with stronger bases.7b-c Theoretical calculations suggest that for
both the Pd- and Cu-based catalyst systems, the respective metallated oxindoles have a strong
preference for the oxindole moiety to coordinate as an N-bound amidate as opposed to a C3-
bound enolate. For the Pd-based catalyst system, the energy difference between the Pd-amide
and Pd-enolates is ~ 5 kcal/mol, however, the selectivity is governed by a rapid C-C reductive
elimination compared to C-N reductive elimination based on calculated transition state energies.
For the Cu-based catalyst system, the preference for the metal to bind at N1 is stronger (- 14
kcal/mol). In this case, the selectivity might be governed by rapid aryl halide activation from the
diamine-Cu(I)-amidate complex compared to the diamine-Cu(I)-enolate. Alternatively, a low
energy pathway for Cu to isomerize from N to C may not exist, and the C-bound enolate might
never form. The implications of this study should be useful for those chemists interested in
understanding the inherent differences between Pd- and Cu-based catalyst systems for
nucleophilic substitution reactions of aryl halides.
2.4 Experimental Procedures
All reactions were carried out in resealable test tubes with Teflon septa under a dry argon
or nitrogen atmosphere. Copper(I) iodide (98%) and Pd2dba3 were purchased from Strem.
Copper(I) mesityl was prepared according to literature precedent and stored in a -20 °C freezer in
a nitrogen-filled glovebox.29 Diamine ligands were purchased from Aldrich and used without
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further purification. XPhos was generously provided by Saltigo. RuPhos was prepared according
to literature precedent.30 Anhydrous K2CO3 (99%) and NaOt-Bu (98%) were purchased from
Aldrich and stored under nitrogen in a Vacuum Atmospheres glovebox. Small portions (~5 g)
were removed from the glovebox in glass vials, stored in the air in a desiccator filled with
anhydrous calcium sulfate, and weighed in the air. Oxindoles were purchased from commercial
sources and used without further purification. Aryl halides were purchased from commercial
sources and, when necessary, filtered through neutral alumina or distilled. Anhydrous 1,4-
dioxane was purchased from Aldrich in Sure-Seal@ bottles. Anhydrous THF was purchased from
J. T. Baker in CYCLE-TRAINER@ solvent delivery kegs and vigorously purged with argon for 2
h. The solvent was further purified by passing it through two packed columns of neutral alumina
under argon. The solvents were transferred by syringe from the solvent purification system or bottle
to the reaction flask. Flash column chromatography was performed using a Biotage SP4 Flash
Purification System using KP-Sil silica cartridges. In all cases, dichloromethane was used to
transfer the crude reaction material onto the silica gel samplet, which was subsequently air-dried
before usage. A gradient elution technique was performed, based on the recommendation from
the Biotage TLC Wizard. In situ monitoring of reactions using infrared spectroscopy was
performed with a Mettler Toledo iC10 ReactIR instrument equipped with a CiFiber with a
diamond-tipped probe.
Yields reported in the publication are of the isolated material and represent an average of
at least two independent runs. Yields reported in the supporting information refer to a single
experiment. Compounds described in the literature were characterized by comparing their 'H
NMR and '3C NMR spectra, and melting points (m.p.) to the previously reported data; their
purity was confirmed by gas chromatography (GC) or elemental analysis. GC analyses were
performed on a Hewlett Packard 6890 instrument with an FID detector and a Hewlett Packard 10
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m x 0.2 mm i.d. HP-1 capillary column using dodecane as an internal standard. Elemental
analyses were performed by Atlantic Microlabs, Inc., Norcross, GA. Previously unknown
compounds were synthesized, purified and analyzed from a single run and were then repeated to
determine an average yield. They were characterized by 'H NMR, 13C NMR, m.p., IR and
elemental analysis. For those compounds that did not give a satisfactory elemental analysis, a
copy of their 1H NMR spectra is included. 'H NMR and 13C NMR spectra were recorded on
Varian 500 MHz instruments with chemical shifts reported relative to the deuterated solvent or
TMS. IR spectra were recorded on a Perkin-Elmer System 2000 FT-IR instrument for all
previously unknown compounds (KBr disc). Melting points (uncorrected) were obtained on a
Mel-Temp II capillary melting point apparatus.
All calculations were performed with the Gaussian '0331 suite of programs. DFT
calculations employed the B3LYP functional32 using the 6-31G(d) basis set for all atoms in the
Cu complexes. Due to the size of the XPhos-Pd complexes, geometry optimization was first
performed using a two-layered ONIOM33 calculation (B3LYP/6-3 g(d):UFF) with the oxindole,
phenyl, Pd and P at a high level and the rest of the ligand at the low level. The resulting
structures were then reoptimized using all atom DFT B3LYP/6-31g(d) with the LANL2DZ basis
set and the Hay-Wadt effective core potential34 (ECP) for Pd. To obtain the final AE values,
single point energy calculations were performed with the 6-311g(d,p) basis set with implicit
solvation included. Frequency calculations were performed on all optimized structures to
confirm that the minima had no negative frequencies and transition states had a single imaginary
frequency. The Gibbs free energies were calculated at 298.15 K and 1 atm.
General procedure for the C3-arylation of oxindoles
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An oven-dried screw-cap test tube was charged with Pd2dba3 (0.010-0.020 mmol), XPhos (0.04-
0.08 mmol), oxindole (1.00 mmol), aryl halide (1.20 mmol, if solid), K2CO3 (2.0 mmol), and a
magnetic stir bar. The reaction vessel was fitted with a rubber septum. The test tube was
evacuated and back-filled with dry argon twice. Aryl halide (1.20 mmol, if liquid), and solvent
(0.50-1.0 mL) were then added successively. The rubber septum was removed and the reaction
tube was quickly sealed with a Teflon-lined septum. The vessel was immersed in a pre-heated oil
bath and stirred vigorously until TLC and/or GC analysis of the crude reaction mixture indicated
that the limiting reagent had been completely consumed. The reaction mixture was cooled to
room temperature, diluted with dichloromethane (15 mL), and filtered through a plug of celite,
eluting with additional ethyl acetate (50 mL). The filtrate was concentrated and the resulting
residue was purified by flash chromatography (hexanes/ethyl acetate or
hexanes/dichloromethane) to provide the desired product.
General procedure for the N1-arylation of oxindoles
An oven-dried screw-cap test tube was charged with Cul (0.010-0.10 mmol), oxindole (1.00
mmol), aryl halide (1.20 mmol, if solid), K2CO3 (2.0 mmol), and a magnetic stir bar. The
reaction vessel was fitted with a rubber septum. The test tube was evacuated and back-filled with
dry argon. Aryl halide (1.20 mmol, if liquid), rac-trans-N,N'-dimethylcyclohexane-1,2-diamine
(0.040-0.20 mmol) and 1,4-dioxane (0.50-1.0 mL) were then added successively. The rubber
septum was removed and the reaction tube was quickly sealed with a Teflon-lined septum. The
vessel was immersed in a pre-heated oil bath and stirred vigorously until TLC and/or GC
analysis of the crude reaction mixture indicated that the limiting reagent had been completely
consumed. The reaction mixture was cooled to room temperature, diluted with ethyl acetate (15
161
mL), and filtered through a plug of silica, eluting with additional ethyl acetate (50 mL). The
filtrate was concentrated and the resulting residue was purified by flash chromatography
(hexanes/ethyl acetate) to provide the desired product.




The general procedure was followed using Pd2dba3 (9.1 mg, 0.010 mmol), XPhos (24 mg, 0.050
mmol), K2CO3 (0.28 g, 2.0 mmol), 4-chloroanisole (128 mg, 1.20 mmol), and oxindole (133 mg,
1.00 mmol) with THF (1.0 mL) as solvent for 24 h at 80 *C. Isolation and chromatographic
purification (hexane / ethyl acetate) afforded the title compound as white solid (226 mg, 94%).
'H NMR (500 MHz, CDCl3) 8 9.53 (s, 1H), 7.25-6.86 (m, 8H), 4.60 (s, 1H), 3.80 (s, 3H). 13C
NMR (125 MHz, CDCI3) 8 179.7, 159.2, 142.0, 130.1, 129.7, 128.7, 128.5, 125.3, 122.8, 114.6,




The general procedure was followed using Pd2dba3 (9.1 mg, 0.010 mmol), XPhos (24 mg, 0.050
mmol), K 2CO3 (0.28 g, 2.0 mmol), (136 [L, 1.00 mmol), and oxindole (146 mg, 1.10 mmol)
with 1,4-dioxane (1.0 mL) as solvent for 24 h at 100 *C. Isolation and chromatographic
purification (hexane / ethyl acetate) afforded the title compound as white solid (228 mg, 82 %).
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'H NMR (500 MHz, CDCl3) 8 9.29 (s, 1H), 7.58 (d, 1H, J = 7.5 Hz), 7.52 (s, 1H), 7.47 (t, 1H, J
= 7.8 Hz), 7.28 (td, 1H, J = 0.6 Hz, 7.8 Hz), 7.12 (d, 1H, J = 7.3 Hz), 7.07 (m, 1H), 6.96 (d, 1H,
J = 7.9 Hz), 4.71 (s, 1H). 13C NMR (125 MHz, CDCl3) 8 178.3, 141.9, 137.6, 132.2, 131.4,
129.6, 129.0, 128.7, 128.1, 125.5, 125.4, 124.8, 123.2, 110.6, 52.5. IR (KBr disc, cm -') 3226,
1712, 1621, 1472, 1332, 1221, 1167, 1127, 1075, 751, 700, 671, 592. Anal. Calc. for




The general procedure was followed using Pd2dba3 (9.1 mg, 0.010 mmol), XPhos (24 mg, 0.050
mmol), K2CO3 (0.42 g, 3.0 mmol), (129 mg, 1.00 mmol), and oxindole (160 mg, 1.20 mmol)
with 1,4-dioxane (1.0 mL) as solvent for 24 h at 100 *C. After cooling to room temperature, the
reaction mixture was dissolved in 2M HCI (5mL) and extracted with EtOAc (3 x 15 mL). The
combined organic fractions were dried over MgSO4 and concentrated. The residue was stirred in
5 mL CH2CI2 to dissolve the soluble impurities. The product was then isolated by filtration and
washed with hexane to provide the title compound as an orange solid (240 mg, 90%). 'H NMR
(500 MHz, CD3OD) 8 7.13 (tt, 1H, J = 0.9, 7.6 Hz), 6.98 (m, 1H), 6.92-6.89 (m, 3H), 6.85 (d,
1H, J = 7.8 Hz), 6.67-6.89 (m, 2H), 3.27 (s, 1H). 13C NMR (125 MHz, CD3OD) 8 180.7, 157.3,
143.0, 131.4, 130.3, 128.9, 128.5, 125.7, 123.3, 116.4, 110.6, 54.4. IR (KBr disc, cmn ') 3266,





The general procedure was followed using Pd2dba3 (9.1 mg, 0.010 mmol), XPhos (24 mg, 0.050
mmol), K2CO3 (0.28 g, 2.0 mmol), 4-chlorobenzonitrile (166 mg, 1.20 mmol), oxindole (133 mg,
1.00 mmol), and 200 mg flame activated 4A mol sieves with THF (1.0 mL) as solvent for 24 h at
80 *C. Isolation and chromatographic purification (hexane / ethyl acetate) afforded the title
compound as white solid (135 mg, 58 %). 1H NMR (500 MHz, CDCl3) 8 9.29 (s, 1H), 7.66-7.64
(m, 2H), 7.38-7.36 (m, 2H), 7.31-7.28 (m, 1H), 7.12-7.06 (m, 2H), 6.97 (d, 1H, J = 7.8 Hz), 4.71
(s, 1H). 13C NMR (125 MHz, CDC13) 8 177.7, 141.9, 132.9, 129.5, 129.2, 128.2, 125.4, 124.7,
123.3, 118.7, 111.8, 110.6, 52.7. IR (KBr disc, cm-') 3250 (br), 2230, 1711, 1620, 1471, 1328,




The general procedure was followed using Pd2dba3 (9.1 mg, 0.010 mmol), XPhos (24 mg, 0.050
mmol), K2CO3 (0.28 g, 2.0 mmol), 4-t-butyl-4-methylbenzenesulfonate (334 mg, 1.10 mmol),
and oxindole (133 mg, 1.00 mmol) with t-BuOH (1.0 mL) as solvent for 24 h at 80 *C. Isolation
and chromatographic purification (hexane / ethyl acetate) afforded the title compound as white
solid (164 mg, 64%). 'H NMR (500 MHz, CDCl3) 6 9.21 (s, 1H), 7.38-7.35 (m, 2H), 7.23 (t, 1H,
J = 7.8 Hz), 7.21-7.13 (m, 3H), 7.02, (1H, td, J = 7.9, 1.0 Hz) 6.88 (d, 1H, 7.8 Hz), 4.62 (s, 1H),
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1.31 (s, 9H). 13C NMR (125 MHz, CDCl3) 8 150.6, 141.9, 133.5, 130.0, 128.5, 128.2, 126.1,
125.4, 122.8, 110.2, 52.4, 34.9, 31.5. IR (KBr disc, cm-1) 3211 (br), 2963, 1709, 1620, 1515,





The general procedure was followed using Pd2dba3 (9.1 mg, 0.010 mmol), XPhos (24 mg, 0.050
mmol), K2CO3 (0.28 g, 2.0 mmol), (171 mg, 1.10 mmol), and 5-fluorooxindole (157 mg, 1.00
mmol) with 1,4-dioxane (1.0 mL) as solvent for 24 h at 100 *C. Isolation and chromatographic
purification (hexane / ethyl acetate) afforded the title compound as white solid (203 mg, 75 %).
1H NMR (500 MHz, CDCl3) 8 9.44 (s, 1H), 7.22 (dd, 1H, J = 7.5, 8.2 Hz), 6.94-6.82 (m, 3H),
6.69 (dd, 1H, J = 2.3, 5.9 Hz), 6.56 (t, 1H, J = 1.6 Hz), 6.50 (d, 1H, J = 7.6 Hz), 4.57, (s, 1H),
2.94 (s, 6H). 13C NMR (125 MHz, CDCl3) 8 180.0, 159.8, 151.7, 138.4, 137.4, 132.4, 132.3,
130.4, 116.9, 115.3, 113.7, 113.1, 112.7, 111.3, 54.4, 41.2. IR (KBr disc, cmn 1) 3219 (br), 3085,
2877, 2808, 1712, 1601, 1501, 1486, 1356, 1302, 1231, 1194, 1126, 999, 910, 815, 761, 732,
694, 592. Anal. Calc. for C16H15FN20: C 71.10, H 5.59. Found: C 70.87, H 5.61. m.p. 126-128
0C.
Methyl 3-(2-oxo-5-(trifluoromethyl)indolin-3-yl)benzoate (entry 7)
The general procedure was followed using Pd2dba3 (9.1 mg, 0.010 mmol), XPhos (24 mg, 0.050
mmol), K2CO 3 (0.28 g, 2.0 mmol), methyl 3-chlorobenzoate (153 [iL, 1.10 mmol), and 5-
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trifluoromethyloxindole (120 mg, 1.00 mmol) with THF (2.0 mL) as solvent for 24 h at 80 *C.
Isolation and chromatographic purification (dichloromethane / ethyl acetate, 1:0 - 9:1) afforded
the title compound as a slightly yellow foam (265 mg, 79%). 'H NMR (500 MHz, CDCl3) 8 9.94
(s, 1H), 8.01 (dt, 1H, J = 1.4, 7.8 Hz), 7.92 (t, 1H, J = 1.7 Hz), 7.52 (dt, 1H, J = 0.9, 8.2 Hz),
7.45 (m, 1H), 7.39 (dt, 1H, J = 1.4, 7.6 Hz) 7.34 (s, 1H), 7.01 (d, 1H, J = 8.2 Hz), 4.74 (s, 1H),
3.90 (s, 3H). 13C NMR (125 MHz, CDCl3) 8 178.9, 166.8, 145.0, 136.0, 133.1, 131.3, 129.9,
129.8, 129.6, 129.5, 126.6, 125.6, 122.3, 121.8, 110.5, 52.5, 36.3. IR (KBr disc, cm-') 3256,
2957, 1722, 1631, 1499, 1415, 1330, 1303, 1264, 1221, 1159, 1117, 1060, 91,0 829, 732, 695,




methyl 2-oxo-3-p-tolylindoline-7-carboxylate (entry 8)
The general procedure was followed using Pd2dba3 (9.1 mg, 0.010 mmol), XPhos (24 mg, 0.050
mmol), K2CO3 (0.28 g, 2.0 mmol), 4-chlorotoluene (130 [L, 1.10 mmol), and methyl oxindole-
7-carboxylate (191 mg, 1.00 mmol) with THF (2.0 mL) as solvent for 24 h at 80 *C. Isolation
and chromatographic purification (hexane / ethyl acetate) afforded the title compound as a white
solid (160 mg, 57%). 1H NMR (500 MHz, CDCl3) 8 9.22 (s, 1H), 7.86 (dt, 1H, J = 0.9, 8.1 Hz.),
7.29 (dd, 1H, J = 0.5, 7.3 Hz), 7.16 (d, 2H, J = 7.9 Hz), 7.01-7.03 (m, 3H), 4.60 (s, 1H), 3.96 (s,
3H), 2.34 (s, 3H). 13C NMR (125 MHz, CDCI3) 8 177.4, 166.6, 144.3, 137.7, 133.0, 131.1, 129.9,
129.8, 129.2, 128.4, 122.1, 111.6, 52.4, 51.5, 21.3. IR (KBr disc, cm' -1) 3267 (br), 3024, 3004,
2952, 1707, 1608, 1514, 1454, 1430, 1312, 1285, 1198, 1133, 1060, 993, 941, 916, 804, 774,






The general procedure was followed using Pd2dba3 (9.1 mg, 0.010 mmol), XPhos (24 mg, 0.050
mmol), K2CO3 (0.28 g, 2.0 mmol), 4-chloroanisole (134 piL, 1.00 mmol), and 1-methyl oxindole
(147 mg, 1.10 mmol) with THF (1.0 mL) as solvent for 24 h at 80 *C. Isolation and
chromatographic purification (hexane / ethyl acetate) afforded the title compound as white solid
(201 mg, 79%). 'H NMR (500 MHz, CDCl3) 8 7.34 (tt, 1H, J = 0.8, 7.6 Hz), 7.20-7.12 (m, 4H),
7.08 (dt, 1H, J = 0.8, 8.5 Hz), 9.91-6.81 (m, 3H), 4.57 (s, 1H), 3.79 (s, 3H), 3.26 (s, 3H). 13C
NMR (125 MHz, CDCl3) 8 176.5, 159.2, 144.6, 129.6, 129.2, 128.8, 128.5, 125.2, 122.8, 114.5,
108.3, 55.5, 51.4, 26.6. Anal. Calc. for Ci6HI5NO2: C 75.97, H 5.97. Found: C 75.58, H 6.00.
m.p. 85-88 *C. (Lit. 90-91oC). 36
1-phenyl-3-(3-(phenylcarbonyl)phenyl)indolin-2-one (entry 10)
The general procedure was followed using Pd2dba3 (9.1 mg, 0.010 mmol), XPhos (24 mg, 0.050
mmol), K3PO4 (0.42 g, 2.0 mmol), 3-chlorobenzophenone (217 mg, 1.00 mmol), and 1-
phenyloxindole (251 mg, 1.20 mmol) with 1,4-dioxane (1.0 mL) as solvent for 24 h at 80 *C.
Isolation and chromatographic purification (hexane / ethyl acetate) afforded the title compound
as white solid (341 mg, 88 %). 'H NMR (500 MHz, CDC13) 8 7.95-7.81 (m, 3H), 7.75 (dt, 1H, J
= 1.6, 7.4 Hz), 7.62-7.41 (m, 10H), 7.30-7.25 (m, 2H), 7.12 (td, 1H, J = 0.8, 7.5 Hz), 6.90 (d,
167
[
1H, J = 7.8 Hz), 4.89 (s, 1H). 13C NMR (125 MHz, CDCl3) 6 196.5, 175.0, 144.6, 138.3, 137.5,
137.3, 134.5, 132.7, 132.6, 130.4, 130.3, 129.8, 129.7, 129.0, 128.8, 128.5, 128.4, 128.1, 126.8,
125.5, 123.5, 109.9, 52.1. IR (KBr disc, cmf ') 1722, 1658, 1612, 1596, 1500, 1465, 1369, 1320,
1283, 1219, 1176, 911, 754, 722, 714, 698, 603. Anal. Calc. for C27H19NO2: C 83.27, H 4.92.




The general procedure was followed using Pd2dba3 (9.1 mg, 0.010 mmol), RuPhos (23 mg, 0.050
mmol), NaOt-Bu (0.20 g, 2.0 mmol), 3-bromoanisole (152 RxL, 1.20 mmol), and 3-
methyloxindole (146 mg, 1.00 mmol) with toluene (1.0 mL) as solvent for 9 h at 100 *C.
Isolation and chromatographic purification (CH2C12 / ethyl acetate) afforded the title compound
as yellow solid (228 mg, 90 %). 1'H NMR (500 MHz, CDCl3) 8 9.60 (s, 1H), 7.26-7.20 (m, 2H),
7.13 (td, 1H, J = 0.6, 7.5 Hz), 7.04 (td, 1H, J = 0.9, 7.65 Hz), 76.97 (d, 1H, J = 7.6 Hz), 6.93-
6.90 (m, 2H), 6.81 (ddd, 1H, J = 0.9, 2.5, 8.2 Hz), 3.77 (s, 3H), 1.83 (s, 3H). 13C NMR (125
MHz, CDCl3) 8 174.0, 159.7, 143.9, 143.6, 129.7, 129.4, 128.0, 128.0, 120.1, 113.1, 112.5, 55.3,
43.3, 37.9, 20.4. IR (KBr disc, cmn ') 3215, 1710, 1618, 1599, 1485, 1472, 1372, 1324, 1259,





The general procedure was followed using Pd2dba3 (9.1 mg, 0.010 mmol), RuPhos (19 mg, 0.040
168
mmol), NaOt-Bu (0.20 g, 2.0 mmol), 1-bromo-3-fluorobenzene (132 [LL, 1.20 mmol), and 3-
benzyloxindole (223 mg, 1.00 mmol) with toluene (1.0 mL) as solvent for 20 h at 100 *C.
Isolation and chromatographic purification (hexane / ethyl acetate) afforded the title compound
as yellow solid (253 mg, 80 %). 'H NMR (500 MHz, CDCI3) 8 8.18 (bs 1H), 7.49-7.42 (m, 2H),
7.20-7.15 (m, 2H), 7.10-6.88 (m, 5H), 6.86-6.63 (m, 2H), 6.73-6.70 (m, 2H), 3.66 (d, 1H, J =
12.8 Hz), 3.44 (d, 1H, J = 12.8 Hz). 13C NMR (125 MHz, CDCl3) 8 180.3, 164.0, 141.0, 135.5,
131.7, 130.2, 129.1, 129.1, 128.6, 127.8, 126.9, 126.0, 122.5, 115.8, 110.2, 58.2, 44.0. IR (KBr
disc, cm-1) 3198, 1697, 1617, 1507, 147, 1225, 1201, 1163, 1014, 855, 815, 754, 697. m.p. 189-
191 *C.




The general procedure was followed using CuI (9.5 mg, 0.050 mmol), rac-trans-N,N'-
dimethylcyclohexane-1,2-diamine (16 [tL, 0.10 mmol), K2CO3 (0.28 g, 2.0 mmol), 4-iodoanisole
(234 mg, 1.00 mmol), and oxindole (160 mg, 1.20 mmol) with 1,4-dioxane (1.0 mL) as solvent
for 24 h at 100 *C. Isolation and chromatographic purification (hexane / ethyl acetate) afforded
the title compound as white solid (204 mg, 85%). 1H NMR (500 MHz, CDC13) 8 7.33-7.30 (m,
311), 7.21 (td, J = 1.2, 7.8 Hz), 7.09-7.04 (m, 3H), 6.74 (dd, 1H, J = 0.3, 7.9 Hz), 3.87 (s, 3H),
2.71 (s, 2H). 13C NMR (125 MHz, CDC13) 8 174.9, 159.3, 145.88, 128.1, 127.9, 127.2, 124.7,
124.4, 122.8, 115.9, 109.4, 55.7, 36.1. Anal. Calc. for C,5H,3NO2: C 75.30, H 5.48. Found: C
75.17, H 5.41. m.p. 131-132 *C. (Lit. 118-122 *C).37
169
F1-(4-fluorophenyl)indolin-2-one (entry 2)
The general procedure was followed using Cul (1.9 mg, 0.010 mmol), rac-trans-N,N'-
dimethylcyclohexane-1,2-diamine (6.4 [LL, 0.040 mmol), K2CO3 (0.28 g, 2.0 mmol), 4-
fluoroiodobenzene (115 [L, 1.00 mmol), and oxindole (160 mg, 1.20 mmol) with 1,4-dioxane
(1.0 mL) as solvent for 24 h at 100 *C. Isolation and chromatographic purification (hexane /
ethyl acetate) afforded the title compound an orange solid (221 mg, 97 %). 'H NMR (500 MHz,
CDCl3) 8 7.42-7.39 (m, 2H), 7.34-7.32 (m, 1H), 7.25-7.21 (m, 2H), 7.10 (td, 1H, J = 0.9, 7.3
Hz), 6.75 (dd, J = 0.5, 7.9 Hz), 3.72 (s, 2H). 13C NMR (125 MHz, CDCl3) 8 174.7, 163.0, 161.1,
145.3, 128.7, 128.0, 124.9, 123.1, 116.9, 116.8, 109.4, 36.1. IR (KBr disc, cmn ') 1710, 1612,
1602, 1512, 1481, 1461, 1371, 1322, 1244, 1222, 1201, 1174, 1100, 952, 840, 814, 746. Anal.




The general procedure was followed using CuI (9.5 mg, 0.050 mmol), rac-trans-N,N'-
dimethylcyclohexane-1,2-diamine (16 [L, 0.10 mmol), K2CO3 (0.28 g, 2.0 mmol), 1-bromo-4-
iodobenzene(340 mg, 1.20 mmol), and oxindole (133 mg, 1.00 mmol) with 1,4-dioxane (1.0 mL)
as solvent for 24 h at 40 *C. Isolation and chromatographic purification (hexane / ethyl acetate)
afforded the title compound as white solid (148 mg, 57%). 'H NMR (500 MHz, CDCl3) 8 7.67-
7.65 (m, 2H), 7.33-7.30 (m, 2H), 7.25-7.18 (m, 2H), 7.10 (t, 1H, J = 7.6 Hz), 6.81 (d, 1H, J =
170
7.8 Hz), 3.72 (s, 2H). 13C NMR (125 MHz, CDC13) 8 174.3, 144.7, 138.9, 133.0, 128.3, 128.0,
124.9, 124.4, 123.2, 121.8, 109.4, 36.1. IR (KBr disc, cmn1) 1722, 1612, 1493, 1464, 1370, 1324,
1240, 1172, 1094, 1070, 1012, 821,751,673. m.p. 115-117 *C.
CN
4-(2-oxoindolin- 1-yl)benzonitrile (entry 4)
The general procedure was followed using Cul (9.5 mg, 0.050 mmol), rac-trans-N,N'-
dimethylcyclohexane-1,2-diamine (16 RL, 0.10 mmol), K 2CO3 (0.28 g, 2.0 mmol), 4-
iodobenzonitrile (343 mg, 1.20 mmol), oxindole (133 mg, 1.00 mmol) and 200 mg 4A flame
activated mol sieves with 1,4-dioxane (1.0 mL) as solvent for 24 h at 80 TC. Isolation and
chromatographic purification (hexane / ethyl acetate) afforded the title compound as white solid
(167 mg, 71%). IH NMR (500 MHz, CDCl3) 8 7.85-7.82 (m, 2H), 7.64-7.61 (m, 2H), 7.37-7.34
(m, 1H), 7.26 (td, 1H, J = 1.3, 8.0 Hz), 7.14 (td, 1H, J = 0.9 7.5, Hz), 6.90 (dd, 1H, J = 0.5, 8.0
Hz), 3.776 (s, 2H). 13C NMR (125 MHz, CDCI3) 8 174.1, 143.7, 138.8, 133.7, 128.1, 126.9,
125.2, 124.4, 123.8, 118.4, 111.4, 109.5, 39.7. IR (KBr disc, cm-n) 2231, 1714, 1607, 1513, 1463,
1365, 1242, 1167, 743, 630. m.p. 190-192 *C.
CF 3
1-(4-(trifluoromethyl)phenyl)indolin-2-one (entry 5)
The general procedure was followed using Cul (1.9 mg, 0.010 mmol), rac-trans-N,N'-
dimethylcyclohexane-1,2-diamine (6.4 [tL, 0.04 mmol), K2CO3 (0.28 g, 2.0 mmol), 4-
iodobenzotrifluoride (176 tL, 1.20 mmol), and oxindole (133 mg, 1.00 mmol) with 1,4-dioxane
171
(1.0 mL) as solvent for 24 h at 100 *C. Isolation and chromatographic purification (hexane /
ethyl acetate) afforded the title compound as white solid (242 mg, 87%). 'H NMR (500 MHz,
CDCl3) 8 7.81 (d, 2H, J = 8.3 Hz), 7.61 (d, 2H, J = 8.2 Hz), 7.36 (dd, 1H, J= 0.5, 7.3 Hz), 7.26
(td, 1H, J = 1.0, 7.7 Hz), 7.14 (td, 1H, J = 0.8, 7.5 Hz), 6.88 (d, 1H, J = 8.0 Hz), 3.76 (s, 2H).
13C NMR (125 MHz, CDCI3) 6 174.3, 144.2, 137.9, 129.9, 128.0, 127.0, 126.9, 126.8, 125.1,
124.4, 123.5, 109.5, 36.1. IR (KBr disc, cm ') 1724, 1613, 1483, 1370, 1324, 1240, 1169, 1123,





The general procedure was followed using Cul (9.5 mg, 0.050 mmol), rac-trans-N,N'-
dimethylcyclohexane-l,2-diamine (16 [LL, 0.10 mmol 1), K2CO3 (0.28 g, 2.0 mmol), 3-
iodonitrobenzene (275 mg, 1.1 mmol), and 6-methyloxindole (147 mg, 1.00 mmol) with 1,4-
dioxane (0.5 mL) as solvent for 24 h at 80 *C. Isolation and chromatographic purification
(hexane / ethyl acetate) afforded the title compound as red/brown solid (196 mg, 73%). 'H NMR
(500 MHz, CDCl3) 8 8.35-8.32 (m, 2H), .84-7.77 (m, 2H), 7.65 (d, 1H, J = 7.7 Hz), 7.07-7.04
(m, 1H), 6.75 (s, 1H), 2.43 (s, 3H). 13C NMR (125 MHz, CDCl3) 8 181.1, 157.9, 151.5, 150.8,
149.3, 134.4, 132.4, 131.2, 126.4, 123.6, 121.2, 115.77, 111.8, 39.8, 17.1. IR (KBr disc, cm-')
3093, 2922, 2865, 1728, 1626, 1533, 1369, 1352, 1242, 1179, 1112, 912, 805, 738, 690, 602.




methyl 3-(4-chloro-2-oxoindolin-1-yl)benzoate (entry 7)
The general procedure was followed using Cul (9.5 mg, 0.050 mmol), rac-trans-N,N'-
dimethylcyclohexane-1,2-diamine (16 [tL, 0.10 mmol), K2CO3 (0.28 g, 2.0 mmol), ethyl 3-
iodobenzoate (202 RtL, 1.20 mmol), and 4-chlorooxindole (168 mg, 1.00 mmol) with 1,4-dioxane
(0.5 mL) as solvent for 24 h at 80 *C. Isolation and chromatographic purification (hexane / ethyl
acetate) afforded the title compound as white solid (276 mg, 88 %). 1'H NMR (500 MHz, CDCI3)
6 8.13-8.08 (m, 2H), 7.65-7.60 (m, 2H), 7.17 (tt, 1H, J = 0.8, 8.0 Hz), 7.09 (dd, 1H, J = 0.8, 8.2
Hz), 6.68 (dd, 1H, J = 0.5, 7.9 Hz), 4.40 (q, 2H, J = 7.1 Hz), 3.73 (s, 2H), 1.40 (t, 3H, J = 7.1
Hz). 13C NMR (125 MHz, CDCl3) 8 173.5, 165.7, 145.9, 134.7, 132.5, 131.2, 131.0, 130.5,
129.6, 129.4, 127.8, 123.4, 123.1, 107.8, 61.6, 35.7, 14.5. IR (KBr disc, cm-') 1726, 1609, 1587,
1491, 1456, 1366, 1262, 1182, 1164, 1142, 1105, 1081, 1023, 755, 717, 687, 614. Anal. Calc. for
C16HI2CINO 3: C 64.67, H 4.47. Found: C 64.41, H 4.48. m.p. 114-116 *C.
& OMe
1-(3-methoxyphenyl)indolin-2-one (entry 8)
The general procedure was followed using Cul (19 mg, 0.10 mmol), rac-trans-N,N'-
dimethylcyclohexane-1,2-diamine (32 [IL, 0.20 mmol), K2C'O3 (0.28 g, 2.0 mmol), 3-
bromoanisole (152 ILL, 1.20 mmol), and oxindole (133 mg, 1.00 mmol) with 1,4-dioxane (1.0
mL) as solvent for 24 h at 100 *C. Isolation and chromatographic purification (hexane / ethyl
acetate) afforded the title compound as a slightly orange solid (139 mg, 58 %). 'H NMR (500
173
MHz, CDCI3) 6 7.46-7.43 (m, 1H), 7.32 (dd, J = 0.6, 7.2 Hz), 7.22 (td, 1H, J = 1.1,7.9 Hz), 7.07
(td, 1H, J = 1.1,7.5 Hz), 7.02-6.96 (m, 3H), 6.83 (dd, 1H, J = 0.3, 7.9 Hz), 3.84 (s, 3H), 3.72 (s,
2H). 13C NMR (125 MHz, CDCl3) 8 174.5, 160.7, 145.3, 135.7, 130.5, 127.9, 124.7, 124.4,




The general procedure was followed using Cul (19 mg, 0.10 mmol), rac-trans-N,N'-
dimethylcyclohexane-1,2-diamine (32 ýIL, 0.20 mmol), K2CO3 (0.28 g, 2.0 mmol), 5-bromo-m-
xylene (163 RL, 1.20 mmol), and oxindole (133 mg, 1.00 mmol) with 1,4-dioxane (0.5 mL) as
solvent for 24 h at 100 *C. Isolation and chromatographic purification (hexane / ethyl acetate)
afforded the title compound as slightly yellow solid (143 mg, 60%). 1'H NMR (500 MHz, CDCl3)
8 7.31 (dd, 1H, J = 0.4, 7.3 Hz), 7.21 (td, 1H, J = 1.1,7.6 Hz), 7.09-7.04 (m, 2H), 7.03 (d, 2H, J
= 0.5 Hz), 6.7 (d, 1H, J = 7.6 Hz), 3.73 (s, 2H), 2.39 (s, 6H). 13C NMR (125 MHz, CDCl3) 8
174.7, 145.7, 139.6, 134.4, 130.1, 127.9, 124.6, 124.5, 124.4, 122.8, 109.6, 36.2, 21.5. IR (KBr
disc, cm-') 1725, 1614, 1593, 1489, 1465, 1369, 1325, 1304, 1240, 1197, 176, 1095, 848, 750,
733,696, 619. m.p. 92-94 OC.
CI
1-(4-chlorophenyl)indolin-2-one3 (entry 10)
The general procedure was followed using Cul (19 mg, 0.10 mmol), rac-trans-N,N'-
dimethylcyclohexane-1 ,2-diamine (32 iLL, 0.20 mmol), K2CO3 (0.28 g, 2.0 mmol), 1-bromo-4-
174
chlorobenzene (287, 1.50 mmol), and oxindole (133 mg, 1.00 mmol) with 1,4-dioxane (1.0 mL)
as solvent for 24 h at 100 *C. Isolation and chromatographic purification (hexane / ethyl acetate)
afforded the title compound as white solid (192 mg, 79%). 'H NMR (500 MHz, CDCl3) 8 7.52-
7.49 (m, 2H), 7.40-7.37 (m, 2H), 7.334-7.31 (m, 1H), 7.23 (td, 1H, J= 0.8, 7.7 Hz), 7.10 (td, 1H,
J = 0.9, 7.5 Hz), 76.80 (dd, 1H, J = 0.6, 7.9 Hz). 13C NMR (125 MHz, CDCl3) 8 174.5, 144.8,
133.8, 133.1, 133.0, 130.0, 128.0, 124.9, 124.4, 123.2, 109.4, 36.1. m.p. 123-125 *C.
NMe 2
1-(4-(dimethylamino)phenyl)indolin-2-one (entry 11)
The general procedure was followed using Cul (19 mg, 0.10 mmol), rac-trans-N,N'-
dimethylcyclohexane-1,2-diamine (32 [IL, 0.20 mmol), K2CO3 (0.28 g, 2.0 mmol), 4-bromo-
N,N-dimethylaninline (200 mg, 1.00 mmol), and oxindole (160 mg, 1.20 mmol) with 1,4-dioxane
(1.0 mL) as solvent for 24 h at 100 *C. Isolation and chromatographic purification (hexane /
ethyl acetate) afforded the title compound as a tan solid (127 mg, 50%). 'H NMR (500 MHz,
CDCl3) 6 7.29 (dt, 1H, J = 0.5, 7.3 Hz), 7.24 (m 2H), 7.20 (td, 1H, J = 0.4, 7.8 Hz), 7.06 (td, 1H,
J = 0.9, 7.5 Hz), 6.8 (d, 2H, J = 8.8 Hz), 6.74 (d, 1H, J = 7.8 Hz), 3.70 (s, 2H), 3.02 (s, 6H). 13C
NMR (125 MHz, CDCl3) 8 175.2, 150.4, 146.4, 127.9, 127.7, 124.6, 124.5, 122.5, 113.2, 109.6,
105.3, 40.8, 36.2. IR (KBr disc, cm -1) 1712, 1610, 1524, 1483, 1462, 1354, 1241, 1168, 1095,
950, 8821,763, 631. Anal. Calc. for C,6H,6N20: C 76.16, H 6.39. Found: C 75.83, H 6.37. m.p.
171-172 *C.
Preparation of complex 13'
175
In a nitrogen-filled glovebox, oxindole (1.33 g, 10.0 mmol) and rac-trans-N,N'-
dimethylcyclohexane-1 ,2-diamine (1.42 g, 10.0 mmol) were stirred in dry toluene (50 mL). To
this solution was slowly added copper(I) mesityl (1.82g, 10.0 mmol) dissolved in toluene (20
mL). After a short time period ( < 5 min) a tan solid began to precipitate. The solution was
allowed to stir for an additional 15 min, after which time pentane (30 mL) was added. After
stirring for an additional 10 min, complete precipitation was achieved by storing the solution at -
15 °C overnight. The resulting solid was filtered, washed with additional pentane and dried
under vacuum to provide 3.2 g (95%) of a white (slightly pink) solid. 'H NMR (500 MHz, C6D6)
8. 7.28 (br s, 1H), 7.19 (br s, 1H), 7.02 (br s, 1H), 6.90 (br t, 1H), 3.42 (s, 2H), 2.31 (s, 6H), 2.14
(br s, 2H), 1.85 (d, 2H, J = 13.4 Hz), 1.80 (m, 2H), 1.49 (m, 2H), 0.91 (m, 2H), 0.73 (m, 2H). 13C
NMR (125 MHz, DMF-d7) 8 185.7, 130.5, 127.8, 123.9, 118.8, 112.6, 67.9, 64.5, 38.4, 30.8,
26.0. This compound was stored in a refrigerator at -15 OC in a nitrogen-filled glovebox.
Although thermally stable, this complex was found to be sensitive to 02. Crystals of 13' suitable
for X-ray diffraction analysis were grown in a nitrogen-filled glovebox by preparing a near-
saturated solution of 13' in acetonitrile at rt. Pentane was layered on top of the acetonitrile
solution, and the biphasic mixture was stored in a freezer at -15 OC. Crystals grew from the
biphasic membrane downward into the acetonitrile layer.
Stoichiometric reaction of 13' with 4-iodoanisole
In a nitrogen-filled glovebox, a dry schlenk tube was charged with 13' (33.5 mg, 0.100
mmol), 4-iodoanisole (234 mg, 1.00 mmol), 1,4-dioxane (1.00 mL), and a magnetic stir bar. The
vessel was sealed, removed from the glovebox, and stirred at rt for 30 min. Dodecane (22.5 mL,
0.100 mmol), ethyl acetate (20 mL), and NH4OH(aq) (2 mL) were stirred into the reaction mixture.
176
Analysis of the organic layer by GC confirmed an 88% corrected yield of 1-(4-
methoxyphenyl)indolin-2-one.
Cross coupling of 4-iodoanisole with oxindole monitored by IR spectroscopy (Figure 6)
In a nitrogen-filled glovebox, a dry 25 mL reaction vessel designed for use with the IR
probe was charged with either 13' (17 mg, 0.050 mmol) or Cul (9.5 mg, 0.050 mmol), oxindole
(133 mg, 1.00 mmol), 4-iodoanisole (351 mg, 1.50 mmol), K2CO3 (278 mg, 2.00 mmol), and a
magnetic stir bar. The vessel was sealed, removed from the glovebox, and attached to a vacuum
manifold. The tube was evacuated and back-filled with Ar. CyDMEDA (7.9 [L, 0.050 mmol, if
necessary), and 1,4-dioxane (1.00 mL) were added successively. Under a purge of Ar, the
reaction vessel was attached to a Mettler Toledo iC10 ReactlR, sealed and stirred in an oil bath at
80 °C, until the reaction was completed by IR monitoring. The reaction was cooled to room
temperature. Dodecane (225 mL) and ethyl acetate (20 ml) were added, and the reaction mixture
was sampled for GC analysis. The corrected GC yield was used to standardize the data obtained
from the IR.
Crystal data and structure refinement for 13'
Identification code 07067






Unit cell dimensions a = 25.053(16) =
b = 8.747(6) =















Completeness to theta = 29.57c0
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Absolute structure parameter




0.50 x 0.23 x 0.05 mm3
2.47 to 29.5700.
-34<=h<=34, -12<=k<= 12, -20<=1<=20
32316




Full-matrix least-squares on F2
8810 / 257 / 488
1.019
R1 = 0.0232, wR2 = 0.0575
R1 = 0.0265, wR2 = 0.0589
0.008(6)
0.350 and -0.173 e.= -3
178
Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (=2x 103) for
13'. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor







































































































































































































































































































































































































































































































































































































Symmetry transformations used to generate equivalent atoms:
Anisotropic displacement parameters (=2x 103) for 13'. The anisotropic displacement
factor exponent takes the form: -2p2 [ h2a*2 U11 + ... + 2 h k a* b* U12 ]














































































































































































































































































































































































Hydrogen coordinates ( x 104) and isotropic displacement parameters (=2 x 103 ) for 13'
x y z U(eq)
H(1) 4909(8) 2478(18) 8709(12)
185
H(1A) 4601 4550 7858 58
H(1B) 5225 4277 7757 58
H(1C) 5042 5588 8422 58
H(2) 5237(8) 4723(16) 10933(12) 28
H(2A) 5273 3039 12162 40
H(2B) 5855 3314 11825 40
H(2C) 5532 1783 11543 40
H(11) 4544 4905 9642 27
H(12A) 3913 3725 8582 39
H(12B) 4020 2107 9074 39
H(13A) 3235 3169 9569 42
H(13B) 3549 4705 9882 42
H(14A) 3468 3195 11184 42
H(14B) 3731 1761 10714 42
H(15A) 4384 2883 11741 34
H(15B) 4279 4522 11274 34
H(16) 4743 1952 10435 25
H(3) 6383(10) 1750(30) 9053(12) 26
H(3A) 6597 -236 9981 45
H(3B) 5960 -40 9903 45
H(3C) 6317 607 10779 45
H(4) 6355(11) 5290(30) 10447(12) 39
H(4A) 6435 7277 9427 71
H(4B) 5814 6930 9512 71
H(4C) 6101 6264 8667 71
H(21) 6840 2867 10671 29
H(22A) 7386 993 10098 36
H(22B) 7345 1791 9113 36
H(23A) 8175 2423 9867 44
H(23B) 7899 3012 10745 44
H(24A) 8127 5150 9890 47
H(24B) 7802 4476 8987 47
H(25A) 7283 6353 9653 43
H(25B) 7325 5421 10595 43
H(26) 6774 4344 8910 32
H(3AN) 6380 1872 10710 23
H(3A1) 6251 78 9192 27
H(3A2) 5903 -119 10045 27
H(3A3) 6536 -404 10170 27
H(4AN) 6403 4795 8772 19
H(4A1) 6522 6660 10217 43
H(4A2) 5902 6503 9857 43
H(4A3) 6323 7124 9188 43
H(21A) 6827 2213 9102 19
H(22C) 7343 1782 10916 25














































































Hydrogen bonds for 13' [= and oo]
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)
N(2)-H(2)...O(2)#1 0.964(14) 2.187(15) 3.109(3) 159.6(16)
N(3)-H(3)...N(5) 0.892(16) 2.650(17) 3.535(3) 171(2)
N(4)-H(4)...O(1)#1 0.891(16) 2.380(17) 3.261(3) 170(2)





SAMPLE DEC. & VT
date May 7 2007 dfrq 300.100
solvent CDC13 dn H1
file exp dpwr 30
ACQUISITION dof 0
sfrq 300.101 dm nnn
tn HI dmra c
at 4.003 dmf 200
np 48052 PROCESSING
sw 6002.4 wtffle
fb not used proC ft
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RAAVI280
exp3 s2pul
SAMIPLE DEC. & VT
date Apr 13 2007 dfrq 125.672
solvent CDC13 dn C13
file exp dpwr 30
ACQUISITION dof 0
sfrq 439.746 dm nnn
tn H1 dmm w
at 3.001 dmf 10000
np 63050 dseq
sw 10504.2 dres 1.0
fb not used homo n
bs 8 DEC2
tpwr 56 dfrq2 0
pw 8.6 dn2
dl 2.000 dpwr2 1
tof 1519.5 dof2 0
nt 16 dm2 n
ct 16 dmm2 c
alock n dmf2 200
gain not used dseq2
FLAGS dres2 1.0
11 n homo2. n
in n DEC3
dp y dfrq3 0
hs nn dn3
DISPLAY dpwr3 1
sp -198.1 dof3 0
wp 5314.1 dm3 n
vs 14 dmm3 c
sc 0 dmf3 200
wc 250 dseq3
hzam 21.26 dres3 1.0
is 33.57 homo3 n
rfl 4866.5 PROCESSING
rfp 3633.1 wtflle
th 7 proc ft
ins 1.000 fn 262144





10 9 8 7 6 5 4 3 2 1 ppm
y YYYYY Lr L7'
1.08 1.01.31 1.00
2.39.1%.08 11.84












































































I .... . .. ' II
9 8 7 6 5 4 3 2
1.183.42 3.35
1.00 2.09 1.00 3.39
ppm
__ _· _ _ __ _
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10 9 8 7
0.70 1.76 2.05
1.64 5.24 1.
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-^I---- " -A -Y
· · · · · · · ~· · · · · · · · -· ---
~flBi
Cartesian Coordinates for Complexes 1-16 and Transition States 1-TS-4-TS
Complex I
C -0.610381 2.338797 -0.191842
C -1.205948 2.173304-1.477423
C -2.574743 1.904434 -1.550257
C -3.386951 1.813495 -0.415244
C -2.787394 1.984173 0.833708
C -1.419580 2.251393 0.973850
C 0.778703 2.925792 -0.108323
C 1.989253 2.196228 -0.047975
C 3.206258 2.903506 -0.093313
C 3.249588 4.294298 -0.153380
C 2.057475 5.015976 -0.160884
C 0.845291 4.331700 -0.145143
H -3.027399 1.757751 -2.526400
H -3.398691 1.922058 1.728481
H 4.146157 2.363585 -0.088523
H 4.207648 4.805495 -0.189126
H 2.068373 6.101993 -0.194242
H -0.085748 4.889936 -0.177700
P 1.982067 0.351523 0.189316
Pd -0.183536 -0.557184 -0.208372
C 3.466187 -0.214449 -0.818764
C 3.882280 -1.679336 -0.559450
C 3.210341 0.027788 -2.323464
H 4.310491 0.418067 -0.511301
C 5.106369 -2.058700 -1.411597
H 3.053062 -2.349674 -0.800105
H 4.114372 -1.830262 0.500536
C 4.426851 -0.376409 -3.173576
H 2.336742 -0.557323 -2.636153
H 2.967539 1.081736 -2.503261
C 4.846185 -1.828741 -2.906637
H 5.365603 -3.108490 -1.225924
H 5.974855 -1.460368 -1.096107
H 4.193451 -0.232747 -4.236098
H 5.269278 0.293965 -2.945285
H 5.739004 -2.081327 -3.492711
H 4.045629 -2.504692 -3.238932
C 2.462274 0.227157 2.024295
C 2.047231 -1.118817 2.653706
C 3.925124 0.573978 2.371929
H 1.826197 1.002331 2.475742
C 2.291677 -1.129153 4.172015
198
H 2.607017 -1.940827 2.189786
H 0.989612 -1.307148 2.441660
C 4.157106 0.553443 3.894720
H 4.602302 -0.150549 1.900543
H 4.189810 1.561922 1.982077
C 3.747590 -0.788446 4.516461
H 2.020125 -2.110675 4.580642
H 1.624532 -0.396417 4.649730
H 5.212104 0.769927 4.106140
H 3.573265 1.362190 4.358201
H 3.887280 -0.761789 5.604439
H 4.406892 -1.582011 4.134628
C 0.429784 -2.419713 -0.653392
C 0.651887 -3.403825 0.313089
C 0.574285 -2.734021 -2.009718
C 1.075770 -4.681553 -0.074733
H 0.488100 -3.199889 1.365274
C 1.000437 -4.012345 -2.388969
H 0.320171 -2.004506 -2.771080
C 1.264229 -4.986488 -1.423265
H 1.249435 -5.438830 0.686628
H 1.109851 -4.245673 -3.445748
H 1.593461 -5.978818 -1.720470
C -0.864503 2.554223 2.366787
C -1.162226 1.442645 3.388891
C -1.382811 3.913391 2.881392
H 0.224515 2.639261 2.284375
H -0.766573 0.479034 3.052480
H -0.705423 1.684384 4.356534
H -2.237636 1.316442 3.554607
H -1.122699 4.726444 2.195117
H -2.473477 3.904014 2.990896
H -0.947998 4.144752 3.861346
C -0.413606 2.389633 -2.769056
C -0.642111 3.816434 -3.314821
C -0.722655 1.356908 -3.867882
H 0.650352 2.299992 -2.525981
H -0.344628 4.586082 -2.595761
H -0.061195 3.969308 -4.232610
H -1.700281 3.971297 -3.557775
H -0.719355 0.335341 -3.482857
H -1.710583 1.524476 -4.312980
H 0.014401 1.450268 -4.675049
C -4.888371 1.607299 -0.583888
C -5.589733 2.966395 -0.794517
C -5.552570 0.827236 0.561455
199
H -5.024898 1.023457 -1.504616
H -5.164592 3.507121 -1.647298
H -6.661852 2.826119 -0.978549
H -5.478886 3.601033 0.093493
H -5.052892 -0.128821 0.746005
H -5.549151 1.398830 1.497659
H -6.601092 0.622865 0.315151
C -2.774274 -2.076119 0.629983
C -3.885170 -2.775443 0.103900
N -2.079142 -1.379800 -0.363771
C -3.900019 -2.527878 -1.378643
H -3.812871 -3.436719 -1.986182
C -4.717069 -3.508283 0.936370
H -5.571635 -4.044718 0.529091
C -4.443519 -3.558839 2.312718
H -5.087173 -4.132687 2.973735
C -3.343207 -2.871072 2.829433
H -3.135744 -2.913461 3.896319
C -2.500116 -2.122574 1.999010
H -1.648683 -1.585663 2.405929
C -2.647810 -1.647526 -1.586137
O -2.237274 -1.258517 -2.678039
H -4.791087 -1.992393 -1.730842
Complex 2
C 0.939518 -2.357536 -0.263768
C 1.521942 -2.055544-1.529013
C 2.885006 -1.743613 -1.585645
C 3.700099 -1.720363 -0.450134
C 3.104412 -1.991560 0.785803
C 1.747369 -2.311888 0.906259
C -0.398764 -3.061125 -0.221911
C -1.673581 -2.458445 -0.107273
C -2.814677 -3.282167 -0.163272
C -2.724235 -4.665390 -0.296476
C -1.467870 -5.263235 -0.371995
C -0.328941 -4.463465 -0.338934
H 3.327686 -1.506563 -2.548608
H 3.717208 -1.975394 1.682699
H -3.802186 -2.838297 -0.108484
H -3.628255 -5.266828 -0.337059
H -1.372170 -6.341385 -0.467690
H 0.650660 -4.925903 -0.419149
P -1.842304 -0.627968 0.184285
Pd 0.239060 0.558808 -0.241123
200
C -3.413186 -0.196759 -0.761122
C -3.940606 1.225355 -0.468311
C -3.184401 -0.394401 -2.276205
H -4.192141 -0.901299 -0.438897
C -5.217771 1.513182 -1.277582
H -3.176177 1.965280-0.721574
H -4.152967 1.342611 0.600014
C -4.454358 -0.082180 -3.085713
H -2.370700 0.266195 -2.600741
H -2.861133 -1.422002 -2.481077
C -4.988009 1.325072 -2.783408
H -5.556867 2.535428 -1.068162
H -6.023264 0.840453 -0.945032
H -4.241684 -0.190666 -4.156906
H -5.230054 -0.824904 -2.844797
H -5.918058 1.506758 -3.337193
H -4.260121 2.071848 -3.130212
C -2.281166 -0.596244 2.032521
C -1.995974 0.777907 2.676368
C -3.685846 -1.106548 2.414573
H -1.551175 -1.304367 2.451704
C -2.195779 0.736311 4.201059
H -2.657857 1.540059 2.245449
H -0.973362 1.089487 2.437060
C -3.871566 -1.139615 3.943369
H -4.451803 -0.450674 1.979475
H -3.855859 -2.109786 2.009664
C -3.593857 0.228525 4.580126
H -2.022878 1.735102 4.621417
H -1.437769 0.074798 4.646416
H -4.888901 -1.475801 4.181894
H -3.187248 -1.886467 4.372472
H -3.696097 0.168187 5.671086
H -4.349219 0.949622 4.234020
C -0.548234 2.362485 -0.702094
C -0.869848 3.308908 0.277031
C -0.825582 2.647458 -2.045853
C -1.507750 4.503734 -0.078977
H -0.617973 3.133628 1.318111
C -1.460604 3.844789 -2.397177
H -0.527278 1.956261 -2.828587
C -1.813790 4.772599 -1.414323
H -1.757280 5.227060 0.694564
H -1.666560 4.052858 -3.445149
H -2.307317 5.701700 -1.688323
C 1.198425 -2.693696 2.281485
201
C 1.456094 -1.610322 3.345312
C 1.756901 -4.053929 2.747716
H 0.113292 -2.807940 2.189012
H 1.041714 -0.643798 3.038880
H 0.992596 -1.895522 4.297632
H 2.526822 -1.469870 3.532488
H 1.522033 -4.848111 2.031192
H 2.846583 -4.016428 2.862151
H 1.326622 -4.333814 3.716825
C 0.724223 -2.151932 -2.830637
C 0.948750 -3.515945 -3.518572
C 1.033377 -1.012083 -3.819806
H -0.337482 -2.084523 -2.571122
H 0.649090 -4.353242 -2.880993
H 0.366371 -3.571986 -4.446225
H 2.006201 -3.647586 -3.778178
H 1.057173 -0.031663 -3.336249
H 2.007413 -1.151689 -4.304028
H 0.279265 -1.003609 -4.616256
C 5.194620 -1.451517 -0.582664
C 5.991156 -2.770402 -0.503165
C 5.725445 -0.428982 0.437516
H 5.354215 -1.029938 -1.583911
H 5.654310 -3.484687 -1.262710
H 7.061179 -2.586688 -0.657935
H 5.869808 -3.244084 0.478883
H 5.168898 0.512770 0.390738
H 5.659205 -0.808316 1.464305
H 6.781238 -0.211189 0.238779
C 2.400198 2.490415 0.784108
C 2.606862 3.766556 0.206255
C 2.838377 4.900820 0.976272
H 2.991992 5.873012 0.515153
C 2.879465 4.750544 2.369106
H 3.062029 5.622115 2.992423
C 2.697997 3.497874 2.961499
H 2.744621 3.399928 4.042962
C 2.455729 2.365230 2.170680
H 2.311989 1.393593 2.636606
C 2.360627 2.304465 -1.570696
O 2.372448 1.930381 -2.739502
N 2.562235 3.629333 -1.178972
H 2.662538 4.375267 -1.852110
C 2.145021 1.521699 -0.308319
H 2.710337 0.586737 -0.284587
202
Complex 3
H 5.791211 1.193580 -0.909510
C 5.527752 -0.895805 -0.497671
C 5.177878 0.453764 -0.402689
H 5.018116 -2.868682 0.149995
C 4.742335 -1.818497 0.195312
C 4.073571 0.887634 0.339266
C 3.625798 -1.442303 0.954207
C 3.266870 -0.070022 1.003513
P -0.015979 0.675735 -0.185884
C 2.117774 0.357177 1.886763
C 0.758910 0.537708 1.505645
H 3.490867 0.415659 3.531155
C 2.449283 0.528244 3.244657
C -0.192678 0.789055 2.519454
H -1.245271 0.880114 2.256551
C 1.501385 0.820095 4.222668
C 0.162440 0.929304 3.858952
H 1.809325 0.941726 5.257736
H -0.607530 1.124600 4.599481
C 1.059150 -0.145915 -1.488712
C 0.842231 -1.673251 -1.479365
C 0.816425 0.404593 -2.911495
H 2.098916 0.065841 -1.217928
C 1.751927 -2.377993 -2.498924
H -0.205705 -1.887248 -1.719715
H 1.009904 -2.078536 -0.477549
C 1.727517 -0.297444 -3.935107
H -0.233831 0.245053 -3.194526
H 1.000698 1.483502-2.954098
C 1.544436 -1.820438 -3.914004
H 1.550235 -3.456785 -2.482890
H 2.802661 -2.248890 -2.203267
H 1.523062 0.100375 -4.937369
H 2.775490 -0.053248 -3.707446
H 2.237256 -2.296022 -4.619828
H 0.528724 -2.067573 -4.256141
C 0.046822 2.541703 -0.572590
C -1.100284 2.910294 -1.546810
C -0.035276 3.450770 0.672483
H 1.008025 2.731707 -1.069753
C -1.056809 4.395628 -1.944318
H -2.065043 2.708283 -1.051358
H -1.081315 2.285241 -2.443961
C 0.008698 4.939239 0.282486
203
H -0.969359 3.246862 1.213984
H 0.777275 3.230517 1.370760
C -1.100394 5.307602 -0.712095
H -1.893395 4.618576 -2.618124
H -0.135302 4.589121 -2.513675
H -0.070884 5.553399 1.188267
H 0.988278 5.166968 -0.164170
H -1.011388 6.359515 -1.011209
H -2.078065 5.202056 -0.219958
C 3.815786 2.388566 0.471281
C 3.950926 3.157495 -0.856130
C 4.740901 3.005873 1.541277
H 2.788289 2.522213 0.822179
H 3.352262 2.703055 -1.653619
H 3.615906 4.193409 -0.726574
H 4.989242 3.197355 -1.204613
H 4.595652 2.529180 2.516125
H 5.794472 2.885966 1.261859
H 4.539999 4.078165 1.654817
C 2.885390 -2.517381 1.758052
C 3.595353 -2.776076 3.105826
C 2.723044 -3.858914 1.016624
H 1.880637 -2.142656 1.980013
H 3.647155-1.874573 3.721940
H 3.060292-3.544339 3.676983
H 4.619810 -3.130981 2.939939
H 2.311207 -3.733211 0.011824
H 3.676548 -4.392134 0.924063
H 2.043242 -4.508700 1.578990
C 6.733669 -1.352019 -1.308920
C 8.049980 -0.773583 -0.754879
C 6.575625 -1.024926 -2.806227
H 6.789689 -2.445117 -1.215359
H 8.186071 -1.036931 0.299750
H 8.908389 -1.160150 -1.317115
H 8.067988 0.320197 -0.831288
H 5.661846-1.470191 -3.215401
H 6.524755 0.057604 -2.973662
H 7.428126-1.410283 -3.378186
Pd -2.333998 0.238590 -0.071139
C -2.233292 -1.728530 0.263691
C -2.702298 -2.597461 -0.725027
C-1.769611 -2.228187 1.481564
C -2.669664 -3.979236 -0.502753
H -3.107236 -2.214781 -1.656477
C -1.747324 -3.612594 1.695005
204
H -1.435815 -1.559962 2.267766
C -2.188715 -4.490576 0.703979
H -3.033830 -4.651483 -1.276214
H -1.389103 -3.997578 2.647163
H -2.170707 -5.563701 0.875116
N -4.363642 0.283580 0.260172
C -4.749513 0.456590 1.573640
C -5.466131 -0.120510 -0.496708
C -6.265317 0.188794 1.692048
O -4.007492 0.774860 2.500956
C -6.640457 -0.196555 0.286409
C -5.508016 -0.399241 -1.864795
H -6.773716 1.090827 2.055284
H -6.441201 -0.598331 2.435571
C -7.847888 -0.557789 -0.290918
C -6.731680 -0.769533 -2.434893
H -4.609449 -0.318874 -2.471289
C -7.893320 -0.851919 -1.663066
H -8.753145 -0.614450 0.310026
H -6.776654 -0.991843 -3.498511
H -8.833924-1.139091 -2.124994
Complex 4
H 5.899073 0.721299 -0.868346
C 5.412931 -1.325692 -0.445980
C 5.204762 0.053722 -0.365704
H 4.687366 -3.229602 0.201853
C 4.523621 -2.155889 0.238360
C 4.139910 0.606460 0.354260
C 3.441402 -1.658581 0.977038
C 3.228909 -0.255691 1.013564
P 0.043953 0.835453 -0.207644
C 2.124605 0.297817 1.883723
C 0.796581 0.621397 1.488486
H 3.484371 0.219412 3.538252
C 2.462325 0.439620 3.243610
C -0.129670 0.971320 2.495695
H -1.163479 1.167893 2.218584
C 1.543325 0.834343 4.213140
C 0.225843 1.080439 3.837909
H 1.854279 0.928027 5.250197
H -0.525027 1.357378 4.572164
C 1.029697 -0.122744 -1.490281
C 0.623079 -1.610556 -1.454014
C 0.853436 0.428089 -2.922491
205
H 2.088446 -0.037562 -1.224902
C 1.433649-2.441251 -2.462180
H -0.444824 -1.694270 -1.688655
H 0.742255 -2.015772 -0.444571
C 1.667243 -0.399140 -3.934150
H -0.209448 0.394056 -3.202170
H 1.168667 1.475682-2.983117
C 1.293263 -1.886301 -3.886629
H 1.100060 -3.486351 -2.427629
H 2.493569 -2.437175 -2.170439
H 1.513476 0.003917 -4.943468
H 2.738124 -0.285634 -3.709757
H 1.918125 -2.457656 -4.584938
H 0.253214 -2.008774 -4.222794
C 0.338422 2.675307 -0.611442
C -0.749109 3.161853 -1.600633
C 0.346001 3.602558 0.622722
H 1.319132 2.751974-1.100899
C -0.536630 4.628622 -2.012534
H -1.734372 3.072563 -1.111052
H -0.792090 2.527362 -2.490313
C 0.566724 5.071347 0.218759
H -0.613206 3.515151 1.152105
H 1.117227 3.298094 1.335885
C -0.483300 5.554524 -0.790507
H -1.337109 4.938365 -2.696166
H 0.404867 4.709464 -2.575922
H 0.551643 5.701961 1.116676
H 1.569901 5.178025 -0.220712
H -0.269824 6.585087 -1.100900
H -1.470568 5.570923 -0.306031
C 4.031357 2.127069 0.464441
C 4.263972 2.858567 -0.870704
C 4.995795 2.666317 1.541771
H 3.015940 2.364418 0.795018
H 3.633317 2.456153 -1.671516
H 4.035912 3.925378 -0.760173
H 5.305962 2.785852 -1.202607
H 4.787423 2.223561 2.521069
H 6.036586 2.436817 1.283591
H 4.902004 3.755209 1.635203
C 2.575744 -2.643910 1.770809
C 3.222455 -2.963934 3.136957
C 2.292018 -3.966897 1.032945
H 1.610160-2.165509 1.966673
H 3.349283 -2.067661 3.749618
206
H 2.598135 -3.670093 3.697730
H 4.209428 -3.421927 2.998725
H 1.927077 -3.806477 0.015088
H 3.184659 -4.600828 0.973743
H 1.529327 -4.534440 1.577813
C 6.578415 -1.911950 -1.232607
C 7.937428 -1.498429 -0.635364
C 6.501607 -1.554012 -2.728946
H 6.503619 -3.005023 -1.151958
H 8.011005 -1.786090 0.419138
H 8.760322 -1.978072 -1.178845
H 8.086007 -0.413643 -0.696822
H 5.551754-1.881293 -3.166343
H 6.586490 -0.471937 -2.884620
H 7.316332 -2.034504 -3.283743
Pd -2.385129 0.619535 -0.133591
C -2.578894 -1.339752 0.254365
C -3.074141 -2.195757 -0.734056
C -2.155452 -1.859078 1.481409
C -3.105353 -3.576894 -0.505955
H -3.452855 -1.800651 -1.671660
C -2.202452 -3.240931 1.704822
H -1.792997 -1.203290 2.266264
C -2.668425 -4.103690 0.710879
H -3.485307 -4.236693 -1.282756
H -1.876130 -3.636960 2.664222
H -2.701611 -5.175838 0.887225
C -4.749135 0.696722 1.569124
C -5.464612 0.106150 -0.607319
O -4.262910 1.237158 2.557964
C -6.164742 -0.669183 0.348336
C -5.785094 -0.033620 -1.955569
C -7.146951 -1.582008 -0.017277
C -6.781823 -0.942043 -2.339360
H -5.263320 0.556885 -2.705931
C -7.447644 -1.710235 -1.380335
H -7.673669 -2.172556 0.727784
H -7.036557 -1.050592 -3.390226
H -8.214900 -2.414869 -1.690412
C -4.471903 0.930593 0.111107
N -5.703952 -0.320564 1.617761
H -6.030297 -0.706848 2.491768
H -4.424527 1.995977 -0.155309
Complex 5
207
H 2.604766 1.727180 -2.962061
C 2.993218 2.542381 -1.018881
C 2.156225 2.083583 -2.040517
H 3.027436 3.409858 0.934682
C 2.391956 3.027390 0.140295
C 0.762912 2.078138 -1.922289
C 1.002359 3.054623 0.314907
C 0.173928 2.540470 -0.715291
P -1.999714 -0.014169 0.354419
C -1.322222 2.717374 -0.587899
C -2.274651 1.792374 -0.085694
H -1.057093 4.703314 -1.348911
C -1.782374 4.003330 -0.946709
C -3.600991 2.241251 0.103781
H -4.335310 1.574586 0.543616
C -3.101349 4.411188 -0.786706
C -4.020055 3.523470 -0.231963
H -3.400575 5.415180 -1.075048
H -5.051682 3.819287 -0.062516
C -3.445050 -0.787175 -0.601709
C -3.260793 -0.636339 -2.126183
C -3.774406 -2.245534 -0.220020
H -4.317799 -0.184514 -0.317745
C -4.479999 -1.170239 -2.898101
H -2.368713 -1.190284 -2.436957
H -3.097316 0.416536 -2.382074
C -4.991530 -2.763504 -1.009493
H -2.912769 -2.890049 -0.417127
H -3.992733 -2.319276 0.850894
C -4.791327 -2.625264 -2.523893
H -4.296240 -1.080913 -3.976420
H -5.355723 -0.541283 -2.677693
H -5.176413 -3.811047 -0.740171
H -5.888530 -2.200379 -0.709737
H -5.682663 -2.975310 -3.060087
H -3.957252 -3.268201 -2.839204
C -2.572145 -0.113828 2.162163
C -2.122227 -1.436066 2.827774
C -2.085501 1.075272 3.018752
H -3.672884 -0.094560 2.130909
C -2.663190 -1.549103 4.263331
H -1.024668 -1.454891 2.850840
H -2.435266 -2.305392 2.241689
C -2.608717 0.971887 4.462494
H -0.988165 1.082191 3.025626
H -2.411260 2.024422 2.582439
208
C -2.219687 -0.357865 5.122994
H -2.321152 -2.491572 4.709628
H -3.762486 -1.595875 4.238111
H -2.224984 1.816089 5.049303
H -3.705202 1.068158 4.457607
H -2.655930 -0.426760 6.127747
H -1.128108 -0.392581 5.249104
C -0.081229 1.654082 -3.126832
C 0.610197 0.618365 -4.033140
C -0.487040 2.869427 -3.990489
H -1.001423 1.197961 -2.745107
H 1.078730 -0.184347 -3.457080
H -0.119912 0.174425 -4.720043
H 1.389386 1.080120 -4.651081
H -1.091211 3.589007 -3.432735
H 0.405054 3.388847 -4.361123
H -1.071440 2.541771 -4.859368
C 0.443050 3.727669 1.572514
C 0.462684 5.265029 1.421175
C 1.176816 3.333111 2.868901
H -0.601579 3.421687 1.684799
H -0.126095 5.604588 0.563757
H 0.054604 5.742168 2.320891
H 1.489460 5.625924 1.286077
H 1.279460 2.249412 2.954393
H 2.180020 3.775171 2.914021
H 0.623037 3.715510 3.735513
C 4.508286 2.555803 -1.176171
C 4.953707 3.556727 -2.260686
C 5.083520 1.154267 -1.452296
H 4.926423 2.901773 -0.220549
H 4.584816 4.565741 -2.044993
H 6.047946 3.598346 -2.323779
H 4.573927 3.265933 -3.247592
H 4.797294 0.440340 -0.672889
H 4.727258 0.757148 -2.410154
H 6.178757 1.190673 -1.496771
Pd 0.173177 -0.929802 0.327336
C -0.257250 -2.561400 -0.746529
C -0.214314 -2.604183 -2.143167
C -0.446299 -3.756318 -0.035904
C -0.374870 -3.819677 -2.822118
H -0.051447 -1.697824 -2.713168
C -0.610165 -4.967581 -0.716643
H -0.458888 -3.751839 1.050250
C -0.578359 -5.004029 -2.112820
209
H -0.335042 -3.833635 -3.909151
H -0.756061 -5.884387 -0.149790
H -0.702757 -5.946119 -2.640322
N 2.143258 -1.518811 0.785745
C 2.335283 -0.615559 1.751840
C 3.292115 -2.303974 0.639693
C 3.729218 -0.745604 2.364441
O 1.417842 0.200563 2.050374
C 4.291131 -1.894283 1.555869
C 3.519118 -3.353586 -0.248001
H 3.659132-0.950525 3.440137
H 4.285078 0.193438 2.251419
C 5.520563 -2.534236 1.581761
C 4.765860 -3.990974 -0.208611
H 2.747247 -3.663515 -0.945152
C 5.758323 -3.592765 0.690378
H 6.293332 -2.224200 2.281992
H 4.961765 -4.812680 -0.893207
H 6.717515 -4.102978 0.701579
Complex 6
C 0.284678 2.499120 0.298059
C 0.163307 2.965712 -1.045551
C -1.091640 3.365655 -1.509637
C -2.236559 3.326112 -0.710483
C -2.110523 2.827043 0.587319
C -0.878817 2.427408 1.118753
C 1.658292 2.469566 0.931236
C 2.514285 1.348129 1.026508
C 3.794568 1.514529 1.587158
C 4.230271 2.746389 2.069292
C 3.378730 3.847693 2.001292
C 2.114720 3.702479 1.435286
H -1.182502 3.738130 -2.526552
H -2.990403 2.772791 1.221611
H 4.473312 0.670847 1.645641
H 5.225650 2.841060 2.494330
H 3.697349 4.816242 2.376802
H 1.456267 4.563570 1.366420
P 1.924792 -0.324397 0.483921
Pd -0.064095 -0.064040 -0.694339
C 3.470492 -1.139049 -0.207324
C 3.300985 -2.645171 -0.508641
C 3.987622 -0.385376 -1.452630
H 4.231358 -1.053380 0.581184
210
C 4.618433 -3.249830 -1.024136
H 2.517670 -2.786622 -1.258325
H 2.979259 -3.183908 0.388844
C 5.292832 -1.006091 -1.979752
H 3.221612 -0.426721 -2.236347
H 4.148912 0.673451 -1.218547
C 5.134450 -2.506450 -2.264033
H 4.465325 -4.311970 -1.252084
H 5.379264 -3.205957 -0.229901
H 5.610389 -0.474712 -2.885916
H 6.090489 -0.858388 -1.236168
H 6.089602 -2.933098 -2.595584
H 4.421304 -2.646468 -3.088838
C 1.545111 -1.163247 2.142978
C 0.541564 -2.328251 2.004999
C 2.774071 -1.569013 2.984072
H 1.027135 -0.361002 2.686769
C 0.138547 -2.875932 3.384307
H 0.984527 -3.138054 1.410087
H -0.350048 -1.986316 1.469383
C 2.346289 -2.120316 4.357466
H 3.349407 -2.342104 2.457514
H 3.443078 -0.713621 3.130049
C 1.357893 -3.286730 4.220327
H -0.542366 -3.726095 3.253041
H -0.428619 -2.103650 3.924573
H 3.236725 -2.432541 4.918367
H 1.877832 -1.312664 4.938864
H 1.044216 -3.6352615.212493
H 1.863550-4.135133 3.735354
C 0.166607 -1.727245 -1.801862
C -0.378072 -2.953177 -1.411559
C 0.779411 -1.609772 -3.054812
C -0.282732 -4.061923 -2.261746
H -0.903209 -3.042363 -0.467790
C 0.866004 -2.721460 -3.902404
H 1.187184 -0.660382 -3.387502
C 0.343357 -3.953171 -3.504723
H -0.710676 -5.011284 -1.947488
H 1.340810 -2.615937 -4.875525
H 0.413545 -4.816266 -4.161680
C -0.805569 2.036177 2.594874
C -1.866695 0.992638 2.993896
C -0.907608 3.281319 3.501099
H 0.180490 1.593840 2.772856
H -1.890376 0.143786 2.303114
211
H -1.663931 0.626497 4.008205
H -2.872375 1.429394 3.007774
H -0.108490 4.000968 3.294191
H -1.867062 3.791966 3.356970
H -0.837003 2.990905 4.556287
C 1.377392 3.128751 -1.960519
C 1.797180 4.609123 -2.073294
C 1.147087 2.531914 -3.361591
H 2.212279 2.583579 -1.508579
H 2.044105 5.034281 -1.095223
H 2.678923 4.709107 -2.717906
H 0.991726 5.211874 -2.509519
H 0.786536 1.500717 -3.297755
H 0.409860 3.106006 -3.934382
H 2.083104 2.541835 -3.932934
C -3.566393 3.837231 -1.246806
C -4.136425 4.975932 -0.379702
C -4.588471 2.699026 -1.415113
H -3.369719 4.251990 -2.244934
H -3.421833 5.801262 -0.283689
H -5.056962 5.371990 -0.824654
H -4.381833 4.625942 0.629898
H -4.182072 1.912152 -2.056442
H -4.840553 2.246850 -0.448482
H -5.515889 3.076762 -1.862598
C -3.858727 -2.041465 0.578282
C -4.800000 -2.002222 -0.477493
N -2.701536 -1.291343 0.310871
C -4.186628 -1.143699 -1.550705
C -6.007323 -2.675704 -0.380248
H -6.732336 -2.643786 -1.191289
C -6.285173 -3.409306 0.785096
H -7.225938 -3.946002 0.875309
C -5.353940 -3.452074 1.826300
H -5.580371 -4.023466 2.723816
C -4.133577 -2.770854 1.736666
H -3.413079 -2.801036 2.549818
C -2.857557 -0.754115 -0.885663
O -2.011939 0.001247 -1.497388
H -3.982507 -1.679989 -2.486523
H -4.780404 -0.260224 -1.811649
Complex 7
C 0.322192 2.499608 -0.033323
C -0.020168 2.699387 -1.403237
212
C -1.353117 2.957770 -1.735404
C -2.367039 3.031701 -0.780149
C -2.016397 2.827826 0.558518
C -0.700356 2.576634 0.957613
C 1.775790 2.588152 0.376157
C 2.664311 1.500807 0.549425
C 4.008064 1.768686 0.872744
C 4.477753 3.068348 1.047603
C 3.597524 4.139299 0.903905
C 2.268357 3.892775 0.569652
H -1.614250 3.109797 -2.778807
H -2.788618 2.900985 1.319943
H 4.710566 0.950543 0.985317
H 5.521896 3.238806 1.294848
H 3.942766 5.160414 1.040806
H 1.584373 4.726762 0.440697
P 2.048875 -0.246487 0.408623
Pd -0.047922 -0.213488 -0.615672
C 3.512271 -1.169671 -0.328714
C 3.356545 -2.707101 -0.303798
C 3.805879 -0.670848 -1.760453
H 4.379934 -0.925140 0.299908
C 4.598699 -3.393324 -0.899862
H 2.469990 -3.000611 -0.873408
H 3.205121 -3.061380 0.721387
C 5.036868 -1.373687 -2.358078
H 2.931463 -0.871807 -2.390539
H 3.960041 0.414667-1.763094
C 4.888797 -2.901217 -2.324323
H 4.449938 -4.480208 -0.893789
H 5.471970 -3.192551 -0.260459
H 5.192708 -1.025520 -3.387048
H 5.933578 -1.081358 -1.790998
H 5.794801 -3.380030 -2.716841
H 4.060960 -3.200468 -2.982673
C 1.935270 -0.765079 2.229974
C 0.982015 -1.960142 2.445648
C 3.283588 -0.983108 2.949205
H 1.459585 0.113281 2.688983
C 0.794707 -2.266137 3.941078
H 1.371859-2.851647 1.938467
H 0.014232 -1.742850 1.981774
C 3.073509 -1.291827 4.443313
H 3.823130 -1.820820 2.487701
H 3.919718 -0.097141 2.847640
C 2.137365 -2.490213 4.650267
213
H 0.147260 -3.144170 4.056537
H 0.269444 -1.425960 4.419006
H 4.045613 -1.476007 4.918326
H 2.646820 -0.406917 4.937927
H 1.978998 -2.667823 5.721333
H 2.613720 -3.396989 4.249070
C 0.002228 -2.096731 -1.334828
C -0.550845 -3.167010 -0.626718
C 0.493756 -2.308941 -2.628552
C -0.576208 -4.446814 -1.194272
H -0.987100 -3.015726 0.355056
C 0.459171 -3.589169 -3.194653
H 0.894582 -1.485049 -3.211832
C -0.065924 -4.663997 -2.474681
H -1.010150 -5.270389 -0.631953
H 0.837648 -3.738685 -4.203662
H -0.091118 -5.657817 -2.914083
C -0.384702 2.500409 2.451940
C -1.237221 1.452482 3.191190
C -0.531466 3.883298 3.120009
H 0.663855 2.204211 2.560378
H -1.120124 0.457638 2.747089
H -0.936665 1.389521 4.243929
H -2.302933 1.709161 3.174655
H 0.115426 4.626789 2.642541
H -1.563704 4.246502 3.055584
H -0.259405 3.828505 4.180993
C 1.035657 2.726305 -2.509896
C 1.317089 4.171714-2.970764
C 0.657757 1.843757 -3.714542
H 1.967799 2.329205 -2.095319
H 1.666734 4.798246 -2.143520
H 2.087723 4.181018 -3.751016
H 0.413676 4.634582 -3.385085
H 0.412111 0.825581 -3.397432
H -0.209726 2.239334 -4.254598
H 1.493484 1.800359-4.423394
C -3.790548 3.386909 -1.187765
C -4.171534 4.793391 -0.681254
C -4.824183 2.338573 -0.739202
H -3.809221 3.417072 -2.285375
H -3.463699 5.552056 -1.034433
H -5.172433 5.069548 -1.033496
H -4.182889 4.830593 0.415000
H -4.588970 1.347426 -1.136924
H -4.872549 2.261645 0.353757
214
H -5.823489 2.622209 -1.090394
C -4.336717 -1.555366 0.824766
C -4.786832 -2.096286 -0.419594
N -3.193744 -0.817000 0.558639
C -3.896357 -1.622210 -1.436787
C -5.922335 -2.924650 -0.412691
H -6.287367 -3.359087 -1.340512
C -6.580275 -3.177247 0.789613
H -7.461667 -3.814155 0.794091
C -6.126308 -2.621609 1.998779
H -6.660281 -2.829819 2.922359
C -4.993104 -1.805008 2.028021
H -4.635757 -1.378072 2.962880
C -2.946926 -0.813032 -0.827529
0 -1.986879 -0.090042 -1.335393
H -2.807895 -0.103636 1.159576
H -3.920612 -1.851958 -2.492751
Complex 8
H -1.988651 2.758101 -2.894183
C -2.474623 3.361344 -0.894174
C -2.259246 2.414641 -1.900509
H -3.041294 3.617886 1.150888
C -2.855839 2.894262 0.361524
C -2.403046 1.041088 -1.678564
C -3.012788 1.531746 0.643399
C -2.756151 0.586702 -0.381230
P -0.328711 -1.799439 0.412486
C -3.084644 -0.866235 -0.122296
C -2.202554 -1.899124 0.291720
H -5.125215 -0.392112 -0.578104
C -4.455704 -1.178912 -0.244566
C -2.761382 -3.150104 0.633667
H -2.118275 -3.940518 1.006436
C -4.977935 -2.429948 0.063606
C -4.120872 -3.423966 0.530071
H -6.042847 -2.617739 -0.043603
H -4.500231 -4.403546 0.807872
C 0.120023 -3.377931 -0.546038
C -0.236616 -3.237074 -2.040569
C 1.577050 -3.851120 -0.361938
H -0.521877 -4.165148 -0.129096
C 0.052570 -4.531804 -2.819694
H 0.347908 -2.418496 -2.474823
H -1.295545 -2.975963 -2.149010
215
C 1.845545 -5.144587 -1.154244
H 2.271444 -3.072540 -0.691362
H 1.782158 -4.039237 0.697714
C 1.507990 -4.983971 -2.641905
H -0.175467 -4.376608 -3.882084
H -0.621706 -5.327468 -2.468491
H 2.897017 -5.432257 -1.028302
H 1.243578 -5.963968 -0.732202
H 1.683241 -5.926431 -3.176646
H 2.179097 -4.235222 -3.085623
C 0.011588 -2.277617 2.219210
C 1.465314 -1.933005 2.617206
C -0.961103 -1.604425 3.210471
H -0.120672 -3.368752 2.286902
C 1.772400 -2.359361 4.063015
H 1.600883 -0.847119 2.520626
H 2.184138 -2.390482 1.931627
C -0.659186 -2.014807 4.663272
H -0.870055 -0.514811 3.110552
H -1.996793 -1.862151 2.968934
C 0.793998 -1.717684 5.055765
H 2.806264 -2.088381 4.313333
H 1.709333 -3.454959 4.143238
H -1.351275 -1.496719 5.339373
H -0.853869 -3.091368 4.782490
H 0.994436 -2.070861 6.075410
H 0.949739 -0.628788 5.062936
C -2.273283 0.078926 -2.860088
C -1.255351 0.532590 -3.921453
C -3.639829 -0.156169 -3.541093
H -1.929994 -0.883403 -2.467832
H -0.313149 0.853261 -3.468384
H -1.043972 -0.290114 -4.614569
H -1.637925 1.366488 -4.522018
H -4.368690 -0.596919 -2.855425
H -4.051317 0.790877 -3.910893
H -3.529635 -0.833822 -4.396973
C -3.532075 1.133358 2.027933
C -5.053556 1.376935 2.131601
C -2.814438 1.851237 3.187742
H -3.363675 0.060018 2.157658
H -5.612252 0.809099 1.380982
H -5.422177 1.081668 3.121912
H -5.286622 2.439160 1.989294
H -1.729038 1.780536 3.092285
H -3.078300 2.915106 3.228496
216
H -3.123955 1.408503 4.142907
C -2.332852 4.854428 -1.160694
C -3.373773 5.351718 -2.182799
C -0.906181 5.233878 -1.599881
H -2.531889 5.370286 -0.211411
H -4.393369 5.123819 -1.852518
H -3.293662 6.436847 -2.321248
H -3.226561 4.879328 -3.161557
H -0.166180 4.915770 -0.857416
H -0.645803 4.764948 -2.556547
H -0.816594 6.319537 -1.727998
Pd 0.875157 0.261034 0.006710
C 2.361879 -0.443117 -1.164039
C 2.256330 -0.568613 -2.555412
C 3.585832 -0.774077 -0.559824
C 3.332391 -1.039518 -3.319647
H 1.334246 -0.302299 -3.060125
C 4.658484 -1.249856 -1.321372
H 3.714826 -0.661801 0.513676
C 4.535687 -1.389693 -2.705655
H 3.224350 -1.127088 -4.398959
H 5.594055 -1.504684 -0.827895
H 5.370174 -1.756227 -3.298046
O 0.094198 1.845232 1.688028
C 1.235739 2.250004 1.345688
N 2.272892 2.553200 2.211072
C 3.453022 2.792888 1.494989
C 4.712481 3.146653 1.966385
C 3.171596 2.648101 0.113034
C 5.720205 3.367579 1.020876
H 4.908457 3.255634 3.029962
C 4.190464 2.887380-0.810381
C 5.461379 3.244594 -0.349910
H 6.715663 3.642007 1.359418
H 3.999748 2.779090-1.874452
H 6.260145 3.423339 -1.064438
C 1.761554 2.280218 -0.018655
H 2.205605 2.417188 3.209622
H 1.138670 2.653948 -0.827285
Complex 9
H 5.778881 1.384538 -0.628112
C 5.613832 -0.722011 -0.257721
C 5.180430 0.603543 -0.167839
H 5.185960 -2.729943 0.338692
217
C 4.845463 -1.698544 0.377949
C 4.010910 0.962171 0.511607
C 3.665652 -1.398976 1.072750
C 3.222519 -0.051116 1.112574
P -0.062896 0.584999 -0.220047
C 2.007388 0.297712 1.941505
C 0.658769 0.430015 1.504197
H 3.305288 0.368359 3.644436
C 2.272286 0.442903 3.317952
C -0.338077 0.612122 2.487745
H -1.375603 0.678279 2.169306
C 1.274787 0.661025 4.264056
C -0.050471 0.724863 3.845167
H 1.534025 0.763386 5.314346
H -0.857191 0.868191 4.558304
C 1.114108 -0.212798 -1.459354
C 0.979061 -1.748326 -1.472290
C 0.976991 0.337671 -2.896512
H 2.118250 0.044471 -1.104737
C 2.010349 -2.397222 -2.410164
H -0.027549 -2.018043 -1.807531
H 1.076510 -2.150601 -0.460093
C 1.996283 -0.322499 -3.843727
H -0.039860 0.152790 -3.270311
H 1.135980 1.419873 -2.916382
C 1.884378 -1.851442 -3.838674
H 1.871252 -3.485993 -2.405401
H 3.024705 -2.205290 -2.033130
H 1.854447 0.071972 -4.858103
H 3.010949 -0.032684 -3.533318
H 2.651856 -2.291196 -4.488469
H 0.910946 -2.146872 -4.256609
C 0.033177 2.449939 -0.589306
C -0.932180 2.856377 -1.732300
C -0.248148 3.333171 0.647125
H 1.067116 2.631579 -0.916379
C -0.775897 4.347035 -2.082417
H -1.960588 2.674377 -1.403851
H -0.771137 2.251818 -2.627897
C -0.116474 4.828732 0.305720
H -1.266081 3.132447 1.003802
H 0.434645 3.088296 1.466466
C -1.028820 5.235763 -0.858287
H -1.472178 4.603151 -2.891169
H 0.237410 4.534184 -2.470301
H -0.345413 5.424208 1.198901
218
H 0.929450 5.050311 0.042994
H -0.875151 6.292824 -1.111504
H -2.077740 5.129253 -0.549077
C 3.661058 2.443486 0.651995
C 3.860747 3.251094 -0.643907
C 4.462996 3.084113 1.804887
H 2.603040 2.513407 0.921864
H 3.365628 2.779266 -1.499994
H 3.447393 4.259437 -0.525636
H 4.920900 3.366447 -0.896411
H 4.267248 2.579371 2.756403
H 5.540475 3.027483 1.608875
H 4.194343 4.141132 1.920997
C 2.951280 -2.526558 1.826826
C 3.624197 -2.778716 3.194644
C 2.884120 -3.858763 1.054688
H 1.921485 -2.207144 2.017798
H 3.614984 -1.887843 3.828185
H 3.104673 -3.580642 3.733053
H 4.668570 -3.085154 3.059139
H 2.488121 -3.734753 0.043908
H 3.868700 -4.333876 0.974265
H 2.231766 -4.559435 1.588096
C 6.889987 -1.095918 -1.000402
C 8.136823 -0.462787 -0.353149
C 6.807699 -0.744195 -2.498129
H 6.998331 -2.186480 -0.924404
H 8.218437 -0.738890 0.703867
H 9.048103 -0.795185 -0.864539
H 8.103765 0.631759 -0.411311
H 5.942363 -1.222221 -2.970609
H 6.715639 0.338048 -2.648676
H 7.710606 -1.077228 -3.023694
Pd -2.359651 0.071136 -0.144856
C -2.097298 -1.905525 -0.153238
C -2.584574 -2.641428 -1.242353
C -1.578524 -2.584480 0.954984
C -2.541114 -4.040099 -1.223569
H -3.008381 -2.131746 -2.103357
C -1.545087 -3.984701 0.971529
H -1.196826 -2.033723 1.810153
C -2.020517 -4.716458 -0.117531
H -2.921445 -4.599200 -2.075690
H -1.144952 -4.500103 1.842063
H -1.990796 -5.802863 -0.103808
N -4.483273 0.104584 -0.017698
219
C -4.572629 1.430284 0.111699
C -5.766714 -0.455230 0.025002
C -6.025011 1.883257 0.249863
O -3.525208 2.143076 0.112528
C -6.745366 0.555391 0.180901
C -6.129781 -1.797282 -0.064181
H -6.289463 2.576841 -0.558308
H -6.171307 2.421256 1.194917
C -8.089768 0.224210 0.244537
C -7.491952 -2.116832 0.002335
H -5.373502 -2.566679 -0.182120
C -8.464820 -1.125805 0.153869
H -8.847212 0.995996 0.363898
H -7.794984 -3.158921 -0.065192
H -9.515325 -1.398966 0.202784
Complex 10
C -3.366826 -0.921406 -0.936542
C -3.383415 -2.215050 -0.360209
C -4.474672 -2.582081 0.438298
C -5.555704 -1.728760 0.670156
C -5.526351 -0.465114 0.072854
C -4.460396 -0.043301 -0.730188
C -2.296719 -0.558545 -1.934805
C -1.056451 0.088926 -1.687664
C -0.206027 0.325789 -2.794410
C -0.536302 -0.041469 -4.095692
C -1.750652 -0.678004 -4.332093
C -2.603814 -0.925074 -3.260509
H -4.494369 -3.574633 0.881247
H -6.365723 0.208222 0.224157
H 0.750893 0.814071 -2.628843
H 0.157909 0.161702 -4.905638
H -2.033104 -0.985210 -5.335202
H -3.552601 -1.422092 -3.440111
P -0.280258 0.715343 -0.096630
Pd 1.942741 0.062117 -0.514920
C -0.790919 2.528494 0.008877
C -0.136097 3.252776 1.207649
C -0.501749 3.312596 -1.289303
H -1.879413 2.511533 0.161518
C -0.648580 4.698918 1.324058
H 0.949456 3.264283 1.069010
H -0.324323 2.720263 2.145470
C -0.993800 4.767209 -1.179622
220
H 0.580724 3.307562 -1.476826
H -0.977651 2.830944 -2.149349
C -0.391195 5.488275 0.033647
H -0.160927 5.189396 2.175741
H -1.727198 4.691161 1.541639
H -0.749668 5.303834 -2.105122
H -2.090998 4.770263 -1.097472
H -0.801472 6.502590 0.116255
H 0.693364 5.596228 -0.110408
C -1.012906 -0.145321 1.421120
C 0.088510 -0.366896 2.487054
C -2.255436 0.507662 2.062410
H-1.307095-1.129674 1.039007
C -0.432676 -1.175316 3.687525
H 0.452611 0.605993 2.843247
H 0.948795 -0.873820 2.034311
C -2.766578 -0.316548 3.259450
H -2.003535 1.514294 2.417862
H -3.056677 0.613801 1.328728
C -1.673850 -0.527899 4.314395
H 0.367248 -1.277435 4.431777
H -0.682095 -2.194535 3.357980
H -3.634465 0.190076 3.700792
H -3.123589 -1.290380 2.898108
H -2.051768 -1.146870 5.137830
H -1.396407 0.442072 4.753423
C 2.889826 1.582385 0.366581
C 3.131701 1.613857 1.742658
C 3.417624 2.578136 -0.461947
C 3.890508 2.656039 2.290775
H 2.740200 0.839547 2.393331
C 4.169782 3.618426 0.096873
H 3.266543 2.542994-1.536335
C 4.4048913.662516 1.472447
H 4.077551 2.673158 3.361933
H 4.581217 4.386871 -0.553156
H 4.993396 4.469098 1.901131
C -4.542857 1.324514-1.412405
C -4.944500 2.462576-0.454666
C -5.507290 1.279119 -2.615997
H -3.549133 1.565678-1.804262
H -4.291466 2.507174 0.423838
H -4.882854 3.427247 -0.972134
H -5.974367 2.353641 -0.096230
H -5.194112 0.530943 -3.351216
H -6.524655 1.027466-2.293408
221
H -5.543311 2.253365 -3.118164
C -2.288771 -3.246511 -0.649457
C -2.741269 -4.228204 -1.751662
C -1.833433 -4.036040 0.592583
H -1.413479 -2.710573 -1.032909
H -2.984063 -3.705848 -2.681938
H -1.947369 -4.952615 -1.968707
H -3.631298 -4.785229 -1.435270
H -1.533450 -3.375821 1.413351
H -2.620640 -4.698934 0.969353
H -0.974492 -4.666631 0.336738
C -6.732937 -2.179539 1.525621
C -8.040144 -2.241188 0.712225
C -6.905049 -1.301782 2.780078
H -6.510360 -3.199905 1.866399
H -7.931415 -2.888475 -0.164846
H -8.858706 -2.633660 1.327099
H -8.337376 -1.246394 0.359433
H -5.990106 -1.285905 3.382298
H -7.146902 -0.266282 2.511906
H -7.720312 -1.681084 3.407593
C 6.781276 -1.901018 -0.772783
C 6.369632 -2.029778 0.575466
N 5.778106 -1.396654 -1.613903
C 4.939155 -1.565620 0.613660
C 7.241857 -2.496692 1.545670
H 6.928020 -2.593203 2.583487
C 8.547854 -2.850549 1.168287
H 9.244114 -3.222786 1.915443
C 8.954223 -2.727603 -0.164110
H 9.968696 -3.005500 -0.441171
C 8.079297 -2.252937 -1.148125
H 8.391630 -2.154127 -2.183633
C 4.720257 -1.206062 -0.864937
O 3.581946 -0.798705 -1.340070
H 4.226559 -2.340218 0.927656
H 4.775288 -0.692385 1.257199
Complex 11
C 3.406345 -0.730628 0.973803
C 3.381402 -2.110568 0.655240
C 4.393057 -2.632219 -0.161909
C 5.436233 -1.847009 -0.657284
C 5.452717 -0.493239 -0.309311
C 4.465656 0.082745 0.498568
222
C 2.426972 -0.176606 1.977389
C 1.156737 0.406374 1.721549
C 0.396331 0.839112 2.833412
C 0.845526 0.730440 4.146346
C 2.092101 0.162642 4.391779
C 2.855654 -0.280875 3.315876
H 4.380575 -3.691035 -0.408123
H 6.266043 0.131849 -0.667522
H -0.585454 1.273362 2.660341
H 0.218611 1.079210 4.961799
H 2.467201 0.057446 5.406047
H 3.826881 -0.730131 3.501851
P 0.243580 0.742654 0.113565
Pd -1.976294 0.252960 0.762542
C 0.787672 2.479102 -0.383855
C 0.041364 2.985058 -1.640348
C 0.635065 3.504679 0.759712
H 1.856860 2.391203 -0.622303
C 0.565019 4.365137 -2.074005
H -1.027399 3.057696 -1.416920
H 0.137855 2.278785 -2.470963
C 1.136986 4.895325 0.330911
H -0.424539 3.571956 1.039996
H 1.181056 3.177393 1.650366
C 0.436065 5.391976 -0.941127
H 0.011589 4.701616 -2.959531
H 1.620042 4.281328 -2.375404
H 0.987284 5.605604 1.153985
H 2.221812 4.847798 0.153271
H 0.850716 6.359548 -1.251065
H -0.629609 5.557523 -0.727667
C 0.820612 -0.414411 -1.271483
C -0.383890 -0.793766 -2.168225
C 2.007027 0.058174 -2.138775
H 1.133945 -1.319057 -0.737205
C 0.000145 -1.833229 -3.234660
H -0.768383 0.105847 -2.667061
H -1.204032 -1.171746 -1.546495
C 2.381193 -0.995462 -3.198679
H 1.741830 0.988113 -2.655706
H 2.878215 0.270862-1.516443
C 1.185871 -1.362315 -4.086704
H -0.870701 -2.043326 -3.868492
H 0.262057 -2.781161 -2.741579
H 3.210371 -0.614328 -3.808750
H 2.753853 -1.896489 -2.693117
223
H 1.469534 -2.139363 -4.807725
H 0.884121 -0.483480 -4.675742
C -2.957511 1.646995 -0.293585
C -3.434580 1.373685 -1.577868
C -3.264749 2.864372 0.323255
C -4.202066 2.331288 -2.252548
H -3.226735 0.422142 -2.056430
C -4.032832 3.816050 -0.358626
H -2.923824 3.075403 1.332599
C -4.497624 3.554637 -1.649033
H -4.572762 2.111046 -3.250954
H -4.272276 4.758611 0.128594
H -5.095287 4.294046 -2.175445
C 4.598807 1.555496 0.894474
C 4.918100 2.481840 -0.294475
C 5.658883 1.731698 2.001999
H 3.639354 1.880548 1.310574
H 4.199238 2.359365 -1.111891
H 4.889518 3.529312 0.028175
H 5.918419 2.297029 -0.702324
H 5.407812 1.148391 2.893640
H 6.646014 1.404820 1.653823
H 5.736417 2.785069 2.297179
C 2.333581 -3.060481 1.242697
C 2.904775 -3.811506 2.464657
C 1.772406 -4.074081 0.227394
H 1.491758 -2.456238 1.598056
H 3.238733 -3.118649 3.242957
H 2.143564 -4.469072 2.901281
H 3.761547 -4.431481 2.174329
H 1.385519 -3.584012 -0.672427
H 2.529554 -4.800435 -0.088768
H 0.951943 -4.640168 0.682978
C 6.531515 -2.461492 -1.520127
C 7.892367 -2.453805 -0.796219
C 6.636716 -1.784193 -2.899093
H 6.256326 -3.511489 -1.689670
H 7.831885 -2.971406 0.167416
H 8.656454 -2.952377 -1.404502
H 8.234716 -1.429785 -0.604519
H 5.679678 -1.815876 -3.431088
H 6.933898 -0.732751 -2.806739
H 7.388690 -2.287302 -3.518410
C -5.926640 -2.440514 -0.099337
C -6.833473 -1.615396 0.637825
N -4.647781 -2.022212 0.218896
224
C -6.046827 -0.714642 1.420541
C -8.213788 -1.827524 0.470354
H -8.929977 -1.214332 1.012271
C -8.653416 -2.830457 -0.389374
H -9.720131 -2.997526 -0.517332
C -7.740630 -3.635246 -1.096273
H -8.110096 -4.413904 -1.758505
C -6.364371 -3.446289 -0.959490
H -5.657426 -4.065685 -1.507224
C -4.708634 -0.991405 1.168546
O -3.629165 -0.480870 1.692645
H -3.792963 -2.508627 -0.004978
H -6.397502 0.057997 2.090129
Complex 12
H 5.712383 -0.095514 -1.201419
C 5.006686 -1.949416 -0.382436
C 4.986332 -0.561039 -0.540696
H 4.109898 -3.589372 0.654878
C 4.086369 -2.513481 0.502440
C 4.070472 0.253247 0.134789
C 3.148658 -1.747447 1.208333
C 3.117901 -0.344372 0.997763
P -0.008304 0.981211 -0.175548
C 2.178752 0.504801 1.822919
C 0.875564 0.957052 1.470253
H 3.667393 0.497075 3.363469
C 2.663514 0.822381 3.106860
C 0.117221 1.621878 2.456074
H -0.897151 1.921545 2.221834
C 1.909734 1.516334 4.049767
C 0.612928 1.902656 3.726056
H 2.329371 1.733730 5.028360
H -0.015763 2.414756 4.448664
C 0.775713 -0.275501 -1.338361
C 0.223104 -1.680859 -1.019326
C 0.546515 0.047950 -2.831874
H 1.853510 -0.270685 -1.148716
C 0.850148 -2.758541 -1.918661
H -0.866589 -1.670989 -1.164576
H 0.389606 -1.924073 0.034892
C 1.185425 -1.027005 -3.730209
H -0.530042 0.104125 -3.037639
H 0.974896 1.023413 -3.087913
C 0.656714 -2.430445 -3.405416
225
H 0.409851 -3.736724 -1.684010
H 1.923872 -2.835119 -1.696970
H 0.994954 -0.781048 -4.782822
H 2.277335 -1.011819 -3.596520
H 1.155944-3.181533 
-4.031075
H -0.414588 -2.478359 -3.651995
C 0.454686 2.681380 -0.901148
C -0.631167 3.154566 -1.895502
C 0.701221 3.789385 0.144248
H 1.394765 2.524110 -1.449270
C -0.231463 4.470895 -2.582626
H -1.566841 3.302647 -1.338440
H -0.853756 2.393296-2.645803
C 1.102864 5.112229 -0.533903
H -0.214697 3.948750 0.730286
H 1.475957 3.494727 0.857985
C 0.060022 5.576169 -1.559674
H -1.030917 4.782074 -3.266723
H 0.661780 4.302269 -3.203015
H 1.256314 5.882506 0.233010
H 2.071975 4.977366 -1.037624
H 0.402046 6.488933 -2.064191
H -0.871184 5.837500 -1.035658
C 4.171456 1.770344-0.025849
C 4.364720 2.223158 -1.484866
C 5.298909 2.336169 0.863055
H 3.233824 2.207390 0.330190
H 3.607191 1.791790 -2.148575
H 4.294392 3.315263 -1.552461
H 5.348465 1.939729-1.876343
H 5.132408 2.095484 1.918060
H 6.271194 1.920456 0.572464
H 5.355168 3.427528 0.768867
C 2.249429-2.445757 2.235086
C 2.994175 -2.630284 3.576110
C 1.712459 -3.815344 1.774418
H 1.385096 -1.800250 2.423736
H 3.313739-1.6753914.001364
H 2.344502-3.124872 4.308338
H 3.885310 -3.254816 3.438683
H 1.244114 -3.770765 0.787298
H 2.504749 -4.571869 1.734402
H 0.963099 -4.175196 2.488871
C 6.006807 -2.823486 -1.128133
C 7.459671 -2.504894 -0.725925
C 5.824541 -2.730531 -2.655118
226
H 5.806023 -3.863176 -0.835420
H 7.602928 -2.607461 0.355344
H 8.157802 -3.184550 -1.229168
H 7.734925 -1.480334 -1.003585
H 4.800844 -2.987900 -2.949132
H 6.032175 -1.717299 -3.019489
H 6.509702 -3.415425 -3.168929
H -7.286039 -4.197359 -0.694443
C -6.749620 -3.252457 -0.680815
C -5.842998 -2.965106 -1.707155
C -6.976457 -2.339116 0.356580
C -5.171611 -1.748817 -1.651786
H -5.675243 -3.667390 -2.519626
C -6.296020 -1.118800 0.400116
H -7.687466 -2.584747 1.140659
C -5.373596 -0.816258 -0.603127
N -4.246468 -1.203059 -2.552158
H -6.465862 -0.420758 1.215193
C -4.514948 0.338733 -0.865037
C -3.830472 0.041871 -2.118280
H -3.765157 -1.710762 -3.280763
H -4.823439 1.355457 -0.637038
O -2.874900 0.706932 -2.612262
Pd -2.390150 0.590527 -0.275689
C -2.756367 0.191186 1.657865
C -3.469799 1.100572 2.454479
C -2.348923 -1.022170 2.230173
C -3.751242 0.810075 3.794818
H -3.812995 2.044174 2.036040
C -2.638348 -1.314745 3.567577
H -1.801297 -1.749065 1.635765
C -3.336068 -0.398636 4.356986
H -4.302964 1.530381 4.395801
H -2.315122 -2.263365 3.991416
H -3.558128 -0.626092 5.396563
Transition State 1-TS
C -0.556715 2.567021 -0.425372
C -1.190641 2.211590 -1.643748
C -2.567920 1.959315 -1.637623
C -3.345179 2.063346 -0.481732
C -2.699973 2.419507 0.705432
C -1.324750 2.673481 0.759965
C 0.876878 3.037191 -0.449920
C 2.028435 2.226000 -0.284154
227
C 3.293061 2.831300 -0.422752
C 3.444769 4.191457 -0.682692
C 2.312860 4.993403 -0.808418
C 1.052776 4.412391 -0.696435
H -3.054941 1.684958 -2.569824
H -3.284514 2.518566 1.616035
H 4.190214 2.229837 -0.333557
H 4.440053 4.616164 -0.782677
H 2.406384 6.058446 -1.003116
H 0.166236 5.029259 -0.813225
P 1.914471 0.415689 0.168575
Pd -0.130341 -0.699601 -0.225750
C 3.398505 -0.333811 -0.718683
C 3.659348 -1.795353 -0.295916
C 3.204242 -0.245144 -2.248138
H 4.290393 0.248070 -0.449735
C 4.858272 -2.390391 -1.056150
H 2.768183 -2.399905 -0.493708
H 3.850645 -1.856250 0.780995
C 4.401183 -0.844334 -3.005873
H 2.290866 -0.791477 -2.518865
H 3.054163 0.796810 -2.554908
C 4.673214 -2.292715 -2.576412
H 4.994580 -3.436848 -0.755313
H 5.777032 -1.857818 -0.766170
H 4.214444 -0.793518 -4.086287
H 5.296273 -0.232886 -2.815088
H 5.557545 -2.685191 -3.094915
H 3.824077 -2.923793 -2.874165
C 2.372349 0.487037 2.014228
C 1.897623 -0.767033 2.780641
C 3.842362 0.810394 2.351279
H 1.761100 1.329507 2.368820
C 2.117116 -0.618648 4.295679
H 2.434967 -1.653979 2.421150
H 0.838335 -0.945088 2.564800
C 4.052904 0.951690 3.870672
H 4.494680 0.009543 1.977044
H 4.156064 1.735969 1.857784
C 3.579909 -0.295375 4.629810
H 1.802064 -1.537592 4.806915
H 1.472553 0.187816 4.675765
H 5.112658 1.148801 4.078271
H 3.495602 1.829097 4.230722
H 3.702744 -0.152453 5.711022
H 4.213635 -1.151055 4.352882
228
C -0.111479 -2.814364 -0.492306
C 0.212769 -3.629243 0.608937
C 0.308812 -3.199526 -1.782538
C 0.988344 -4.774786 0.422419
H -0.123076 -3.375288 1.605360
C 1.079880 -4.351823 -1.943306
H 0.025370 -2.607131 -2.641100
C 1.431337 -5.146964 -0.848808
H 1.243749 -5.380460 1.289103
H 1.405203 -4.626406 -2.944349
H 2.028864 -6.043745 -0.985301
C -0.711563 3.119101 2.087472
C -1.038800 2.154537 3.243054
C -1.138436 4.557453 2.444911
H 0.377190 3.129894 1.968443
H -0.756825 1.126085 2.993586
H -0.499943 2.451223 4.151405
H -2.108237 2.155069 3.482946
H -0.845205 5.265588 1.662447
H -2.225701 4.627153 2.568415
H -0.671629 4.877749 3.384548
C -0.434188 2.185431 -2.973246
C -0.672324 3.492392 -3.759615
C -0.777978 0.968999 -3.850876
H 0.635654 2.132943 -2.747748
H -0.351182 4.372343 -3.192622
H -0.116135 3.477515 -4.705046
H -1.736103 3.614515 -3.997137
H -0.716444 0.029808 -3.294576
H -1.791911 1.035852 -4.262661
H -0.088257 0.921153 -4.702735
C -4.854464 1.863554 -0.548763
C -5.584917 3.222227 -0.536685
C -5.398102 0.941356 0.556132
H -5.070816 1.385058 -1.514093
H -5.238026 3.866284 -1.352354
H -6.667584 3.083904 -0.646611
H -5.407908 3.753429 0.406639
H -4.892708 -0.029829 0.556438
H -5.269614 1.383171 1.551371
H -6.471784 0.768898 0.413300
C -2.615093 -2.351825 0.688948
C -3.870003 -2.818647 0.257077
N -1.777782 -2.029020 -0.412508
C -3.898586 -2.761940 -1.242375
H -3.999626 -3.742064 -1.726773
229
C -4.844112 -3.177612 1.179319
H -5.815984 -3.531240 0.843298
C -4.563560 -3.072525 2.548168
H -5.315432 -3.355778 3.279200
C -3.325720 -2.583753 2.971340
H -3.121343 -2.480992 4.033883
C -2.342963 -2.205867 2.049224
H -1.402263 -1.782397 2.384492
C -2.523930 -2.177703 -1.594175
O -2.129745 -1.922675 -2.718677
H -4.690584 -2.121188 -1.647567
Transition State 2-TS
C 0.454677 2.617400 -0.576890
C -0.501793 2.451653 -1.609330
C -1.845022 2.744718 -1.341347
C -2.278942 3.199395 -0.094054
C -1.317991 3.349349 0.910836
C 0.037917 3.076194 0.696796
C 1.922144 2.503340 -0.911362
C 2.711659 1.328680 -0.818920
C 4.048970 1.390614 -1.257536
C 4.618765 2.563419 -1.748420
C 3.849799 3.723408 -1.809925
C 2.520297 3.681283 -1.398423
H -2.578079 2.634692 -2.137335
H -1.628667 3.710502 1.887642
H 4.666445 0.500082 -1.224146
H 5.654622 2.566568 -2.077053
H 4.274886 4.651052 -2.183847
H 1.911088 4.578828 -1.461957
P 2.045433 -0.258813 -0.092674
Pd -0.308609 -0.566927 0.113855
C 2.897373 -1.586478 -1.123315
C 2.656453 -2.998203 -0.545250
C 2.405155 -1.513225 -2.585653
H 3.980627 -1.403807 -1.112979
C 3.298134 -4.085237 -1.425239
H 1.579059 -3.182647 -0.465719
H 3.061759 -3.070389 0.470046
C 3.043755 -2.606290 -3.459221
H 1.312963 -1.633261 -2.594975
H 2.619228 -0.525046 -3.010308
C 2.803773 -4.005634 -2.875437
H 3.077668 -5.072716 -1.000568
230
H 4.393028 -3.973060 -1.407620
H 2.643009 -2.541843 -4.479194
H 4.126343 -2.424668 -3.537435
H 3.300177 -4.766665 -3.491380
H 1.727551 -4.229004 -2.899663
C 2.887126 -0.254877 1.612862
C 2.144649 -1.150295 2.630169
C 4.402858 -0.533835 1.632917
H 2.739270 0.785556 1.936826
C 2.735470 -0.997760 4.042451
H 2.214048 -2.202088 2.322773
H 1.076951 -0.902416 2.638065
C 4.981336 -0.385130 3.052836
H 4.597180 -1.554857 1.276802
H 4.929308 0.147109 0.955768
C 4.245239 -1.274995 4.063640
H 2.211291 -1.669155 4.734102
H 2.549723 0.025421 4.401133
H 6.053315 -0.622118 3.040122
H 4.897631 0.666064 3.365892
H 4.649906 -1.119623 5.072021
H 4.423949 -2.331525 3.813429
C -1.229510 -2.430255 0.142046
C -0.862470 -3.323999 1.162816
C -1.526638 -2.939759 -1.134326
C -0.732997 -4.688212 0.888287
H -0.679773 -2.954179 2.166137
C -1.379195 -4.303298 -1.401791
H -1.870510 -2.277909 -1.922095
C -0.980536 -5.184955 -0.393919
H -0.437753 -5.364605 1.687516
H -1.592653 -4.676087 -2.401161
H -0.882917 -6.247399 -0.600560
C 1.031371 3.345221 1.826752
C 0.619664 2.682004 3.154762
C 1.250257 4.859845 2.020434
H 1.996537 2.918815 1.533198
H 0.424961 1.611971 3.028708
H 1.415199 2.804041 3.900073
H -0.286964 3.134418 3.572940
H 1.615245 5.331264 1.101394
H 0.316185 5.358990 2.304873
H 1.985880 5.045603 2.812591
C -0.104946 2.030588 -3.024761
C -0.207325 3.218114 -4.003295
C -0.917112 0.827603 -3.537771
231
H 0.943336 1.718706 -3.001852
H 0.427343 4.051947 -3.684068
H 0.108359 2.917206 -5.009732
H -1.237344 3.588520 -4.070448
H -0.836260 -0.016773 -2.844154
H -1.979405 1.072184 -3.658215
H -0.542709 0.506806 -4.517625
C -3.739392 3.569541 0.136597
C -3.899708 5.085521 0.367595
C -4.381659 2.767591 1.283349
H -4.284049 3.318285 -0.783781
H -3.478962 5.660860 -0.464629
H -4.959057 5.351567 0.466449
H -3.388973 5.402808 1.284749
H -4.338773 1.691604 1.085749
H -3.877106 2.957024 2.238219
H -5.435118 3.047911 1.403225
C -3.695761 -1.082915 0.002711
C -4.600366 -1.694269 0.899012
C -5.890566 -2.045312 0.520690
H -6.575569 -2.515680 1.220861
C -6.285210 -1.761657 -0.793718
H -7.289173 -2.026431 -1.114392
C -5.413140 -1.137287 -1.688349
H -5.743728 -0.916537 -2.699440
C -4.112656 -0.793513 -1.292106
H -3.436131 -0.304168 -1.987146
C -2.703296-1.267701 2.151211
O -1.987440 -1.166588 3.137484
N -3.978479 -1.819348 2.144435
H -4.408141 -2.178566 2.984962
C -2.418938 -0.845931 0.727239
H -2.122889 0.229057 0.725203
Transition State 3-TS
H -5.828729 1.011747 1.035861
C -5.462191 -1.079481 0.728094
C -5.198901 0.279599 0.538444
H -4.875615 -3.054359 0.158211
C -4.662307 -1.994954 0.042811
C -4.159499 0.730826 -0.282759
C -3.609967 -1.601325 -0.794863
C -3.329773 -0.216149 -0.933644
P -0.027855 0.806681 0.057154
C -2.243134 0.216794 -1.891400
232
C -0.879849 0.488934 -1.582007
H -3.684119 0.083048 -3.471771
C -2.638435 0.266562 -3.242113
C 0.013729 0.688580 -2.656320
H 1.067296 0.839397 -2.432365
C -1.746611 0.521144 -4.281533
C -0.399765 0.709347 -3.986247
H -2.101925 0.548507 -5.308253
H 0.328318 0.874207 -4.775536
C -0.981933 -0.061807 1.426858
C -0.609550 -1.558461 1.426516
C -0.726367 0.541541 2.824268
H -2.049839 0.037874 1.208509
C -1.369905 -2.334870 2.513595
H 0.470770 -1.653701 1.595551
H -0.801060 -1.996126 0.441530
C -1.487082 -0.235453 3.914144
H 0.350598 0.514302 3.045438
H -1.034012 1.592586 2.856508
C -1.133602 -1.728387 3.903644
H -1.059232 -3.387785 2.500183
H -2.445669 -2.319536 2.287536
H -1.270366 0.204333 4.896316
H -2.568226 -0.118260 3.748690
H -1.720365 -2.263724 4.661217
H -0.075996 -1.852695 4.179901
C -0.295338 2.670991 0.345498
C 0.789268 3.220144 1.303701
C -0.277266 3.498141 -0.957938
H -1.279733 2.792363 0.818234
C 0.595629 4.719251 1.590685
H 1.773700 3.060636 0.838615
H 0.806180 2.665526 2.245863
C -0.469278 4.999962 -0.681856
H 0.685485 3.345019 -1.466136
H -1.048560 3.153196 -1.652559
C 0.579187 5.543442 0.297112
H 1.392782 5.069479 2.258916
H -0.351839 4.867110 2.130534
H -0.430729 5.551892 -1.629810
H -1.474587 5.165415 -0.265904
H 0.385654 6.601048 0.517553
H 1.572274 5.496454 -0.173167
C -3.997483 2.232787 -0.513738
C -4.154578 3.075871 0.765407
C -4.980234 2.725420 -1.597156
233
H -2.987224 2.403229 -0.896684
H -3.522819 2.703804 1.579764
H -3.875352 4.117123 0.565882
H -5.189405 3.084882 1.126653
H -4.823824 2.201597 -2.545568
H -6.018597 2.557638 -1.286750
H -4.849550 3.799470 -1.777749
C -2.859016 -2.679374 -1.585302
C -3.638204 -3.059051 -2.864150
C -2.567700 -3.962820 -0.783121
H -1.895820 -2.262528 -1.896942
H -3.792098 -2.198638 -3.520460
H -3.091363 -3.822261 -3.431113
H -4.622736 -3.469472 -2.608374
H -2.084898 -3.754297 0.174885
H -3.481011 -4.534924 -0.581373
H -1.902055 -4.613332 -1.361863
C -6.589027 -1.555720 1.635674
C -7.967027 -1.062501 1.154940
C -6.343644 -1.159986 3.104633
H -6.598411 -2.653276 1.587954
H -8.158658 -1.368122 0.120519
H -8.765151 -1.471951 1.785700
H -8.037613 0.030867 1.199191
H -5.381940 -1.543783 3.463269
H -6.334621 -0.070058 3.225753
H -7.133471 -1.560703 3.751408
Pd 2.284564 0.326796 -0.077386
C 3.081495 -1.589832 -0.498035
C 3.144125 -2.509269 0.561432
C 2.805934 -2.036352 -1.802740
C 2.867953 -3.857137 0.319596
H 3.393039 -2.188409 1.564170
C 2.533548 -3.388500 -2.017679
H 2.809062 -1.336513 -2.627122
C 2.557958 -4.307010 -0.964925
H 2.900980 -4.556684 1.151659
H 2.299901 -3.720272 -3.026688
H 2.349237 -5.357784 -1.145059
N 4.308175 -0.169580 -0.355043
C 4.960217 0.107098 -1.567733
C 5.274831 -0.214266 0.681080
C 6.476044 0.103055 -1.320896
O 4.410383 0.288779 -2.640164
C 6.577722 -0.083752 0.166161
C 5.056406 -0.298824 2.055979
234
H 6.915506 1.039887 -1.682740
H 6.926387 -0.709667 -1.906107
C 7.672294 -0.077418 1.019486
C 6.167968 -0.306632 2.906635
H 4.048118 -0.323428 2.456941
C 7.465506 -0.205592 2.399797
H 8.678945 0.032367 0.623037
H 6.012806 -0.378292 3.979996
H 8.314891 -0.207824 3.076993
Transition State 4-TS
H 5.933380 0.743906 -1.106226
C 5.480569 -1.315969 -0.713537
C 5.280532 0.059730 -0.571741
H 4.817044 -3.240235 -0.061124
C 4.652153 -2.168773 0.017265
C 4.275282 0.587346 0.246350
C 3.631181 -1.697401 0.853839
C 3.414412 -0.296985 0.943229
P 0.149415 0.831778 -0.052165
C 2.360756 0.220600 1.895751
C 1.008537 0.544615 1.588316
H 3.810456 0.079025 3.467678
C 2.772366 0.303392 3.240004
C 0.138095 0.830479 2.661963
H -0.908870 1.022974 2.440207
C 1.905095 0.640682 4.276609
C 0.565940 0.883569 3.986280
H 2.272339 0.690231 5.298247
H -0.144272 1.114931 4.775172
C 1.050415 -0.131182 -1.395346
C 0.602404 -1.606433 -1.340199
C 0.818412 0.434619 -2.812714
H 2.123533 -0.078713 -1.186829
C 1.313334-2.459701 -2.403112
H -0.483680 -1.652093 -1.497484
H 0.780980 -2.017466 -0.341177
C 1.533588 -0.418501 -3.875946
H -0.259199 0.454191 -3.031391
H 1.178832 1.466888 -2.883433
C 1.102497 -1.889361 -3.812623
H 0.946691 -3.493281 -2.352110
H 2.389534 -2.494521 -2.181169
H 1.335863 -0.002772 -4.872518
H 2.620093 -0.351779 -3.717425
235
H 1.656735 -2.480722 -4.552818
H 0.038529 -1.967430 -4.081147
C 0.500967 2.668121 -0.422233
C -0.561466 3.230731 -1.396267
C 0.536699 3.550587 0.844021
H 1.485540 2.718671 -0.906997
C -0.288163 4.702115 -1.753462
H -1.547426 3.148885 -0.916081
H -0.618651 2.632835 -2.309997
C 0.805782 5.026581 0.500100
H -0.428553 3.470564 1.364174
H 1.294682 3.196215 1.548576
C -0.218327 5.581255 -0.498228
H -1.069597 5.065226 -2.433353
H 0.662213 4.773691 -2.303403
H 0.803135 5.622044 1.422125
H 1.815604 5.118968 0.072607
H 0.030749 6.615817 -0.767000
.H -1.209352 5.610039 -0.022146
C 4.183325 2.102751 0.421756
C 4.368011 2.889504 -0.889242
C 5.196353 2.590534 1.479243
H 3.184961 2.333966 0.804078
H 3.714662 2.515449 -1.685485
H 4.136189 3.948819 -0.727701
H 5.399586 2.839800-1.256492
H 5.024830 2.110267 2.447848
H 6.223476 2.364653 1.168301
H 5.115526 3.675402 1.620073
C 2.847430 -2.709051 1.698009
C 3.636097 -3.076259 2.974704
C 2.479552 -4.006467 0.951938
H 1.911554 -2.235737 2.012394
H 3.849317 -2.198564 3.590347
H 3.065051 -3.786244 3.585179
H 4.592318 -3.546849 2.715052
H 1.981118 -3.811848 -0.001052
H 3.361275 -4.625621 0.749516
H 1.802058 -4.605696 1.570979
C 6.570574 -1.875260 -1.618724
C 7.976385 -1.424774 -1.178249
C 6.318306 -1.525453 -3.098205
H 6.533287 -2.969554 -1.528708
H 8.172005 -1.698821 -0.135766
H 8.745336-1.892483 -1.804719
H 8.093325 -0.337995 -1.265944
236
H 5.335106 -1.879994 -3.427418
H 6.354601 -0.441651 -3.261426
H 7.079231 -1.984900 -3.740540
Pd -2.215974 0.382362 0.106931
C -3.317859 -1.290738 0.594708
C -3.451577 -2.261578 -0.407905
C -3.235904 -1.682757 1.939204
C -3.429927 -3.617898 -0.069800
H -3.575157 -1.967470 -1.444753
C -3.219215 -3.042188 2.264296
H -3.208948 -0.933971 2.723541
C -3.311286 -4.013144 1.264350
H -3.516462 -4.364799 -0.855650
H -3.143665 -3.338275 3.308078
H -3.308004 -5.068529 1.524109
C -5.222490 0.461021 1.478173
C -5.368156 0.093388 -0.862684
O -4.898728 0.821363 2.599509
C -6.595927 -0.238449 -0.247806
C -5.259057 0.029347 -2.247562
C -7.700485 -0.648893 -0.984479
C -6.366307 -0.377447 -3.005726
H -4.321668 0.290186 -2.733202
C -7.567218 -0.717378 -2.378038
H -8.639954 -0.901277 -0.500280
H -6.288738 -0.429642 -4.088040
H -8.417192 -1.035018 -2.976036
C -4.412115 0.484655 0.201814
N -6.470835 -0.046189 1.129963
H -7.210617 -0.149624 1.809652
H -3.988907 1.505528 0.068400
Complex 13
C 2.770923 -0.864727 0.279571
C 2.567312 0.629174 -0.094172
C 3.833984 1.450660 0.210349
C 5.096440 0.849354 -0.422081
C 5.287739 -0.604976 0.026126
C 4.054309 -1.446958 -0.333124
H 3.679313 2.480923 -0.133060
H 2.390902 0.675205 -1.178398
H 2.860836 -0.913666 1.373513
H 5.018499 0.885235 -1.518466
H 5.972426 1.451735 -0.152290
H 6.179882 -1.040272 -0.439986
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H 5.455260 -0.634974 1.112612
H 3.964079 -1.472648 -1.426720
H 4.186914 -2.486265 -0.002460
H 3.981108 1.501684 1.297571
N 1.333257 1.125997 0.529613
N 1.523234 -1.643577 -0.031147
Cu -0.014737 -0.460999 0.220787
N -1.690797 0.260903 -0.109839
C -1.759902 1.512613 -0.652350
C -3.231304 1.904106 -0.882604
H -3.395563 2.105974-1.948753
O -0.802091 2.251520 -0.938959
H -3.454724 2.835617 -0.347532
C -3.971468 0.702971 -0.365262
C -5.320885 0.401851 -0.268619
C -2.995602 -0.216674 0.075119
C -5.711241 -0.832129 0.275075
H -6.072334 1.111510 -0.609170
C -3.378171 -1.443161 0.618305
C -4.742812 -1.738999 0.712192
H -6.766157 -1.079457 0.357712
H -2.625193 -2.146483 0.965442
H -5.052023 -2.692166 1.135287
C 1.397073 1.644725 1.896421
H 2.027156 2.538629 2.011325
H 0.378145 1.900860 2.200286
H 1.763617 0.876946 2.588195
H 0.824751 1.784174 -0.074494
C 1.403505 -2.154812 -1.421202
H 2.207740 -2.850197 -1.692480
H 0.441907 -2.661825 -1.512149
H 1.407100 -1.318424 -2.123317
H 1.511217 -2.456674 0.583315
Complex 14
C 2.671791 0.713641 -0.621858
C 2.472456 -0.628174 0.129375
C 3.645551 -1.592035 -0.123532
C 5.005378 -0.949755 0.183982
C 5.192629 0.336708 -0.630219
C 4.054978 1.327094 -0.343378
H 3.500055 -2.498395 0.477490
H 2.445970 -0.404108 1.204298
H 2.605427 0.497052 -1.697237
H 5.072475 -0.715662 1.256176
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H 5.810849 -1.662015 -0.031753
H 6.157210 0.804142 -0.398476
H 5.212468 0.092371 -1.702311
H 4.117301 1.627626 0.710421
H 4.178594 2.241155 -0.939572
H 3.641815 -1.907620 -1.175418
N 1.131123 -1.179603 -0.179777
N 1.519577 1.624896 -0.340879
Cu -0.123320 0.442428 -0.004193
N -2.461832 -1.562571 0.664594
C -1.499264 -0.764899 1.317235
C -1.809023 0.623782 0.960927
O -0.629356 -1.262065 2.075343
C -3.098650 0.579395 0.261598
C -3.963607 1.562293 -0.220198
C -3.455783 -0.783155 0.079523
C -5.144650 1.190224 -0.873150
H -3.720916 2.614529 -0.086878
C -4.616912 -1.166345 -0.583551
C -5.465394 -0.158788 -1.058496
H -5.818704 1.959103 -1.242685
H -4.868464 -2.216192 -0.715860
H -6.384228 -0.432165 -1.570916
H -2.517009 -2.556279 0.834597
H-1.629490 1.387347 1.719354
C 0.998318 -2.025850 -1.374747
H 1.592789 -2.949064 -1.335707
H -0.056253 -2.294652 -1.476245
H 1.287110-1.467362 -2.271443
H 0.771122 -1.676992 0.642234
C 1.616545 2.464652 0.874112
H 2.449147 3.179406 0.846964
H 0.677924 3.012448 0.979232
H 1.727362 1.828943 1.755965
H 1.410333 2.250714-1.136675
Complex 15
C 3.085366 -0.214017 0.010453
C 1.973628 0.862989 0.136835
C 2.562609 2.231224 0.529667
C 3.720946 2.664870 -0.378134
C 4.824877 1.600716 -0.389516
C 4.262957 0.251678 -0.860364
H 1.759171 2.978153 0.519571
H 1.507052 0.968441 -0.852959
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H 3.462733 -0.407615 1.023780
H 3.355392 2.821629 -1.403414
H 4.119970 3.628389 -0.038402
H 5.650569 1.904865 -1.044082
H 5.246866 1.498541 0.620926
H 3.931061 0.366683 -1.899950
H 5.049116 -0.515721 -0.863148
H 2.933149 2.185658 1.562514
N 0.906846 0.367185 1.020706
N 2.474753 -1.518649 -0.423079
Cu 0.673369 -1.604612 0.284495
C 1.031879 0.589107 2.461205
H 1.057683 1.648159 2.757345
H 0.170678 0.119431 2.945323
H 1.933685 0.103320 2.852920
H -0.022194 0.657072 0.685043
O -1.088416 -2.188215 0.350490
C -1.972739 -1.279927 0.158481
C -4.075200 -0.276036 -0.107135
H -3.754575 -2.069203 1.119910
C -2.992917 0.626873 -0.224958
C -5.383564 0.161037 -0.236098
C -3.232178 1.978467 -0.475532
C -5.625588 1.521322 -0.487438
H -6.215807 -0.534222 -0.144682
C -4.556838 2.413285 -0.604240
H -2.402733 2.674672 -0.569237
H -6.646376 1.879565 -0.590931
H -4.755471 3.464803 -0.799317
N -1.743168 0.007502 -0.067024
C -3.465195 -1.625802 0.158511
H 3.071685 -2.266525 -0.071473
C 2.350110 -1.726623 -1.889599
H 3.318707 -1.729197 -2.405552
H 1.851992 -2.683570 -2.051199
H 1.721087 -0.945341 -2.321388
H -3.681769 -2.375782 -0.612929
Complex 16
C -3.121557 -0.139537 -0.187302
C -2.077413 0.977912 0.075451
C -2.587887 2.333268 -0.449570
C -3.975500 2.692496 0.100891
C -4.989068 1.583602 -0.209313
C -4.509740 0.237917 0.355383
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H -1.857340 3.111538 -0.196019
H -1.955158 1.064664 1.164506
H -3.205142 -0.258267 -1.275953
H -3.917349 2.838406 1.189365
H -4.309925 3.646709 -0.323545
H -5.972070 1.830039 0.209227
H -5.122848 1.502592 -1.297650
H -4.474047 0.316026 1.449700
H -5.228951 -0.557886 0.117842
H -2.643253 2.300749 -1.545765
N -0.767521 0.557407 -0.439350
N -2.604220 -1.466119 0.291120
Cu -0.740569 -1.581931 -0.145960
C -0.495380 0.722654 -1.870437
H -0.502640 1.766265 -2.213195
H 0.489541 0.295111 -2.071742
H -1.226241 0.160301 -2.462361
H 0.003685 0.953799 0.095295
0 0.999440 -2.097307 -0.382943
C 1.908894 -1.208849 -0.092010
C 3.287003 0.406449 0.764952
H 1.328953 -0.147095 1.747330
C 3.919819 -0.162755 -0.382865
H 3.232766 -1.756364 -1.648523
C 3.964710 1.423850 1.455707
C 5.168373 0.255212 -0.833884
C 5.217397 1.844537 1.008590
H 3.517653 1.878807 2.337342
C 5.816173 1.270159 -0.123913
H 5.628316 -0.195166 -1.710892
H 5.740575 2.631082 1.547578
H 6.792967 1.614725 -0.453173
N 3.056380 -1.125016 -0.882071
C 2.023984 -0.256421 0.923963
H -3.140830 -2.186425 -0.192182
C -2.748850 -1.731179 1.746628
H -3.794212 -1.721406 2.077548
H -2.312348 -2.708805 1.956202
H -2.189342 -0.984764 2.313932
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Copper-catalyzed Reactions of Hydroxypyridines
and Related Compounds with Aryl Halides
X.- R2  Cul cat.
base, 80-150 "C
X = Br, I
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N-Aryl 2-, 4-hydroxypyridines, and O-aryl 3-hydroxypyridines manifest significant
biological activities' and exhibit interesting photochemical properties.2 The successful N- or O-
arylation of 2-, 3-, and 4-hydroxypyridines with aryl halides have not been reported with the use
of Pd-based methods; 3' however, the use of Cu for this transformation has been described."
Although the Cu-mediated cross-coupling of 2-hydroxypyridines with aryl boronic acids,6 aryl
stannanes,7 and aryl bismuth reagents8 has been previously reported, aryl halides are preferred
substrates as these electrophiles tend to be more stable, easier to prepare, and/or less toxic than
the corresponding B, Sn, and Bi counterparts. Several accounts of the Cu-catalyzed N-arylation
of 2-hydroxypyridines with aryl halides have been reported without the use of added ligand and
with ligands 1, 2, and 5.9 However, the Cu-catalyzed N- and O-arylations of 4- and 3-
hydroxypyridines, respectively, are yet to be disclosed. Herein, we describe our recent progress
in coupling hydroxypyridines and hydroxyquinolines with aryl halides.




1 2 3 4 5
Previous accounts of the Cu-catalyzed N-arylation of 2-hydroxypyridine with N-
containing aryl halides reported that many substrates were incompatible with the methods.9 First,
N-containing heteroaryl halides could not be utilized. Li proposed that the coordination of the
sp2-hybridized nitrogen lone pair electrons of these electrophiles to the copper catalyst impeded
the cross-coupling reaction.d Second, ortho-substituted aryl halides were unreactive, as a
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maximum yield of 2% was reported for the reactions of 2-hydroxypyridines with such
substrates. 9 This finding agrees with the well-established notion that Cu-catalyzed C-heteroatom
bond-forming reactions of aryl halides are particularly sensitive to steric hindrance on the
electrophilic component.6 Finally, 2-hydroxypyridines bearing strongly electron-withdrawing
groups or containing substituents at the 6-position were also unreactive.df
3.2 Results and Discussion
While ligands 1 and 2 were first designed and reported for reactions of Cu-catalyzed N-
arylations of indoles lo and amides" (pKa = 21-26), using aryl iodides and bromides, 2-
hyroxypyridine is significantly more acidic (pK, = 17).12 Since the plK of imidazole (pK, = 19) is
closer to that of the hydroxypyridine, we felt that a good catalyst system for the N-arylation of
imidazoles13 might also be effective for the N-arylation 2-hydroxypyridines. We recently
reported that a catalytic system based on Cu20, 4,7-dimethoxy-1,10-phenanthroline (3) as a
ligand, and poly(ethylene glycol) as an additive was efficient for promoting the N-arylation of
imidazoles. Using a combination of Cul and 3, we found that N-containing heterocyclic aryl
halides could be coupled to 2-hydroxypyridine in modest to good yields (Table 1 entries 1-4).
The reactions of 2-hydroxypyridine with aryl iodides and bromides can be successfully
accomplished even in the presence of free N-H groups (Table 1, entries 3 and 6). By using this
catalyst system, a nonconjugated electron-withdrawing group at the 5-position was tolerated
(Table 1, entry 7). However, 2-hydroxy-3-methyl-5-nitropyridine was unreactive, presumably
due to the decreased coordinating ability (nucleophilicity) of the hydroxypyridine (Table 1, entry
8).
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Table 1. N-Arylation of 2-Hydroxypyridinesa
0•NH :R2 Y% Cul, Z% L
R k +* X K2CO3 , DMSO
24-30 h
entry product X L Y/Z temperature yieldb entry
t(C) (%)
1 •NBr 3 5/7.5 1106N
O S
2 N N Br 3 5/7.5 110
O H,, N
3 • 1I 110/20 100
4 ,
4 NIN 1 3 5/7.5 
110
" General reaction conditions: 1.2 mmol
K2CO3, 1.0 mL of DMSO under Ar or N2
product X L Y/Z temperature yieldb(CC) (%)
82c  5 ý• C I 3 10/15 110 80
NHO
850 6 N, Br 3 5/7.5 110 78
(I O NMe2
75  h N -• Br 3 10/15 120 71
47 8 Me - Me I 3 10/15 80-150 0
NO2
of 2-hydroxypyridine, 1.0 mmol of ArX, 2.0 mmol of
atmosphere. b Isolated yield. c DMF used as solvent.
In our own attempts to improve the reaction of 2-hydroxypyridine with hindered aryl
iodides, we discovered that a mixture of N- and O-aryl products was produced under the reaction
conditions, with the latter being the major product. This phenomenon had not been previously
reported for reactions of this type.' Using 5 as a ligand, we were able to achieve modest
selectivity for coupling the 2-substituted aryl halides with 2-hydroxypyridine to afford moderate
yields of 2-pyridylaryl ethers (Table 2). Under more forcing conditions, the selectivity changed
from O to N, providing the N-aryl product in poor yield with 3 as a ligand. Interestingly,
although N-arylation is the preferential pathway for the Cu-catalyzed arylation of 2-
hydroxypyridines with unhindered aryl halides, the milder conditions for achieving the O-aryl
product when using hindered aryl iodides suggest that the inherent preference for C-N bond-
formation over C-O can be overcome by steric effects. While the procedures are not very
selective, they do provide access to usable amounts of both the N-aryl and O-aryl products.
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Table 2. Arylation of 2-Hydroxypyridine with Hindered Aryl Iodidesa
A: 10% Cul, 20% 5
O K2CO3, DMSO + (0O
N 120 *C, 48 h O
H + I B: 10% Cul, 15%3  +
R K2CO3, DMSO R
150 'C, 96 h N-Aryl O-Aryl
entry Arl conditions a  N-Aryl O-Arylb yield of major productc
1 A 1.0 : 4.8 67
2 B 1.8:1.0 40
3 A 1.0:4.0 64
4 B 1.6:1.0 42
a Conditions A: 1.2 mmol of 2-hydroxypyridine, 1.0 mmol of ArI, 0.10 mmol of Cul, 0.15 mmol
of 3, 2.0 mmol of K2CO3, 1.0 mL of DMSO at 150 OC for 96 h under Ar or N2 atmosphere.
Conditions B: 1.2 mmol of 2-hydroxypyridine, 1.0 mmol of ArI, 0.10 mmol of CuI, 0.20 mmol
of 5, 2.0 mmol of K2CO3, 1.0 mL of DMSO at 120 OC for 48 h under Ar or N2 atmosphere. b
Detected by GC Analysis. c Isolated yield.
Although we have shown that 3 is a better ligand than diamines 1 and 2 for Cu-catalyzed
reactions of 2-hydroxypyridine with N-containing heteroaryl halides and with 2-substituted aryl
iodides, commercially available ligands 1-2 and 5 are still viable alternatives for other coupling
transformations of 2-hydroxypyridines with aryl halides. Attempts to arylate 2-hydroxy-6-
methylpyridine were met with limited success, even under forcing conditions. Presumably, the
hindered amide coordinates too poorly to Cu(I) for the catalytic reaction to proceed. If the
substrate does coordinate at N1, the methyl presumably impedes the aryl halide from interacting
with- the metal. On the other hand, if the methyl group provides too much hindrance to coordinate
at nitrogen, the resulting L-Cu(I)-O species might not react with the aryl halide, to form the 0-
aryl product.
Since with Cu-catalysis 2-hydroxypyridines reacted preferentially with aryl halides at
nitrogen instead of at oxygen, we became interested in exploring the selectivity difference
between the N- and the O-positions for 4-hydroxypyridines. Previous investigations have shown
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that, depending on the nature of the electrophile, reactions of 4-hydroxypyridine with an
electrophile can form the O-substituted product as the major product, the N-substituted product
as the major product, or mixtures of the N- and O-substituted products. 14 No O-arylation was
detected in reports of the uncatalyzed N-arylation of 4-hydroxypyridine with activated aryl
chlorides, 14 or in the Cu(II)-mediated vinylation with tetravinyl tin'" or arylation with arylboronic
acids.'6 Similarly, we have found that the Cu(I)-catalyzed coupling of 4-hydroxypyridine with a
variety of aryl and heteroaryl iodides and bromides showed complete selectivity for reaction at
nitrogen using ligands 3 and 4 (Table 3).17 The use of other N- and O-based chelating ligands,
including 1, 2, and 5, provided significantly lower yields of the N-substituted product. Only
when using 2-iodotoluene as the electrophile did we detect trace amounts of O-aryl product as
identified by GC/MS (Table 3, entry 4). However, we were unable to achieve selectivity for
formation of the aryl 4-pyridyl ether as the major product using a variety of conditions and
ligands. Reactions of 4-hydroxyquinolines were accomplished by employing a stronger base and
slightly higher temperatures (Table 3, entries 7 and 8). As with 2-hydroxypyridines, a 4-
hydroxyquinoline with an electron-withdrawing group conjugated with the nitrogen was
unreactive toward an aryl iodide under a variety of conditions (Table 3, entry 9).
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Table 3. N-Arylation of 4-Hydroxypyridines and Conjugated Hydroxyquinolinesa
R N Y% Cul, ZO/% L Ri -R2
+ -R2 K2CO3, DMSO
HOe •  24-48 h Oarid
tamn at ra• lrlb
entry product X L Y/Z
1 O N~•C OMe Br 3 5/7.5
I
OOQ2 O -O Br 3 7/7.5
3 (••~Me Br 4 5/20
OL NMe,
4 O N I 4 10/40
5 ~IN Br 4 10/40
a General reaction conditions: 1.2
K2CO3, 1.0 mL of DMSO under Ar
enp proue L /











I 4 2/8 110 90
I 4 10/40 120 68c
I 4 10/40 120
110 76
I 4 10/40 140 0
mmol of hydroxypyridine, 1.0 mmol of ArX, 2.0 mmol of
or N2atmosphere. b Isolated yield. c K3PO4 used as base.
For the 2- and 4-hydroxypyridines, we tentatively propose that the selectivity favoring N-
arylation occurs due to one of two factors. If the Cu-N binding affinity is significantly stronger
than that for the Cu-O bond, isomerization from Cu-N to Cu-O might be slower than aryl halide
activation (Scheme 1). Thus, the N-aryl product would form selectively. In the case that a non-
negligible amount of the Cu-O species is present in solution, the selectivity might be due to a
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For 3-hydroxypyridine and related compounds, N-arylation is not a viable reaction
pathway, and exclusive O-arylation might be possible. In our previous attempts to O-arylate 3-
hydroxypyridines with aryl halides (using Pd catalysts), none of the desired product was
observed.4 To construct the aryl-3-pyridyl ether structure, it was necessary to cross-couple the 3-
halopyridine with a phenol.
We have found that using a system based on Cul and 2,2,6,6-tetramethylheptane-3,5-
dione, 4,18 3-hydroxypyridines were successfully coupled with aryl bromides. The use of other
N- and O-based chelating ligands in this reaction, including those depicted in Figure 1 and other
fP-diketones,1 9 provided lower conversions and yields of product. Reactions of 3-
hydroxypyridines with aryl halides containing water and/or base-sensitive functional groups
could be accomplished at a lower temperature (80 °C) with the addition of molecular sieves to
prevent hydrolysis of the nitrile and ester groups (Table 4, entries 2 and 7). The reaction of an
aryl bromide was successful with a catalyst loading of 1% Cu, making this one of the most
efficient Cu-catalyzed N- or O-arylation reaction of an aryl bromide reported to date (Table 4,
entry 3). To O-arylate 8-hydroxyquinoline (Table 4, entry 4), ligand was not necessary, although
more forcing conditions were required to achieve complete conversion of the aryl halide. In
contrast, the presence of a neighboring coordinating group on the nucleophile has been
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demonstrated to accelerate the N-arylation of R-amino acids significantly.20 The requirement for
more strenuous conditions to O-arylate 8-hydroxyquinoline is not surprising since it is an
effective ligand for Cu-catalyzed O-arylation reactions of phenols. 21 Reactions of 3-
hydroxypyridines with 3-bromoquinoline and 4-bromoisoquinoline were successful (Table 4,
entries 2 and 6). This is notable, since the 3-pyridyl-3-(iso)quinolinyl ether structure cannot be
accessed by other direct routes such as Pd-catalyzed methods or SnAr of the corresponding 3-
halopyridine under mild conditions without further activation (e.g., using 3-hydroxypyridine N-
oxide). Under standard reaction conditions, the use of an aryl iodide gave significant amounts of
diaryl ether as a byproduct. However, by using 4 A molecular sieves and Cs2CO3 as a base,22 a
higher yield of aryl-pyridyl ether could be obtained (Table 4, entry 8).
Table 4. O-Arylation of 3-Hydroxypyridine and Nonconjugated Hydroxyquinolinesa
O X 
_ Y%fCul, Z% L 0 '--__R Y + X R2  1 R O R2
K3PO 4, DMF24- 8 h
entry product X L Y/Z temperature yieldb entry product X L Y/Z temperature yieldb('C) (%) ('C) (%)
1 •( /•- Br 4 5/20 110 82CI O 0r
c Me 5 Br 4 10/40 120 69
2 O CN Br 4 10/40 80 78C
6 ia, Br - 10/0 110 77
3 \OMe Br 4 1/4 120 91 N e t-Bu
NMe2
Me yO k0A CO 2EtM e. 1 4 10 140 80 gle
4 > Br 4 10/40 130 56d 7 N 4 10/40 80 91
e
" General reaction conditions: 1.2 mmol of hydroxypyridine, 1.0 mmol of ArX, 2.0 mmol of
K3PO4, 1.0 mL of DMF under Ar or N2 atmosphere. b Isolated yield. c MeCN used as solvent




In conclusion, we have developed a series of catalysts for the N- and O-arylation of
hydroxypyridines and hydroxyquinolines. Future efforts will be devoted both to maximizing the
efficiency and scope of this method as well as to determining the mechanistic basis behind the
observed selectivity.
3.4 Experimental Procedures
All reactions were carried out in resealable test tubes with teflon septa under a dry argon
or nitrogen atmosphere. Copper(I) iodide (99.99%) was purchased from Strem as an off-white
solid. Ligands 1, 2, 4 and 5 were purchased from commercial sources and used without further
purification. Ligand 3 was prepared according to our previously reported procedure.23 Anhydrous
K2CO3 (99.99%) was purchased from Aldrich in glass ampules. Powdered K3PO4 was purchased
from Riedel-de Haen. Cs 2CO3 (99.9%) was purchased from Alfa Aesar. The bulk of the bases
were stored under nitrogen in a Vacuum Atmospheres glovebox. Small portions (~5 g) were
removed from the glovebox in glass vials, stored in the air in a desiccator filled with anhydrous
calcium sulfate, and weighed in the air. Hydroxypyridines and hydroxyquinolines were
purchased from commercial sources and used without further purification. Aryl halides were
purchased from commercial sources and filtered through neutral alumina or distilled. Anhydrous
solvents were purchased from Aldrich in Sure-Seal® bottles. Flash column chromatography was
performed using a Biotage SP4 Flash Purification System using KP-Sil silica cartridges. In all
cases, dichloromethane was used to transfer the crude reaction material onto the silica gel
samplet. A gradient elution technique was performed, based on the recommendation from the
Biotage TLC Wizard.
Yields reported in the publication are of the isolated material and represent an average of
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at least two independent runs. Yields reported in the supporting information refer to a single
experiment. Compounds described in the literature were characterized by comparing their 'H
NMR and '3C NMR spectra, and melting points (m.p.) to the previously reported data; their
purity was confirmed by gas chromatography (GC) or elemental analysis. GC analyses were
performed on a Hewlett Packard 6890 instrument with an FID detector and a Hewlett Packard 10
m x 0.2 mm i.d. HP-1 capillary column using dodecane as an internal standard. Previously
unknown compounds were synthesized, purified and analyzed from a single run and were then
repeated to determine an average yield. They were characterized by 'H NMR, 13C NMR, m.p., IR
and elemental analysis. Elemental analyses were performed by Atlantic Microlabs, Inc.,
Norcross, GA. For those compounds that did not give a satisfactory elemental analysis, a copy of
their 'H NMR spectra is included. 'H NMR and '3C NMR spectra were recorded on Varian 500
MHz instruments with chemical shifts reported relative to the deuterated solvent or TMS. IR
spectra were recorded on a Perkin-Elmer System 2000 FT-IR instrument for all previously
unknown compounds (KBr disc). Melting points (uncorrected) were obtained on a Mel-Temp II
capillary melting point apparatus.
General procedure for the N- and O-Arylation of hydoxypyridines and hydroxyquinolines
An oven-dried screw-cap test tube was charged with Cul, ligand (if solid), hydroxypyridine (1.2
mmol), aryl halide (1.00 mmol, if solid), base (2.0 mmol), and a magnetic stir bar. The reaction
vessel was fitted with a rubber septum. The test tube was evacuated and back-filled with dry
argon or nitrogen. Aryl halide (1.00 mmol, if liquid), ligand (if liquid) and solvent were then
added successively. The rubber septum was removed and the reaction tube was quickly sealed
with a Teflon septum. The vessel was immersed in a pre-heated oil bath and stirred vigorously
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for the designated time period.
Workup A: The reaction mixture was cooled to room temperature, diluted with ethyl acetate (15
mL), and filtered through a plug of silica, eluting with additional ethyl acetate (50 mL). The
filtrate was concentrated and the resulting residue was purified by flash chromatography to
provide the desired product.
Workup B: The crude reaction mixture was diluted in CH2CI, (15 mL) and filtered through a
celite plug eluting with additional CH2C12 (20 mL). The filtrate was washed successively with
aqueous NH4OH then brine. The combined aqueous layers were extracted twice with CHzCI2.
The combined organic layers were dried over MgSO 4 and then concentrated. The resulting
residue was purified by flash chromatography to provide the desired product.
Experimental procedures for compounds in Table 1
1-(quinolin-3-yl)pyridin-2(1H)-one (entry 1)
The general procedure was followed using CuI (9.5 mg, 0.05 mmol), 3 (36 mg, 0.15 mmol),
K2CO3 (0.28 g, 2.0 mmol), 3-bromoquinoline (136 ýL, 1.00 mmol), 2-hydroxypyridine (114 mg,
1.2 mmol) with DMF (0.5 mL) as solvent for 24 h at 110 "C. Workup B, followed by
chromatographic purification (hexane / ethyl acetate) provided the title compound as a white
solid (177 mg, 80%). 1H NMR (500 MHz, CDCI3) 8 8.95 (d, 1H, J= 2.4 Hz), 8.21 (d, 1H, J= 2.3
Hz), 8.16 (d, 1H, J = 8.5 Hz), 7.85 (d, 1H, J = 8.4 Hz), 7.78 (m, 1H), 7.61 (m, 1H), 7.47-7.40 (m,
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3H), 6.72 (d, 1H, J = 9.7 Hz), 6.33 (td, 1H, J = 6.7, 1.2 Hz). 13C NMR (125 MHz, CDC13) 6
162.6, 148.5, 147.5, 140.6, 137.7, 134.5, 133.0, 130.6, 129.6, 128.2, 127.8, 122.3, 106.9. IR
(KBr disc, cm ') 1661, 1584, 1535, 1148, 927, 767, 759, 747. Anal. Calc. for C14H10N20: C
75.66, H 4.54. Found: C 75.34, H 4.71. m.p. 145-146 *C. (Lit. 145-146 "C).2 4
1-(thiazol-2-yl)pyridin-2(1H)-one (entry 2)
The general procedure was followed using Cul (19 mg, 0.10 mmol), 3 (36 mg, 0.15 mmol),
K2CO3 (0.28 g, 2.0 mmol), 2-bromothiazole (90 [L, 1.00 mmol), 2-hydroxypyridine (114 mg,
1.2 mmol) with DMF (1.0 mL) as solvent for 24 h at 110 "C. Workup A followed by
chromatographic purification (hexane / ethyl acetate) provided the title compound (white solid,
142 mg, 80%). tH NMR (500 MHz, CDC13) 8 8.74 (ddd, 1H, J = 0.6, 1.9, 8.2 Hz), 7.59 (d, 1H, J
= 3.5 Hz), 7.37-7.34 (m, 1H), 7.17 (d, 1H, 3.5 Hz), 6.68 (dt, 1H, J = 1.0, 9.2 Hz), 6.33 (m, 1H).
'
3C NMR (125 MHz, CDCI3) 8 160.6, 156.1, 139.8, 137.9, 131.9, 121.6, 118.8, 107.5. IR (KBr
disc, cm-') 3118, 1670, 1543, 1500, 1275, 1138, 981, 867, 844, 771, 717, 621. Anal. Calc. for
C8 H6N2OS: C 53.92, H 3.39. Found: C 53.94, H 3.42. m.p. 89-90 "C. (Lit. 85.5-86 *C).25
0 N
1-(1H-indol-5-yl)pyridin-2(1H)-one (entry 3)
The general procedure was followed using Cul (19 mg, 0.10 mmol), 1 (32 mL, 0.40 mmol),
K2CO3 (0.28 g, 2.0 mmol), 5-iodoindole (243 mg, 1.00 mmol), 2-hydroxypyridine (114 mg, 1.2
mmol) with DMSO (0.5 mL) as solvent for 24 h at 110 "C. Workup A followed by
chromatographic purification (CH 2C12 / ethyl acetate), and then recrystallization from CH2C12,
provided 165 mg of the product as a white solid (78%). 1H NMR (500 MHz, DMSO-D6) 8 11.3
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(bs, 1H), 7.65 (dd, J = 1.6, 6.8 Hz), 7.51-7.45 (m 3H), 7.03 (dd, 1H, J = 4.3, 6.1 Hz), 6.50-6.45
(m, 2H), 6.28 (td, 1H, J = 6.7, 1.7 Hz). 13C NMR (125 MHz, DMSO-D 6) 6 161.8, 140.3, 140.0,
135.0, 133.0, 127.5, 126.9, 120.4, 119.9, 118.0, 111.5,105.1,101.6. m.p. 218-220 "C.
1-(pyrimidin-5-yl)pyridin-2(1H)-one (entry 4)
The general procedure was followed using CuI (19 mg, 0.10 mmol), 3 (36 mg, 0.15 mmol),
K2CO3 (0.28 g, 2.0 mmol), 5-bromopyrimidine (159 mg, 1.00 mmol), 2-hydroxypyridine (114
mg, 1.2 mmol) with DMSO (0.5mL) as solvent for 24 h at 110 *C. The crude reaction mixture
was diluted with CH 2CI2 and filtered. The filtrate was concentrated to a white/yellow solid. The
product was recrystallized from hot EtOAc to provide 1-(pyrimidin-5-yl)pyridin-2(1H)-one as a
white solid (83.5 mg, 48%). 'H NMR (500 MHz, CDC13) 8 9.26 (s, 1H), 8.91 (s, 2H), 7.47 (m,
1H), 7.31 (m, 1H), 6.70 (m, 1H), 7.36 (m, 1H). 13C NMR (125 MHz, CDCI3) 8 161.9, 158.0,
154.6, 141.1, 136.5, 122.4, 107.5, 100.0. IR (KBr disc, cm -') 1664, 1591, 1415, 1299, 1147, 994,
847, 765, 721. Anal. Calc. for C9H7N30: C 62.42, H 4.07. Found: C 62.63, H 4.03. m.p. 201-202
"C.
0 C1
1-(4-chlorophenyl)pyridin-2( H)-one (entry 5)
The general procedure was followed using Cul (19 mg, 0.10 mmol), 3 (36 mg, 0.15 mmol),
K2CO3 (0.28 g, 2.0 mmol), 1-chloro-4-iodobenzene (243 mg, 1.00 mmol), 2-hydroxypyridine
(114 mg, 1.2 mmol) with DMSO (0.5 mL) as solvent for 24 h at 110 "C. Workup B, followed by
chromatographic purification (hexane / ethyl acetate) provided the title compound (white solid,
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169 mg, 82%). 1H NMR (500 MHz, CDCl3) 8 7.49-7.45 (m, 2H), 7.43-7.39 (m, 1H), 7.35-7.25
(m, 2H), 7.30 (ddd, J = 0.8, 2.1, 6.9 Hz), 6.66 (m, 1H), 6.26 (td, 1H, J = 6.7, 1.3 Hz). 13C NMR
(125 MHz, CDCl3) 8 162.4, 140.2, 139.5, 137.8, 1344.6, 129.7, 128.1, 122.2, 106.4. Anal. Calc.
for C,,H 8NOCl: C 64.25, H 3.92. Found: C 64.09, H 3.92. m.p. 122-124 "C. (Lit. 133 °C)26
NH2
1-(3-aminophenyl)pyridin-2(1H)-one (entry 6)
The general procedure was followed using Cul (19 mg, 0.10 mmol), 3 (36 mg, 0.15 mmol),
K2CO3 (0.28 g, 2.0 mmol), 3-bromoaniline (109 [IL, 1.00 mmol), 2-hydroxypyridine (114 mg,
1.2 mmol) with DMSO (0.5 mL) as solvent for 24 h at 110 "C. Workup A followed by
chromatographic purification (ethyl acetate / isopropanol) provided the title compound (off-white
solid, 162 mg, 87%). 1H NMR (500 MHz, CDCl3) 8 7.41-7.19 (m, 3H), 6.70-6.21 (m, 3H), 62.1
(td, 1H, J = 1.1, 6.9 Hz), 3.54 (bs, 2H). 13C NMR (125 MHz, CDCl3) 8 162.7, 147.8, 142.0,
140.0, 138.3,130.3,121.8, 116.1,115.4, 113.4, 105.9. m.p. 180-182 "C. (Lit. 182.5-184.50 C).27
0 . NMe2
4-chloro-l-(4-(dimethylamino)phenyl)pyridin-2(1H)-one (entry 7)
The general procedure was followed using Cul (19 mg, 0.10 mmol), 3 (36 mg, 0.15 mmol),
K2CO3 (0.28 g, 2.0 mmol), N,N-dimethyl-4-bromoanilne (200 mg, 1.00 mmol), 5-chloro-2-
hydroxypyridine (156 mg, 1.2 mmol) with DMSO (1.0 mL) as solvent for 24 h at 110 "C.
Workup B, followed by chromatographic purification (hexane / ethyl acetate) provided the
product as a pale yellow solid (193 mg, 78%). 'H NMR (500 MHz, CDCl3) 8 7.39 (d, 1H, J = 2.9
Hz), 7.32 (dd, 2.9, J = 9.8 Hz), 7.21-7.18 (m, 2H), 6.77-6.74 (m, 2H), 6.61 (d, 1H, J = 9.8 Hz),
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3.00 (s, 6H). 13C NMR (125 MHz, CDC13) 8 161.5, 150.6, 140.6, 136.4, 129.2, 126.9, 122.5,
112.5, 112.1. IR (KBr disc, cm- ') 1664, 1363, 1266, 1120, 1062, 944, 782, 728, 646. Anal. Calc.
for C13H13CIN20: C 62.78, H 5.27. Found: C 62.52, H 5.24. m.p. 159-160 "C.
Experimental procedures for compounds in Table 2
2-(o-tolyloxy)pyridine2 8 (entry 1)
The general procedure was followed using Cul (19 mg, 0.10 mmol), 5 (29 mg, 0.20 mmol),
K2CO3 (0.28 g, 2.0 mmol), 2-iodotoluene (127 tL, 1.00 mmol), 2-hydroxypyridine (114 mg, 1.2
mmol) with DMSO (1.0 mL) as solvent for 48 h at 120 "C. GC analysis of the crude reaction
mixture showed full conversion of the aryl iodide and a 1.0 : 4.7 ratio of N- to O-arylated
products. Workup B, followed by chromatographic purification (hexane / ethyl acetate) provided
the O-arylated product (white solid, 135 mg, 73%). 'H NMR (500 MHz, CDCI3) 8 8.09 (dd, J =
1.2, 4.9 Hz), 7.59-7.56 (m, 1H), 7.20-7.14 (m, 2H), 7.06 (td, 1H, J = 0.8, 7.5 Hz), 6.98 (dd, 1H, J
= 1.2, 7.9 Hz), 6.87 (ddd, 1H, J = 0.9, 5.0, 7.2 Hz), 6.77 (m, 1H), 2.10 (s, 3H). 13C NMR (125
MHz, CDCI3) 8 163.9, 152.4, 148.0, 139.5, 133.3, 131.6, 131.0, 130.7, 127.3, 125.4, 122.0,
118.1, 110.8, 16.6. m.p. 44-45.5 "C.
0N
Me
1-o-tolylpyridin-2(1H)-one 29 (entry 2)
The general procedure was followed using Cul (19 mg, 0.10 mmol), 3 (36 mg, 0.15 mmol),
K2CO3 (0.28 g, 2.0 mmol), 2-iodotoluene (153 [tL, 1.20 mmol), 2-hydroxypyridine (96 mg, 1.0
mmol) with DMSO (0.5 mL) as solvent for 96 h at 150 "C. GC analysis of the crude reaction
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mixture showed full conversion of the aryl iodide and a 1.6 : 1 ratio of N- to O-arylated products.
Workup B, followed by chromatographic purification (hexane / ethyl acetate) provided the N-
arylated product as a slightly yellow solid (79 mg, 43%). 'H NMR (500 MHz, CDCI3) 6 7.45-
7.42 (m, 1H), 7.36-7.30 (m, 3H), 7.21-7.18 (m, 2H), 6.69-6.67 (m, 1H), 6.27-6.24 (m, 1H), 2.16
(s, 3H). 13C NMR (125 MHz, CDCI3) 8 162.21, 140.3, 140.1, 138.1, 135.1, 131.2, 129.2, 127.2,
127.1, 121.9, 105.9, 17.7. Anal. Calc. for C,2H,,NO: C 77.81, H 77.19. Found: C 77.49, H 6.03.
m.p. 71-72.5 *C.
2-(naphthalen- 1-yloxy)pyridine (entry 3)
The general procedure was followed using Cul (19 mg, 0.10 mmol), 5 (36 mg, 0.15 mmol),
K2CO3 (0.28 g, 2.0 mmol), 1-iodonaphthalene (260 IL, 1.00 mmol), 2-hydroxypyridine (114 mg,
1.2 mmol) with DMSO (1.0 mL) as solvent for 48 h at 120 "C. GC analysis of the crude reaction
mixture showed full conversion of the aryl iodide and a 1.0 : 3.7 ratio of N- to O-arylated
products. Workup B, followed by chromatographic purification (hexane / ethyl acetate) provided
137 mg of the O-arylated product (white solid, 62%). 'H NMR (500 MHz, CDCI3) 6 8.2 (dd, 1H,
J= 1.3, 4.6 Hz), 8.04-8.02 (m, 1H), 7.91 (dd, 1H, J = 0.6, 8.2 Hz), 7.76 (d, 1H, J = 8.2 Hz), 7.53-
7.46 (m, 3H), 7.26 (dd, 1H, J = 0.9, 7.5 Hz), 7.02-6.99 (m, 1H), 6.96 (d, 1H, J = 8.2 Hz). "3C
NMR (125 MHz, CDCl3) 6 150.2, 148.2, 139.7, 125.2, 128.2, 127.7, 126.6, 126.3, 126.0, 125.2,
122.2, 118.6, 117.3, 111.1. IR (KBr disc, cm-') 1592, 1465, 1426, 1387, 1282, 1156, 1070, 1037,
1013, 890, 839, 799, 773, 672, 534. Anal. Calc. for C15H,lNO: C 81.43, H 5.01. Found: C 81.27,
H 4.98. m.p. 80.5-82 "C.
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01-(naphthalen- 1-yl)pyridin-2(1H)-one (entry 4)
The general procedure was followed using Cul (19 mg, 0.10 mmol), 3 (36 mg, 0.15 mmol),
K2CO3 (0.28 g, 2.0 mmol), 1-iodonaphthalene (175 [tL, 1.20 mmol), 2-hydroxypyridine (96 mg,
1.0 mmol) with DMSO (0.5 mL) as solvent for 96 h at 150 *C. GC analysis of the crude reaction
mixture showed full conversion of the aryl iodide and a 1.7 : 1.0 ratio of N- to O-arylated
products. Workup B, followed by chromatographic purification (hexane / ethyl acetate) provided
97 mg of the N-arylated product (yellow solid, 44%). ' H NMR (500 MHz, CDC13) 8 7.98-7.89
(m, 1H), 7.60-7.46 (m, 7H), 7.33-7.31 (m, 1H), 6.77 (dd, 1H, J = 0.8, 9.3 Hz), 6.32 (td, 1H, J =
6.7, 1.2 Hz). 13C NMR (125 MHz, CDC13) 8 162.9, 140.5, 139.1, 137.8, 134.5, 129.7, 129.4,
128.1, 127.6, 126.9, 125.6, 125.2, 122.5, 122.0, 106.0. IR (KBr disc, cm-') 3062, 1660, 1590,
1571, 1394, 1284, 1136, 964, 773. Anal. Calc. for Cs5H, NO: C 81.43, H 5.01. Found: C 81.05,
H 5.00. m.p. 132-134 *C.
Experimental procedures for compounds in Table 3
N "I OMe
1-(3-methoxyphenyl)pyridin-4(1H)-one (entry 1)
The general procedure was followed using Cul (19 mg, 0.10 mmol), 3 (36 mg, 0.15 mmol),
K 2CO3 (0.28 g, 2.0 mmol), 3-bromoanisole (125 [iL, 1.00 mmol), 4-hydroxypyridine (114 mg,
1.2 mmol) with DMF (0.5 mL) as solvent for 24 h at 110 *C. Workup B, followed by
chromatographic purification (ethyl acetate/ isopropanol) provided 197 mg of product (white
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solid, 98%). 'H NMR (500 MHz, CDCl3) 8 7.64-759 (m, 2H), 7.43 (t, 1H, J = 8.3 Hz), 7.00-6.91
(m, 2H), 6.85 (t, 1H, J = 2.5 Hz), 6.52 (m, 2H), 3.88 (s, 3H). 13C NMR (125 MHz, CDCl3) 6
179.1, 160.0, 144.3, 139.2, 131.1, 119.0, 114.8, 113.8, 109.0, 55.8. IR (KBr disc, cm-') 3034,
2954, 16.6, 1569, 1347, 1286, 1051, 845, 762, 679. Anal. Calc. for C12H,,NO 2: C 71.63, H 5.51.
Found: C 71.85, H 5.43. m.p. 151-152 *C.
1-(pyridin-3-yl)pyridin-4( H)-one (entry 2)
The general procedure was followed using Cul (19 mg, 0.10 mmol), 3 (36 mg, 0.15 mmol),
K2CO3 (0.28 g, 2.0 mmol), 3-bromopyridine (98 RL, 1.00 mmol), 4-hydroxypyridine (114 mg,
1.2 mmol) with DMSO (0.5 mL) as solvent for 24 h at 110 "C. Workup A followed by
chromatographic purification (ethyl acetate/ isopropanol) provided 1-(pyridin-3-yl)pyridin-
4(IH)-one (white solid, 167 mg, 97%). 'H NMR (500 MHz, CDCl3) 8 8.71-8.69 (m, 2H), 7.74
(m, 1H), 7.59 (m, 2H), 7.30 (m, 1H), 6.52 (m, 2H). '3C NMR (125 MHz, CDCl3) 8 178.9, 149.8,




The general procedure was followed using Cul (9.5 mg, 0.05 mmol), 4 (20 mL, 0.20 mmol),
K2CO3 (0.28 g, 2.0 mmol), 4'-bromopropiophenone (213 mg, 1.00 mmol), 4-hydroxypyridine
(114 mg, 1.2 mmol) with DMSO (0.5 mL) as solvent for 24 h at 110 "C. Workup B, followed by
chromatographic purification (ethyl acetate/ methanol) provided the title compound as a white
solid (199 mg, 87%). 1H NMR (500 MHz, CDCl3) 8 8.10 (m, 2H), 7.65 (m, 2H), 7.44 (m, 2H),
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6.48 (m, 2H), 3.02 (q, 2H, J = 7.2 Hz), 1.22 (t, 3H, J = 7.2 Hz). 13C NMR (125 MHz, CDCl3)
199.2. 179.0. 146.1. 138.6. 138.3. 130.2. 122.5. 119.3. 32.0. 8.1. IR (KBr disc, cml') 1636, 1412,
1342, 1281, 1192, 1017, 952. m.p. 182-184"C.
Me
I-o-tolylpyridin-4(1H)-one (entry 4)
The general procedure was followed using Cul (19 mg, 0.10 mmol), 4 (40 mL, 0.40 mmol),
K2CO3 (0.28 g, 2.0 mmol), 2-iodotoluene (127 [iL, 1.00 mmol), 4-hydroxypyridine (114 mg, 1.2
mmol) with DMSO (1.0 mL) as solvent for 24 h at 110 "C. Workup B, followed by
chromatographic purification (ethyl acetate/ methanol) provided a white solid (121 mg, 65%). 1H
NMR (500 MHz, CDCI3) 67.41-7.31 (m, 4H), 7.24 (dd, 1H, J = 1.2, 7.8 Hz), 6.48-6.45 (m, 2H).
13C NMR (125 MHz, CDCI3) 8 178.9, 1.42.4, 140.5, 133.9, 132.0, 129.9, 127.7, 126.3, 118.7,
17.6. m.p. 149-150 "C. (Lit. 148 "C).31
1-(benzo[b]thiophen-3-yl)pyridin-4(1H)-one (entry 5)
The general procedure was followed using Cul (19 mg, 0.10 mmol), 4 (42 mL, 0.40 mmol),
K 2CO3 (0.28 g, 2.0 mmol), 3-bromothianaphthene (131 pL, 1.00 mmol), 4-hydroxypyridine (114
mg, 1.2 mmol) with DMSO (0.5 mL) as solvent for 24 h at 110 "C. Workup B followed by
chromatographic purification (ethyl acetate/ methanol) provided the title product as an oil, which
was then triturated with CH2Cl2 and hexane (white solid, 164 mg, 72%). 1 H NMR (500 MHz,
CDC13) 7.95-7.93 (m, 1H), 7.66-7.49 (m, 6H), 6.56-6.53 (m, 2H). 13C NMR (125 MHz, CDCI3)
8 179.1, 140.4, 139.1, 135.7, 133.2, 126.3, 125.8, 123.8, 121.5, 120.6, 119.1. IR (KBr disc, cm-')
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1632, 1558, 1402, 1367, 1191, 939, 855, 760, 586, 564. Anal. Calc. for C13H9NOS: C 68.70, H
3.99. Found: C 68.44, H 4.12. m.p. 188.5-190 *C.
Me
1-(3,5-dimethylphenyl)pyridin-4(1H)-one (entry 6)
The general procedure was followed using Cul (3.8 mg, 0.020 mmol), 4 (8 mL, 0.08 mmol),
K2CO3 (0.28 g, 2.0 mmol), 5-iodo-m-xylene (144 4L, 1.00 mmol), 4-hydroxypyridine (114 mg,
1.2 mmol) with DMSO (0.5 mL) as solvent for 24 h at 110 "C. Workup B followed by
chromatographic purification (ethyl acetate/ methanol) provided the product as a white solid (175
mg, 88%). '11 NMR (500 MHz, CDC13) 8 7.59-7.57 (m, 2H), 7.07 (s, 1H), 6.95 (s, 2H), 6.49-6.47
(m, 2H). 13C NMR (125 MHz, CDCl3) 8 179.1,143.3,140.4, 139.4, 130.2, 120.6, 119.0,21.4. IR
(KBr disc, cm -') 1650, 1617, 1555, 1457, 1333, 1203, 846, 696. Anal. Calc. for CI3H13NO: C
78.36, H 6.58 Found: C 77.96 H 6.49. m.p. 138-139 "C.
OMe
7-chloro- 1-(4-methoxyphenyl)quinolin-4(1H)-one (entry 7)
The general procedure was followed using Cul (19 mg, 0.10 mmol), 4 (40 mL, 0.15 mmol),
K3PO4 (0.42 g, 2.0 mmol), 4-iodoanisole (234 mg, 1.00 mmol), 7-chloro-4-
hydroxyphenanthroline (216 mg, 1.2 mmol) with DMSO (1.0 mL) as solvent for 24 h at 120 "C.
Workup B followed by chromatographic purification (hexane / ethyl acetate) provided 198 mg of
the title compound as a white solid (69%). 'H NMR (500 MHz, CDCI3) 8 8.28 (dd, 1H, J = 0.5,
8.7 Hz), 7.47 (d, 1H, J = 7.8 Hz), 7.24-7.20 (m, 3H), 7.03-7.00 (m, 2H), 6.88 (d, 1H, J = 3.3 Hz),
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6.24 (d, 1H, J = 7.8 Hz), 3.84 (s, 3H). 13C NMR (125 MHz, CDCl3) 8 177.7, 160.5, 143.6, 142.6,
138.4, 133.6, 128.7, 128.4, 125.0, 124.6, 117.1, 115.7, 110.7, 55.9. IR (KBr disc, cmr') 1603,
1510, 1449, 1252, 1169, 1032, 909, 813, 734, 646. Anal. Calc. for C1,H12NO2CI: C 67.26, H
4.23. Found: C 66.99, H 4.19. m.p. 173-176 TC.
4-(pyridin-3-yl)thieno[3,2-b]pyridin-7(4H)-one (entry 8)
The general procedure was followed using Cul (9.5 mg, 0.05 mmol), 4 (21 mL, 0.20 mmol),
K3PO4 (0.42 g, 2.0 mmol), 2-bromopyridine (49 [pL, 1.00 mmol), thieno[3,2-b]pyridin-7-ol (90
mg, 1.2 mmol) with DMSO (0.5 mL) as solvent for 24 h at 110 "C. Workup B followed by
chromatographic purification (ethyl acetate/ methanol) provided the product (white solid, 83 mg,
73%). 1H NMR (500 MHz, CDCl3) 8 8.76-8.74 (m, 2H), 7.87 (ddd, 1H, J = 1.5, 2.6, 8.1 Hz),
7.61 (d, 1H, J = 5.5 Hz), 7.56 (dd, 1H, J = 4.7, 8.1 Hz), 7.49 (d, 1H, J = 7.6 Hz), 6.76 (d, J = 5.5
Hz), 6.33 (d, 1H, J = 7.6 Hz). 13C NMR (125 MHz, CDCl3) 8 174.1, 150.6, 147.1, 144.5, 139.9,
133.7, 132.5, 130.7, 129.7, 124.7, 117.3, 112.1. IR (KBr disc, cmr-) 1610, 1493, 1425, 1291,
1221, 1124, 877, 820, 711. m.p. 189-190 "C.
Experimental procedures for compounds in Table 4
3-(2-methylpyridin-3-yloxy)quinoline (entry 1)
The general procedure was followed using Cul (9.5 mg, 0.05 mmol), 4 (20 mL, 0.20 mmol),
K3PO4 (0.42 g, 2.0 mmol), 3-bromoquinoline (136 [L, 1.00 mmol), 3-hydroxy-2-methylpyridine
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(131 mg, 1.2 mmol) with DMF (1.0 mL) as solvent for 24 h at 110 *C. Workup B followed by
chromatographic purification (hexane / ethyl acetate) provided the title compound as a white
solid (184 mg, 78%). 1H NMR (500 MHz, CDCl3) 6 8.84 (d, 1H, J = 2.7 Hz), 8.42 (dd, 1H, J =
1.2, 4.7 Hz), 8.12 (d, 1H, J = 8.4 Hz), 7.69-7.52 (m, 3H), 7.37 (d, 1H, J = 2.7 Hz), 7.30 (m, 1H),
7.21 (m, 1H), 2.56 (s, 3H). 13C NMR (125 MHz, CDCI3) 8 151.7, 150.7, 150.5, 145.4, 144.9,
144.6, 129.4, 128.6, 128.3, 127.7, 127.2, 126.9, 122.6, 119.1, 19.6. IR (KBr disc, cm-') 1602,
1497, 1424, 1342, 1246, 1175, 984, 911,783, 754. Anal. Calc. for C15H12N20: C 76.25, H 5.12.
Found: C 76.36, H 5.09. m.p. 67-69 "C.
3-(quinolin-3-yloxy)benzonitrile (entry 2)
The general procedure was followed using Cul (19 mg, 1.0 mmol), 4 (42 mL, 0.40 mmol),
K3PO4 (0.42 g, 2.0 mmol), 3-bromobenzonitrile (182 mg, 1.00 mmol), 6-hydroxyquinoline (174
mg, 1.2 mmol) and 3A mol. sieves (200 mg flame activated under vacuum) with DMF (1.0 mL)
as solvent for 24 h at 110 "C. Workup A followed by chromatographic purification (hexane /
ethyl acetate) provided 191 mg of the title compound as a white solid (78%). 'H NMR (500
MHz, CDCI3) 8 8.85 (s, 1H), 8.10 (d, 1H, J = 9.2 Hz), 8.02 (dd, 1H, J = 1.4, 8.2 Hz), 7.45-7.37
(m, 4H), 7.28-7.24 (m, 3H). 13C NMR (125 MHz, CDCl3) 8 157.5, 153.9, 149.9, 145.7, 135.5,
132.1, 131.0, 127.3, 123.5, 123.3, 122.0, 118.2, 115.1, 114.8, 113.8. IR (KBr disc, cm-1) 2232,
1622, 1579, 1500, 1480, 1326, 1216, 1156, 967, 795, 682. Anal. Calc. for C1 6H10N 20: C 78.03, H






The general procedure was followed using CuI (1.9 mg, 0.01 mmol), 4 (4 mL, 0.04 mmol),
K3PO4 (0.42 g, 2.0 mmol), 5-iodo-m-xylene (145 [LL, 1.00 mmol), 2-hydroxypyridine (114 mg,
1.2 mmol) with DMF (1.0 mL) as solvent for 24 h at 110 "C. Workup A followed by
chromatographic purification (hexane / ethyl acetate) provided the title compound as a yellow oil
(177 mg, 89%). 'H NMR (500 MHz, CDCI3) 8 8.40 (s, 1H), 8.34 (d, 1H, J = 3.6 Hz), 7.29-7.23
(m, 2H), 6.79 (m, 1H), 6.64 (m, 2H). 13C NMR (125 MHz, CDCl3) 8 156.3, 144.2, 141.5, 140.0,
125.9, 125.5, 124.1, 116.8, 21.4. IR (KBr disc, cm-') 1615, 1573, 1475, 1422, 1297, 1137, 1022,
950, 853, 803, 709. Anal. Calc. for C13H13NO: C 78.36, H 6.58. Found: C 78.55, H 6.80.
8-(benzo[d][1,3]dioxol-5-yloxy)quinoline (entry 4)
The general procedure was followed using CuI (19 mg, 0.10 mmol), 4 (42 mL, 0.40 mmol),
K3PO4 (0.42 g, 2.0 mmol), 4-bromo-1,2-methylenedioxybenzene (120 RL 1.00 mmol), 8-
hydroxyquinoline (174 mg, 1.2 mmol) with DMSO (1.0 mL) as solvent for 48 h at 130 "C.
Workup B followed by chromatographic purification (hexane / ethyl acetate) provided 145 mg of
the title compound (yellow oil, 56%). 'H NMR (500 MHz, CDCI3) 8 8.99 (dd, 2H, J = 1.7, 4.1
Hz), 8.18 (dd, 1H, J = 1.7, 8.4 Hz), 7.50 (dd, 1H, J = 1.2, 8.2 Hz), 7.39 (t, 1H, J = 7.9 Hz), 7.01
(dd, 1H, J = 1.2, 7.8 Hz), 6.80 (d, 1H, J = 8.3 Hz), 6.72 (d, 1H, J = 2.2.3 Hz), 6.65 (dd, 1H, J =
2.3, 8.4 Hz), 5.99 (s, 2H). 13C NMR (125 MHz, CDC13) 8 155.0, 151.1, 150.2, 148.5, 144.4,
140.6, 136.2, 129.8, 126.7, 122.1, 121.8, 114.0, 113.2, 108.6, 103.1, 101.7. IR (KBr disc, cm -')
1614, 1500, 1373, 1315, 1181, 1125, 1037, 930, 792, 770. Anal. Calc. for C,6HIINO 3: C 72.45, H




The general procedure was followed using Cul (19 mg, 0.05 mmol), 4 (40 mL, 0.40 mmol),
K3PO4 (0.42 g, 2.0 mmol), 4-bromoisoquinoline (229 mg, 1.00 mmol), 5-chloro-3-
hydroxypyridine (130 mg, 1.2 mmol) with DMF (0.8 mL) as solvent for 24 h at 120 "C. Workup
B followed by chromatographic purification (hexane / ethyl acetate) provided a yellow solid (180
mg, 70%). 'H NMR (500 MHz, CDC 3) 8 9.19 (bs, 1H), 8.37-8.15 (m, 3H), 8.07 (dd, 1H, J = 0.7,
8.2 Hz), 8.00 (d, 1H, J = 8.4 Hz), 7.77-7.68 (m, 2H), 7.23 (m, 1H). 13C NMR (125 MHz, CDCl3)
6 154.7, 149.7, 143.7, 138.4, 133.2, 131.2, 130.5, 129.5, 128.6, 127.9, 126.7, 124.5, 120.8. IR
(KBr disc, cm-') 1627, 1574, 1499, 1417, 1386, 1305, 1252, 1164, 1092, 1064, 1051, 920, 872,




The general procedure was followed using CuI (19 mg, 0.05 mmol), K3PO4 (0.42 g, 2.0 mmol),
4-tert-butylbromobenzene (173 RtL, 1.00 mmol), 2(dimethylaminomethyl)-3-hydroxypyridine
(182 mg, 1.2 mmol) with DMF (0.8 mL) as solvent for 24 h at 110 "C. Workup B followed by
chromatographic purification (ethyl acetate/ methanol) provided the product as a brown oil (214
mg, 75%). 'H NMR (500 MHz, CDCI3) 6 8.37 (dd, 1H, J= 1.5, 4.5 Hz), 7.36-7.34 (m, 2H), 7.19-
7.12 (m, 2H), 6.91-6.89 (m, 2H), 3.68 (s, 2H), 2.34 (s, 6H), 1.31 (s, 9H). ' 3C NMR (125 MHz,
CDCl3) 154.5, 152.5, 150.4, 146.7, 144.1, 128.9, 125.8, 123.1, 118.2, 59.3, 45.9, 34.5, 31.6. IR
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(KBr disc, cm7) 1575, 1508, 1364, 1211, 1179, 1105, 1014, 853, 728, 608, 550.
O,(,C02Et
ethyl 3-(pyridin-3-yloxy)benzoate (entry 7)
The general procedure was followed using Cul (9.5 mg, 0.05 mmol), 4 (20 mL, 0.20 mmol),
Cs2CO3 (0.65 g, 2.0 mmol), ethyl-3-iodobenzoate (140 [xL, 1.00 mmol), 3-hydroxypyridine (114
mg, 1.2 mmol) and 3A mol sieves (200 mg flame activated under vacuum) with DMF (1.0 mL)
as solvent for 36 h at 80 *C. Workup A followed by chromatographic purification (hexane / ethyl
acetate) provided the title compound (yellow oil, 260 mg, 89%). 1H NMR (500 MHz, CDCl3) 8
8.42 (bs, 1H), 8.40 (bs, 1H), 7.84 (m, 1H), 7.68 (dd, 1H, J = 1.5, 10.1 Hz), 7.44 (td, 1H, J = 7.8,
0.5 Hz), 7.31-7.28 (m, 2H), 7.23-7.21 (m, 1H). 13C NMR (125 MHz, CDCI3) b 165.9, 156.6,
144.9, 141.7, 132.8, 130.8, 130.2, 125.8, 125.4, 124.4, 123.5, 119.9, 61.5, 14.5. IR (KBr disc,
cm-1) 1717, 1575, 1444, 1161, 1100, 1021, 940, 756, 692, 621. Anal. Calc. for CI4HI4NO 3: C
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Chapter Four
Pyrrole-2-carboxylic Acid as a Ligand for the Cu-catalyzed
Reactions of Primary Anilines with Aryl Halides
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The diaryl amine moiety can be found in a variety of biologically active pharmaceuticals,
natural products, and materials.1 Metal-catalyzed cross-coupling reactions of anilines with aryl
halides are among the foremost methods for assembling this substructure." For reactions of
poorly nucleophilic primary anilines with aryl halides, Pd-based catalyst systems are highly
efficient.' This is due, in great part, to the rapid transmetallation of anilines to Pd(II), a
phenomenon that arises from the large increase in acidity of the nucleophile when coordinated to
Pd(II).3 The complementary nature of Pd- and Cu-catalyzed C-N bond-forming processes, and
the issues involving removal of the trace Pd from the products encourage the development of Cu-
based catalyst systems for the preparation of diaryl amines.
In recent years, Cu-catalyzed C-N bond-forming reactions have evolved as reliable
alternatives to Pd-catalyzed reactions. 2 However, Cu-based catalyst systems for the synthesis of
diaryl amines are less general and useful than the Pd-based protocols.4 The Cu-catalyzed
reactions of anilines with aryl halides are slow enough that a wide variety of N-H and O-H
nucleophiles, including amides, nitrogen heterocycles, aliphatic, benzylic and allylic amines, as
well as aliphatic and benzylic alcohols are selectively arylated in the presence of an anilino-NH2
group.5 In the absence of a competing reactant, the poor nucleophilicity of the aniline, when
employing Cu-based catalysts, further manifests itself in the need to use high catalyst loadings (>
20% Cu),a" long reaction times (> 30 h),4 b-c'e strong bases that preclude the presence of many
common functional groups,4g and/or anilines with strong electron-withdrawing groups in the
para-position.4b Further, the few examples of Cu-catalyzed reactions of anilines with ortho-
substituted aryl halides require even higher catalyst loadings (35-50% Cu).4f Finally, when
employing Cu-based catalysts, the propensity of the diaryl amine product to undergo further N-
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arylation to form a triarylamine provides an added level of complexity to developing a suitable
catalyst system.6
4.2 Results and Discussion
We began our investigation into the Cu-catalyzed reactions of aromatic amines with aryl
iodides, by evaluating previously reported catalysts for this transformation. 4 Since the more
successful systems employed proline-type ligands,4b-e we sought to evaluate the use of new
ligands that would provide a more active and generally applicable catalyst for the reaction of
aniline with an aryl iodide (Table 1). While several heterocyclic-2-carboxylic acids, including
some previously reported as ligands for Cu-catalyzed and -mediated nucleophilic substitution
reactions of aryl halides,7 provided poor results for this transformation (entries 1-4), pyrrole-2-
carboxylic acid, L5, manifested good catalytic activity (entry 5). Both the N-H and carboxylate
functional groups of this ligand are important to the activity of the catalysts derived from it. This
can be seen as modification of these groups provided less-active catalysts (entries 6-8).
Benzannulated analogs L9 and L10 also provided less-active catalyst (entries 9-10); presumably
because they are too hindered. Finally, L5 provided a more active catalyst system than those




Figure 1. Ligands Examined for N-Arylation Reactions of Aniline
co 2 H CO2 H NCO2H N CO2H OHCO2H H Me H O H OH
L1 L2 L3 L4 L5 L6 L7 L8
Co2H N COH CO2  H NCO2H N(H)Me
L9 L10 L11 L12 L13 L14 L15




Entry Ligand GC Conversion (%) GC Yield (%)
1 L1 58 35
2 L2 46 27
3 L3 47 27
4 L4 0 0
5 L5 94 68
6 L6 57 37
7 L7 55 22
8 L8 66 0
9 L9 62 26
10 L10 60 22
11 L11 64 34
12 L12 64 29
13 L13 48 15
14 L14 64 19
15 L15 51 30
a Reactions Conditions: 1.0 mmol ArNH2, 0.5 mmol Arl, 1.0 mmol K3PO4, 0.050 mmol Cul,
0.10 mmol ligand, 0.25 mL DMSO, at 80 'C in a sealed tube under an N2 atmosphere for 17 h.
Further optimization of the reaction conditions using L5 revealed that the base/solvent
combination of K3PO4/DMSO typically provided a superior system than combinations involving
K2CO3, Cs2CO3, KOH, and NaOt-Bu in DMF, 1,4-dioxane, toluene, and acetonitrile. Since diaryl
ether and phenolic products (up to 20% of ArX consumption) were frequently produced under
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the reaction conditions and observed by GC/MS,8 the base was flame-dried under reduced
pressure then cooled under a positive pressure of N2 prior to use.
The reaction conditions we developed (1.0 equiv ArX/2.0 equiv ArNH2/10% CuI/20%
L5/K3PO4/DMSO/80-90 °C) could be used to couple aryl iodides with anilines in moderate to
good yields (Table 2). For the reaction of p-anisidine with 4-chloroiodobenzene, the catalyst
loading and reaction temperature could be reduced to 5% Cul and 70 'C, respectively (entry 1).
Substrates containing base-sensitive functional groups such as benzoic esters and benzonitriles,
which do not tolerate heating in the presence of hydroxide," were transformed to the desired
product in respectable yields (entries 2-3). In addition, the presence of an ortho substituent on the
aryl halide was tolerated (entry 4). Using the standard conditions, reactions of anilines containing
strongly electron-withdrawing substituents at the 4-position provided the diaryl amine product in
lower yields (entries 5-7). In these reactions, significant quantities of triarylamine byproducts
were observed. d Although the reaction of 4-nitroaniline with an aryl iodide provided the
triarylamine as the major product, an aryl halide could be coupled with N-(4-
aminophenyl)acetamide to provide a product with a similar substitution pattern (entry 8). As
previously noted, the Cu-catalyzed coupling of an anilino-NH2 group in the presence of an amide
is unusual for a Cu-catalyzed reaction of this type.~ -b In this case, the observed chemoselectivity
is likely due to the slow reaction of secondary amides.9 In contrast to this result, the reaction of
4-aminobenzamide with 4-iodoanisole provided a complex mixture of products. Lastly, the
Cu/L5-catalyzed reaction of 2-aminobenzothiazole with 4-iodoanisole arylated the heterocyclic
nitrogen as opposed to the anilino-NH 2 (entry 9).'0 This result is noteworthy, since the Pd-
catalyzed reactions of this nucleophile with aryl bromides selectively react at the anilino-NH 2
position."
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Table 2. Cu-Catalyzed Reactions of Anilines with Aryl lodidesa
10% Cul
,NH2 I. 20% LS HRc + R2 R1R2K3 P0 4 , DMSO   R2
24 h
entry product temperature (°C) yield (%)b entry product temperature (*C) yield (%)b
H H
1N 70 82c  5 = eR Ac 90 60
6 CO2 Et 90 50
MeO CI 90 52
H Me
2 NN RR =CO2 Et 80 78 H3 I1 CN 80 73 N
8Me ,'O  80 82
Me Me N OMe
H H
4 N 80 71 S f
N H
qe9 / N 90 68
Me
OMe
a General reactions conditions: 2.0 mmol ArNH2, 1.0 mmol ArI, 2.0 mmol K3PO4 , 0.10 mmol
Cul, 0.20 mmol L5, 0.5 mL DMSO, in a sealed tube under an N2 atmosphere for 24 h. b Yields
reported are the average of at least two runs determined to be > 95% pure by elemental analysis
or 'H NMR. c 5% Cul, 10% L5, 1.5 mmol ArNH2
Aryl bromides were also successfully coupled using the CuI/L catalyst system (Table 3),
although higher temperatures were required (100 °C). Increasing the reaction temperature to 110
'C provided significant quantities of N-arylated and decarboxylated pyrrole, and low yields of
the diarylamine products. Electron-donating and -withdrawing substituents were tolerated on
both the nucleophile and electrophile (entries 1-4). In addition, anilines and aryl bromides
containing ortho-substituents were effectively combined (entries 5-8). When employing 3-
bromoquinoline as a substrate, a significant quantity of reduced heteroarene was observed (entry
9). The formation of this byproduct is common for Cu-catalyzed reactions of heteroaryl halides
with amines."
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Table 3. Cu-Catalyzed Reactions of Anilines with Aryl Bromidesa
10% Cul
NH2 Br- 20% L5 H
K3PO4 , DMSO R  R2
100 *C, 24 h
entry product yield (%)b entry product yield (%)b
H H
2 N X 76 R = 2,5-Me 2  7 5 c
Me
H
FC N k OMe  55 H_6
7 R =Me 74d
8 OMe 67d
4 N 71 Me H
F' SMe 9 51
Me
a General reactions conditions: 2.0 mmol ArNH 2, 1.0 mmol ArBr, 2.0 mmol K3PO4, 0.10 mmol
Cul, 0.20 mmol L5, 0.5 mL DMSO, in a sealed tube under an N2 atmosphere for 24 h. b Yields
reported are the average of at least two runs determined to be > 95% pure by elemental analysis
or 1H NMR. c 20% L15 employed as a ligand in DMF at 110 oC. d 30 h.
4.3 Conclusion
In conclusion, pyrrole 2-carboxylic acid was employed as a suitable ligand for the Cu-
catalyzed monoarylation of anilines with aryl iodides and bromides. Anilines and aryl halides
possessing diverse electronic properties and useful functional groups were all tolerated. In many
cases, the relatively low catalyst loading (10% Cu), the breadth of functional groups tolerated by
the catalyst system, and the cost and commercial availability of the metal and ligand, might
offset the required use of two equivalents of amine, and the moderate yields obtained. We are
continuing our investigations to develop newer and more active Cu-based catalyst systems for
this transformation.
4.4 Experimental Procedures
All reactions were carried out in resealable test tubes with Teflon septa under an argon or
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nitrogen atmosphere. Copper(I) iodide (98%) was purchased from Strem. Pyrrole-2-carboxylic
acid was purchased from Aldrich. Finely milled K3PO4 was purchased from Fluka. The base was
flame-dried under vacuum and cooled under nitrogen immediately before usage. The base is
hygroscopic and excessive amounts of water lead to the formation of phenol and diaryl ether
byproducts. Anilines were purchased from commercial sources and, when necessary, purified by
distillation or sublimation. Aryl halides were purchased from commercial sources and, when
necessary, were distilled or filtered through a plug of alumina before use. Anhydrous
dimethylsulfoxide (DMSO) and N,N'-dimethylformamide (DMF) were purchased from Aldrich
in SureSeal@ bottles and used as received. Flash column chromatography was performed using a
Biotage SP4 Flash Purification System using SNAP 10g silica cartridges. In all cases,
dichloromethane was used to transfer the crude reaction material onto the silica gel samplet. The
samplet was then air-dried before usage. A gradient elution using hexanes and ethyl acetate was
performed, based on the recommendation from the Biotage TLC Wizard.
Yields reported in the publication are of isolated material and represent an average of at
least two independent runs. Yields reported in the supporting information refer to a single
experiment. Compounds described in the literature were characterized by comparing their 'H
NMR and 13C NMR spectra, and melting points (m.p.) to the previously reported data; their
purity was confirmed by gas chromatography (GC) or elemental analysis. GC analyses were
performed on a Hewlett Packard 6890 instrument with an FID detector and a Hewlett Packard 10
m x 0.2 mm i.d. HP-1 capillary column using dodecane as an internal standard. Elemental
analyses were performed by Atlantic Microlabs, Inc., Norcross, GA. Previously unknown
compounds were synthesized, purified and analyzed from a single run and the reactions used to
form them were then repeated to determine an average yield. They were characterized by 'H
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NMR, 13C NMR, m.p., IR and elemental analysis. 'H NMR and 13C NMR spectra were recorded
on Varian 500 MHz instruments with chemical shifts reported relative to the deuterated solvent
or TMS. IR spectra were recorded on a Perkin-Elmer System 2000 FT-IR instrument for all
previously unknown compounds (KBr disc). Melting points (uncorrected) were obtained on a
Mel-Temp II capillary melting point apparatus.
General procedure for the Cu-catalyzed cross-coupling of anilines with aryl halides
An oven-dried screw-cap test tube was charged with K3PO4 (424 mg, 2.0 mmol). The
tube was sealed and the base was flame-dried under vacuum, and cooled under a purge of N2.
Cul (19 mg, 0.10 mmol), Pyrrole-2-carboxylic acid (22 mg, 0.20 mmol), aryl halide (1.0 mmol,
if solid), amine (2.0 mmol, if solid) and a magnetic stir bar were added to the cooled vessel. The
tube was then evacuated and back-filled with nitrogen. The evacuation/backfill sequence was
repeated two additional times. Aryl halide (1.0 mmol, if liquid), amine (2.0 mmol, if liquid) and
DMSO (0.50 mL) were then added by syringe. The vessel was immersed in a preheated oil bath
and the reaction mixture was stirred vigorously until TLC and/or GC analysis of the crude
reaction mixture indicated that the aryl halide had been completely consumed. The reaction
mixture was cooled to room temperature. Ethyl acetate (15 mL), NH4CI(aq) (2 mL), and H20
(lmL) were added and the mixture was stirred. The organic layer was separated, and filtered
through a plug of silica. The aqueous layer was extracted twice more with ethyl acetate (10 mL),
and each extract was sequentially filtered through the pad of silica gel. The filtrate was
concentrated and the resulting residue was purified by flash chromatography (hexanes/ethyl
acetate, gradient elution) to provide the desired product.
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Experimental procedure for the reactions described in Table 1
An oven-dried screw-cap test tube was charged with Cul (9.5 mg, 0.050 mmol), ligand
(0.20 mmol, if solid), and a magnetic stir bar. The tubes were transferred into a nitrogen-filled
glove box where flame-dried anhydrous K3PO4 (212 mg, 1.0 mmol) was added. The tubes were
sealed with a Teflon septum and removed from the glovebox, where iodobenzene (56 [L, 0.5
mmol), aniline (92 mL, 1.0 mmol) and DMSO (0.25 mL) were successfully added by syringe.
The vessel was immersed in a pre-heated oil bath and stirred vigorously for 12 h at 80 OC. The
reaction mixture was cooled to room temperature. Dodecane (112 IiL), ethyl acetate (15 mL),
NH4CI(aq) (2 mL), and H20 (lmL) were added and stirred. The organic layer was sampled for GC
analysis.
Experimental procedures for compounds in Table 2
H
4-chloro-N-(4-methoxyphenyl)aniline (Entry 1)
The general procedure was followed using Cul (19 mg, 0.10 mmol), pyrrole-2-carboxylic acid
(22 mg, 0.20 mmol), K3PO4 (424 mg, 2.0 mmol), 4-chloroiodobenzene (238 mg, 1.00 mmol),
and p-anisidine (182 mg, 1.5 mmol) with DMSO (0.50 mL) as solvent for 20 h at 80 *C. Workup
and chromatographic purification (hexanes / ethyl acetate 1:0 - 4:1) afforded the title compound
as an off-white solid (188 mg, 81 %). m.p. 49-50.5 °C (lit. 50-51oC).12 'H NMR (500 MHz,
CDCI3) 8 7.18-7.13 (2H, m), 7.09-7.03 (2H, m), 6.90-6.80 (m, 4H), 5.48 (1H, bs), 3.81 (3H, s).
13C NMR (125 MHz, CDCl3) 8 155.8, 144.1, 135.4, 129.4, 124.5, 122.7, 116.8, 114.9, 55.8.
H
Me, N C0 2Et
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ethyl 3-(p-tolylamino)benzoate (Entry 2)
The general procedure was followed using Cul (9.5 mg, 0.05 mmol), pyrrole-2-carboxylic acid
(11 mg, 0.10 mmol), K3PO4 (424 mg, 2.0 mmol), ethyl-3-iodobenzoate (167 RL, 1.00 mmol),
and p-toluidine (214 mg, 2.0 mmol) with DMSO (0.50 mL) as solvent for 24 h at 80 *C. Workup
and chromatographic purification (hexanes / ethyl acetate 1:0 - 4:1) afforded the title compound
as a tan solid (199 mg, 78 %). m.p. 95-96 'C. 'H NMR (500 MHz, CDCI3) 6 7.66 (1H, dd, J =
1.8, 2.0 Hz), 7.54 (1H, ddd, J= 1.1, 1.5, 7.6 Hz), 7.29 (1H, t, J = 7.8 Hz), 7.20 (1H, ddd, J= 0.9,
2.5, 8.1 Hz), 7.13-7.11 (2H, m), 7.04-7.01 (2H, m), 5.73 (1H, bs), 4.37 (2H, q,J = 7.1 Hz), 2.33
(3H, s), 1.39 (3H, t, J = 7.1 Hz). '3C NMR (125 MHz, CDCI3) 8 166.9, 144.4, 139.8, 131.8,
130.2, 120.4, 121.2, 120.6, 119.5, 117.5, 61.1,20.9, 14.5. IR (KBr disc, cm ') 3356, 1701, 1604,
1589, 1526, 1487, 1367, 1280, 1219, 1106, 1025, 829, 801, 752. Anal. Calc. for C16H17NO 2: C
75.27, H 6.71. Found: C 75.51, H 6.74.
H
3-(p-tolylamino)benzonitrile (Entry 3)13
The general procedure was followed using Cul (9.5 mg, 0.05 mmol), pyrrole-2-carboxylic acid
(11 mg, 0.10 mmol), K3PO4 (424 mg, 2.0 mmol), 3-iodobenzonitrile (229 mg, 1.00 mmol), and
p-toluidine (214 mg, 2.0 mmol) with DMSO (0.50 mL) as solvent for 24 h at 90 *C. Workup and
chromatographic purification (hexanes / ethyl acetate 1:0 - 4:1) afforded the title compound as
an tan solid (150mg, 72 %). m.p. 71-730C. 'H NMR (500 MHz, CDCI3) 8 7.30-7.28 (1H, m),
7.20-7.15 (2H, m), 7.13 (1H, ddd, J = 0.9, 2.4, 7.4 Hz), 7.09 (1H, ddd, J = 1.1, 1.4, 7.5 Hz), 7.05-
7.02 (2H, m), 5.78 (1H, bs), 2.35 (3H, s). 13C NMR (125 MHz, CDCl3) 8 145.5, 138.4, 133.3,
130.4, 130.3, 123.1, 120.1, 119.3, 118.1, 113.2, 21.0. IR (KBr disc, cm1n) 3398, 2226, 1598,





The general procedure was followed using Cul (19 mg, 0.10 mmol), pyrrole-2-carboxylic acid
(22 mg, 0.20 mmol), K3PO4 (424 mg, 2.0 mmol), 2-iodotoluene (127 [tL, 1.00 mmol), and m-
toluidine (216 [L, 2.0 mmol) with DMSO (0.50 mL) as solvent for 30 h at 80 OC. Workup and
chromatographic purification (hexanes / ethyl acetate 1:0 - 4:1) afforded the title compound as
a tan oil (144 mg, 75 %). 'H NMR (500 MHz, CDCl3) 8 7.26 (1H, d, J = 6.9 Hz), 7.22 (1H, d, J
= 7.5 Hz), 7.17 (2H, m), 6.97-6.94 (1H, m), 6.81-6.75 (m, 3H), 5.36 (1H, bs), 2.33 (3H, s), 2.28
(3H, s). 13C NMR (125 MHz, CDCl3) 6 144.0, 141.5, 139.3, 131.1, 129.3, 128.3, 126.9, 122.0,




The general procedure was followed using Cul (19 mg, 0.10 mmol), pyrrole-2-carboxylic acid
(22 mg, 0.20 mmol), K3PO4 (424 mg, 2.0 mmol), 5-iodo-m-xylene (144 ýtL, 1.00 mmol), and 1-
(4-aminophenyl)ethanone (270 mg, 2.0 mmol) with DMSO (0.50 mL) as solvent for 24 h at 90
*C. Workup and chromatographic purification (hexanes / ethyl acetate 1:0 -- 4:1) afforded the
title compound as a yellow solid (136 mg, 57 %). m.p. 131-134 oC. 1H NMR (500 MHz, CDCl3)
6 7.90-7.86 (2H, m), 7.01-6.97 (2H, m), 6.81 (2H, s), 6.74 (1H, s), 6.02 (1H, bs), 2.54 (3H, s),
2.32 (6H, s). 13 C NMR (125 MHz, CDCl3) 8 196.6, 148.8, 140.6, 139.5, 130.8, 129.0, 125.4,
118.7, 114.6, 26.4, 21.6. IR (KBr disc, cm -1 ) 3331, 1653, 1570, 1342, 1274, 1181, 1168, 827.
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Anal. Calc. for C,,H,7NO: C 80.30, H 7.16. Found: C 80.22, H 7.18.
Me
ethyl 4-(3,5-dimethylphenylamino)benzoate (Entry 6)
The general procedure was followed using Cul (19 mg, 0.10 mmol), pyrrole-2-carboxylic acid
(22 mg, 0.20 mmol), K3PO 4 (424 mg, 2.0 mmol), 5-iodo-m-xylene (144 p[L, 1.00 mmol), and
ethyl-4-aminobenzoate (330 mg, 2.0 mmol) with DMSO (0.50 mL) as solvent for 24 h at 90 *C.
Workup and chromatographic purification (hexanes / ethyl acetate 1:0 - 4:1) afforded the title
compound as a white solid (138 mg, 51%). m.p. 119-120 'C. 1H NMR (500 MHz, CDCl3) 8
7.94-7.91 (2H, m), 7.00-6.96 (2H, m), 6.81 (2H, m), 6.72 (1H, m), 5.96 (1H, s), 4.35 (2H, q, J =
7.1 Hz), 2.31 (3H, s), 1.38 (3H, t, J = 7.1 Hz). 13C NMR (125 MHz, CDCI3) 8 166.7, 148.3,
141.0, 139.4, 131.6, 125.1, 121.4, 118.3, 114.8, 60.6, 21.6, 14.6. IR (KBr disc, cm-') 2241, 1697,





The general procedure was followed using Cul (19 mg, 0.10 mmol), pyrrole-2-carboxylic acid
(22 mg, 0.20 mmol), K3PO4 (424 mg, 2.0 mmol), 5-iodo-m-xylene (144 [L, 1.00 mmol), and 4-
aminobenzonitrile (236 mg, 2.0 mmol) with DMSO (0.50 mL) as solvent for 24 h at 90 *C.
Workup and chromatographic purification (hexanes / ethyl acetate 1:0 - 4:1) afforded the title
compound as a yellow solid (113 mg, 51%). m.p. 154-155 'C. 'H NMR (500 MHz, CDCl3) 6
2.32 (3H, S)7.49-7.46 (2H, m), 6.97-6.94 (2H, m), 6.80 (2H, s), 6.77 (1H, s), 6.00 (1H, bs). 13C
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NMR (125 MHz, CDCl3) 8 148.1, 139.7, 139.4, 133.7, 125.7, 120.0, 118.9, 114.8, 101.1, 21.3.
IR (KBr disc, cm-') 3335, 2214, 1591, 1532, 1350, 1170, 826. Anal. Calc. for C15H,4N 2: C 81.05,





The general procedure was followed using Cul (19 mg, 0.10 mmol), pyrrole-2-carboxylic acid
(22 mg, 0.20 mmol), K3PO4 (424 mg, 2.0 mmol), 4-iodoanisole (234 mg, 1.00 mmol), and N-(4-
aminophenyl)acetamide (300 mg, 2.0 mmol) with DMSO (0.70 mL) as solvent for 24 h at 80 *C.
Workup and chromatographic purification (hexanes / ethyl acetate 1:0 - 4:1) afforded the title
compound as a white solid (212 mg, 83 %). m.p. 138-139 'C (lit. 138 oC).16 'H NMR (500 MHz,
CDCI3) 8 7.33-7.30 (2H, m), 7.16 (1H, bs), 7.10-7.02 (2H, m), 6.90-.84 (m, 4H), 5.47 (1H, bs),
3.80 (3H, s), 2.15 (3H, s). 13C NMR (125 MHz, CDC13) 8 168.4, 155.2, 142.1, 136.3, 130.4,
122.2, 121.7, 116.7, 114.9, 55.8, 24.6. IR (KBr disc, cmf1) 3270, 1653, 1512, 1297, 1248, 1035,




The general procedure was followed using Cul (19 mg, 0.10 mmol), pyrrole-2-carboxylic acid
(22 mg, 0.20 mmol), K2CO3 (280 mg, 2.0 mmol), 4-iodoanisole (234 mg, 1.00 mmol), and 2-
aminobenzothiazole (298 mg, 2.0 mmol) with DMSO (0.80 mL) as solvent for 24 h at 90 *C.
Workup and chromatographic purification (hexanes / ethyl acetate 1:0 - 4:1) afforded the title
compound as a white solid (169 mg, 66 %). m.p. 91.5-92 *C. 'H NMR (500 MHz, CDCI3) 8 7.53
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(1H, td, J = 0.6, 7.8 Hz), 7.-7.41 (1H, m), 7.31 (1H, dd, J = 0.6, 8.2 Hz), 7.13-7.07 (3H, m), 6.07
(1H, bs), 6.84-6.82 (2H, bs), 3.78 (3H, s). '3C NMR (125 MHz, CDC13) 8 159.3, 139.0, 136.6,
131.2, 130.7, 125.0, 124.2, 119.9, 115.4, 115.3, 110.4, 55.6. IR (KBr disc, cmrn) 3220, 2235,
1591, 1580, 1493, 1404, 1289, 1246, 1175, 1021,824, 753. Anal. Calc. for C14HI2N20S: C 65.60,
H 54.72. Found: C 65.64, H 4.75.




The general procedure was followed using CuI (19 mg, 0.10 mmol), pyrrole-2-carboxylic acid
(22 mg, 0.20 mmol), K3PO4 (424 mg, 2.0 mmol), 1-bromo-4-chlorobenzene (191 mg, 1.00
mmol), and p-anisidine (248 mg, 2.0 mmol) with DMSO (0.50 mL) as solvent for 24 h at 100 *C.
Workup and chromatographic purification (hexanes / ethyl acetate 1:0 - 4:1) afforded the title
compound as a tan solid (180 mg, 77 %). m.p. 50-51 °C (lit. 50-51oC).17 'H NMR (500 MHz,




The general procedure was followed using Cul (19 mg, 0.10 mmol), pyrrole-2-carboxylic acid
(22 mg, 0.20 mmol), K3PO4 (424 mg, 2.0 mmol), 1-bromo-4-fluorobenzene (109 pL, 1.00
mmol), and p-anisidine (248 mg, 2.0 mmol) with DMSO (0.50 mL) as solvent for 24 h at 80 *C.
Workup and chromatographic purification (hexanes / ethyl acetate 1:0 4 4:1) afforded the title
299
compound as a tan solid (155 mg, 71 %). m.p. 57-59 'C (lit. 59 oC).' 8 1H NMR (500 MHz,
CDCI3) 8 7.03-7.00 (2H, m), 6.96-6.85 (6H, m), 5.40 (1H, bs), 3.81 (3H, s). 13C NMR (125 MHz,




The general procedure was followed using Cul (19 mg, 0.10 mmol), pyrrole-2-carboxylic acid
(22 mg, 0.20 mmol), K3PO4 (424 mg, 2.0 mmol), 3-bromoanisole (127 [tL, 1.00 mmol), and 3-
aminobenzotrifluoride (250 IL, 2.0 mmol) with DMSO (0.50 mL) as solvent for 24 h at 100 OC.
Workup and chromatographic purification (hexanes / ethyl acetate 1:0 - 4:1) afforded the title
compound as an orange oil (153 mg, 57%). 1H NMR (500 MHz, CDC13) 8 7.36 (1H, t, J = 7.9
Hz), 7.30 (IH, s), 7.26-7.20 (2H, m), 7.16 (1H, d, J = 7.8 Hz), 6.70 (1H, dd, J = 1.2, 8.1 Hz),
6.67 (1H, s), 6.59 (1H, d, J = 8.2 Hz), 5.85 (1H, bs), 3.81 (3H, s). 13C NMR (125 MHz, CDC13)6





The general procedure was followed using Cul (19 mg, 0.10 mmol), pyrrole-2-carboxylic acid
(22 mg, 0.20 mmol), K3PO4 (424 mg, 2.0 mmol), 4-bromothioanisole (203 mg, 1.00 mmol), and
4-fluoroaniline (189 [L, 2.0 mmol) with DMSO (0.50 mL) as solvent for 24 h at 100 'C.
Workup and chromatographic purification (hexanes / ethyl acetate 1:0 - 4:1) afforded the title
compound as a brown oil (170 mg, 73 %). 'H NMR (500 MHz, CDCl3) 8 7.21-7.17 (2H, m),
7.02-6.92 (4H, m), 6.89-6.86 (2H, m), 5.56 (1H, bs), 2.41 (3H, s). 13C NMR (125 MHz, CDCl 3)6
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159.2, 142.4, 139.0 (d), 130.3, 129.7, 120.6 (d), 117.7, 116.1 (d), 18.2. IR (KBr disc, cm ') 3396,






The general procedure was followed using Cul (19 mg, 0.10 mmol), 2-isobutyrylcyclohexanone
(33 RL, 0.20 mmol), K3PO4 (424 mg, 2.0 mmol), 5-bromo-m-xylene (136 RL, 1.00 mmol), and
2,5-dimethylaniline (249 [L, 2.0 mmol) with DMF (0.50 mL) as solvent for 24 h at 110 *C.
Workup and chromatographic purification (hexanes / ethyl acetate 1:0 - 4:1) afforded the title
compound as a yellow oil (166 mg, 74 %). 'H NMR (500 MHz, CDC13) 8 7.05-7.02 (2H, s), 6.72
(1H, td, J = 0.4, 7.6 Hz), 6.56 (2H, d, J = 0.6 Hz), 6.53 (1H, t, J = 0.6 Hz), 5.22 (1H, bs), 2.26
(3H, s), 2.23 (6H, s), 2.17 (3H, s). 13C NMR (125 MHz, CDCl3) 8 144.2, 141.3, 139.2, 136.6,
130.9, 125.4, 122.8, 122.4, 119.9, 116.8, 115.4, 21.6, 21.4, 17.7. IR (KBr disc, cn1') 3383, 3020,
2919, 1601, 1578, 1522, 1466, 1221, 1177, 829, 802. Anal. Calc. for C,4H,2F3NO: C 62.92, H





The general procedure was followed using Cul (19 mg, 0.10 mmol), pyrrole-2-carboxylic acid
(22 mg, 0.20 mmol), K 3PO4 (424 mg, 2.0 mmol), 5-bromo-m-xylene (136 RL, 1.00 mmol), and
o-anisidine (225 tiL, 2.0 mmol) with DMSO (0.50 mL) as solvent for 24 h at 100 *C. Workup
and chromatographic purification (hexanes / ethyl acetate 4:1 - 1:0) afforded the title compound
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as an orange oil (155 mg, 68%). 'H NMR (500 MHz, CDC13) 8 7.33-7.31 (1H, m), 6.91-6.84
(3H, m), 6.81 (2H, d, J = 0.6 Hz), 6.62 (1H, t, J = 0.6 Hz), 6.10 (1H, s), 3.89 (3H, s), 2.30 (3H,





The general procedure was followed using Cul (19 mg, 0.10 mmol), pyrrole-2-carboxylic acid
(22 mg, 0.20 mmol), K3PO4 (424 mg, 2.0 mmol), 2-bromotoluene (120 RL, 1.00 mmol), and m-
toluidine (216 [tL, 2.0 mmol) with DMSO (0.50 mL) as solvent for 30 h at 100 *C. Workup and
chromatographic purification (hexanes / ethyl acetate 1:0 -) 4:1) afforded the title compound as
a tan oil (129 mg, 66 %). 'H NMR (500 MHz, CDCl3) 8 7.26 (1H, d, J = 6.9 Hz), 7.22 (1H, d, J
= 7.5 Hz), 7.17 (2H, m), 6.97-6.94 (1H, m), 6.81-6.75 (3H, m), 5.36 (1H, bs), 2.33 (3H, s), 2.28
(3H, s). 13C NMR (125 MHz, CDCI3) 8 144.0, 141.5, 139.3, 131.1, 139.3, 128.3, 126.9, 122.0,




The general procedure was followed using CuI (19 mg, 0.10 mmol), pyrrole-2-carboxylic acid
(22 mg, 0.20 mmol), K3PO4 (424 mg, 2.0 mmol), 2-bromoanisole (125 [L, 1.00 mmol), and m-
toluidine (216 [L, 2.0 mmol) with DMSO (0.50 mL) as solvent for 30 h at 100 *C. Workup and
chromatographic purification (hexanes / ethyl acetate 1:0 4 4:1) afforded the title compound as
an orange oil (142 mg, 66%). ' H NMR (500 MHz, CDCI3) 8 7.36-7.33 (1H, m), 7.23-7.18 (1H,
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m), 7.02-6.87 (5H, m), 6.81 (1H, d, J = 7.5 Hz), 6.16 (1H, bs), 3.29 (3H, s), 2.36 (3H, s). 13C
NMR (125 MHz, CDCl3) 8 148.4, 142.8, 139.3, 133.2, 129.3, 122.2, 121.0, 119.9, 119.4, 115.8,




The general procedure was followed using Cul (19 mg, 0.10 mmol), pyrrole-2-carboxylic acid
(22 mg, 0.20 mmol), K3PO4 (424 mg, 2.0 mmol), 3-bromoquinoline (136 [tL, 1.00 mmol), and
3,5-dimethylaniline (248 ILL, 2.0 mmol) with DMSO (0.50 mL) as solvent for 24 h at 100 *C.
Workup and chromatographic purification (hexanes / ethyl acetate 4:1 - 1:0) afforded the title
compound as a green oil (135 mg, 54 %). 'H NMR (500 MHz, CDCl3) 8 .72 (1H, d, J = 2.8 Hz),
8.02 (1H, dd, J = 0.6, 8.2 Hz), 7.70 (1H, d, J = 2.8 Hz), 7.65 (1H, dd, J = 1.2, 8.1 Hz), 7.54-7.46
(2H, m), 6.82 (2H, s), 6.71 (1H, d, J = 0.6 Hz), 6.12 (1H, s), 2.32 (6H, s). 13C NMR (125 MHz,
CDCl3) 8 145.3, 143.7, 141.9, 139.6, 137.4, 120.2, 129.1, 127.2, 126.6, 126.5, 124.4, 117.2,
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Chapter Five
An Improved Copper-based Catalyst System for the
Reactions of Aryl Halides with Aliphatic Alcohols
d X 5% Cul, 10% Me4-Phen OR2
+ HOR2 CS2 C003, tolueneR 80-130 °C, 12-30 h R
X = I, Br R2= 1 0 and 20 Alkyl, Benzyl, Allyl, Propargyl
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5.1 Introduction
Recently developed transition metal-catalyzed nucleophilic substitution reactions of aryl
halides have complemented traditional approaches for synthetic organic chemists to prepare C-
heteroatom bonds. For the synthesis of alkyl aryl ethers, a traditional preparation might involve
nucleophilic displacement of an alkyl halide by a phenol,' while the complementary metal-
catalyzed variant would involve displacement of an aryl halide with an aliphatic alcohol. While
the scope of products that can be accessed by the former method might be limited by the
nucleophilicity of the phenol and the steric hindrance at the electrophilic carbon atom, the latter
reaction can be limited by the activation of the aryl halide or reductive elimination processes.
In our continuing quest to improve metal-catalyzed C- heteroatom bond-forming reactions,
we have developed several Pd- and Cu-based catalyst systems for the intermolecular coupling
reactions of aliphatic alcohols with aryl halides to prepare alkyl aryl ethers.2-3 Using Pd-based
catalysts, the low yields observed in the coupling of certain substrates have been attributed to the
slow rate of CO reductive elimination relative to P-hydride elimination from the
LPd(II)(Ar)(alkoxide) intermediate.la 'b4 In these cases, Cu-based catalyst systems can provide
complementary reactivities, as the analogous intermediates derived from these catalysts do not
readily undergo 3-hydride elimination reactions.5
330




Ar R1 R2HC, ,
I p-Hydride 0 LnPd-Ar
LnPd-H . I I






n n-n-u= + Lnru + rn BaseBase
The substrate scopes and the overall utility of the traditional Cu-based methods for the
synthesis of alkyl aryl ether are severely limited by (1) the use of superstoichiometric quantities
of Cu, (2) high reaction temperatures, and (3) the use of strong alkoxide bases.6 Currently, few
generally applicable Cu-based catalyst systems, which facilitate the reaction under mild
conditions, have been reported for the cross-coupling of aliphatic alcohols with aryl halides.2'7-8
In 2002, we reported that 10 mol % of Cul in conjunction with 20 mol % of 1,10-
phenanthroline (Phen, Figure 1) could facilitate CO bond formation between aryl iodides and
aliphatic alcohols under mild reaction conditions (Cs2CO3/ 110 *C/18-38 h); however, in most
cases, the use of the alcohol as a solvent was required to achieve satisfactory yields, thus
rendering the procedure impractical for the use of precious or highly functionalized alcohols.2 In
certain simple cases, toluene could be utilized as a solvent to reduce the quantity of alcohol
required for the reactions. Recently developed catalysts systems that employ amino acids as
ligands or KF/A120 3 as the base have also failed to overcome the required use of excess
quantities of alcohols for these reactions.7 In addition, reactions of both secondary (20) cyclic and
acyclic alcohols provided the corresponding products in low yields due to incomplete conversion
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of the aryl iodides in reasonable time periods (24 h).2'7 More recently, we reported that the use of
a commercially available ligand, 3,4,7,8-tetramethyl-1,10-phenanthroline (Me 4-Phen, Figure 2),
improved the Cu-catalyzed nucleophilic substitution reactions of aryl iodides and alkyl-
substituted vinyl iodides with amino alcohols and allylic alcohols, respectively; however, the
scope of the reaction was not investigated/explored beyond these selected substrates. 9-'0 Herein,
we report an in-depth account of the use of Me4-Phen in Cu-catalyzed CO bond-forming
reactions that presents the scope and limitations of this catalyst system.






5.2 Results and Discussion
A variety of 1,10-phenanthroline-substituted ligands were tested in the reaction of 4-
iodoanisole with n-hexanol using the following catalyst system: 5 mol % Cul/10 mol %
ligand/Cs2CO 3/toluene/80 °C/12 h (Table 1). The data presented suggest that the presence of
methyl and phenyl substituents in positions 3-5 of the phenanthroline backbone increase the
activity of the catalyst (entries 17). More specifically, the catalytic activity of the methyl-
substituted ligands increases as a function of the number of methyl substituents present on the
Phen core: Phen 4-Me-Phen 5-Me-Phen 4,7-Me2-Phen 5,6-Me2-Phen Me4-Phen. Two hypotheses
to explain the high activity of the catalyst systems, which employ methyl-substituted Phen
ligands, are (1) the alkyl substituents might increase the solubility of the metal catalyst in a
nonpolar organic solvent, thus raising the effective concentration of catalyst in solution, and/or
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(2) the presence of the alkyl substituents on the ligand increases the o-donating ability of the
nitrogen atoms" and accelerates the rate-limiting aryl halide activation step. Neocuproine (2,9-
Me2-Phen) is not a good ligand for this transformation and reinforces the notion that Cu-
catalyzed C-heteroatom bond-forming reactions are extremely sensitive to steric hindrance.4
When 4,7-(MeO)2-Phen is employed as a ligand for this transformation, 1,4-dimethoxybenzene
is produced as a byproduct (15% GC yield), presumably due to nucleophilic displacement of the
methoxy groups of the ligand by n-hexanol, followed by cross-coupling of the resulting
methoxide nucleophile with the aryl iodide (entry 9). Interestingly, the combined yield of
methoxy- and n-hexyloxy-substituted products (81%) when employing the dimethoxy-
substituted ligand is comparable to the yield of product observed when Me4-Phen is used (79%),
suggesting that these two catalyst systems facilitate C-O bond formation at comparable rates.
Other 4,7-bis-heteroatom-substituted-Phen derivatives provide relatively inactive catalysts
(entries 10, 11).
333
Table 1. Cu-Catalyzed Reaction of 4-Iodoanisole with n-Hexanol Using 1,10-Phenanthroline-
derived Ligandsa
HI n 15e/65% Cul, 10% Ligand On-Hex
Cs 2CO3, tolueneM -C,1280 *  12heO
entry ligand conversion (%) yield (%)
1 1, 10-phenanthroline (Phen) 50 44
2 4-Me-Phen 56 54
3 5-Me-Phen 55 51
4 4,7-Me2-Phen 68 57
5 5,6-Me2-Phen 64 54
6 Me4-Phen 82 79
7 4,7-Ph2-Phen 63 64
8 neocuproine 10 0
9 4,7-(MeO)2-Phen 83 66
10 4,7-(NMe)2-Phen 37 19
11 4,7-CI2-Phen 35 33
" Reaction conditions: 1.0 mmol of 4-iodoanisole, 1.5 mmol of n-hexanol, 0.050 mmol of Cul,
0.10 mmol of ligand, 1.5 mmol of Cs2CO3, and 0.5 mL of toluene under Ar atmosphere at 80 °C
for 12 h. Corrected conversion and yield data were calculated from GC analyses of the crude
reaction mixtures using dodecane as an internal standard.
Using the optimized reaction conditions, a wide variety of substrates containing useful
functional groups can be success- fully cross-coupled (Table 2). The reaction of our model
substrates (n-hexanol with 4-iodoanisole) proceeds in excellent yield at temperatures as low as
80 °C using 5% catalyst (entry 1). At 110 °C using 2% and 5% catalyst loading, this same
reaction proceeds in 24 and 12 h, respectively (entries 2, 3).
The catalyst system is tolerant of ortho-substituents on the aryl halide (entries 4-6), as well
as both electron-donating and withdrawing substituents on the aromatic ring. Aryl iodides can be
selectively cross-coupled in the presence of aryl bromides, chlorides, and fluorides (entries 8-
10). Low-boiling point alcohols, as well as allyl, propargyl, and benzyl alcohols, furnish the
corresponding aryl ethers in good to excellent yields (entries 7, 8, 10-13). The latter example
334
provides ready access to the corresponding phenols, as the resulting aryl benzyl ether can be
readily cleaved. 12 Remarkably, the catalyst system can selectively cross-couple alcohols in the
presence of an unprotected aniline (entry 11) or aliphatic amines.9
Although the Cu-catalyzed reaction of ethyl 4-iodobenzoate with n-hexanol provides a
complex mixture of transesterified and cross-coupled products, the formation of the
transesterified product can be drastically reduced by employing the tert-butyl ester (entry 14).
Heterocyclic compounds can be employed either as the electrophilic or nucleophilic reactant
(entries 12, 13, 15-18). Products containing water-sensitive functional groups can be provided in
good yields by adding activated molecular sieves to the reaction mixtures. (entries 17, 18).
The Cu-catalyzed cross-coupling reactions of secondary alcohols with aryl halides are
particularly important reactions, due to the increased propensity for 20 alcohols to undergo 3-
hydride elimination using Pd-based catalyst systems.' Further, the complementary uncatalyzed
Williamson reactions of 20 alkyl halides with poorly nucleophilic phenols typically provide low
yields of the aryl alkyl ether products. 13 The CuI/Me4-Phen- catalyzed reactions of 20 cyclic
alcohols with aryl iodides are generally slower than the respective primary (10) alcohol
counterparts (entries 18-20), requiring higher reaction temperatures (110 'C compared to 80 OC).
However, the reactions of secondary acyclic alcohols (e.g., isopropyl alcohol and 3-pentanol)
with simple aryl iodides are unsuccessful, unless the reactions are run in neat alcohol. This
difference in reactivity can be exploited to selectively cross-couple a 10 alcohol in the presence
of a 20 alcohol (entry 21). We speculate that this selectivity difference occurs due to the poor
coordinating ability of the 20 alcohol relative to the 10 alcohol.
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Table 2. CuI/Me4-Phen-Catalyzed Cross-coupling Reactions of Alcohols with Aryl Iodides and
Bromidesa
5% Cul, 10% Me4-Phen
+ HOR2
CS2CO3 , toluene 80-110 0CX = Br, I 9-24 h
entry product X = temperature time yield
(0C) (h) (%)
entry product X = temperature time yield
(0C) (h) (%)
2 •MO O'n-Hex3 MeO"':
4 O R= Me
5 • -Hex OMe
6 RCI



















I 80 20 82
I 80 24 72d
I 80 16 75
I 80 20 74
I 80 16 81
I 80 20 92
1 80 16 59












21 Me 0 Me
22 MeO. O .k
23 MeO ;k
O 'n H ex
80 16 86
I 110 24 95
80 24 78'
I 110 24 85'
I 110 24 88
110 24 75
80 24 739
110 24 94 h
Br 130 24 77'
a Reaction conditions: 1.0 mmol of ArX, 1.5 of mmol alcohol, 0.050 of mmol Cul (5%), 0.10
mmol of Me4-Phen (10%), 1.5 mmol of Cs2CO3,
atmosphere. The isolated yields reported are averages
be 95% pure by 'H NMR and/or elemental analysis.
and 0.50 mL of toluene under an Ar
of two or more runs of material judged to
b GC yield reported. c 2% Cul, 4% Me4-
Phen. d GC analysis: 14:1 mixture of I- to Br-substituted products that were separated by column
chromatography. e Inseparable 7:1 mixture of depicted product and n-hexyl 4-
(hexyloxy)benzoate. 1 200 mg of 4 A mol sieves added to reaction mixture. g One regioisomer
detected by GCMS and 'H NMR. h 10% Cul, 20% Me4-Phen. i 130 °C, 0.50 mL of n-hexanol
used as solvent.
The cross-coupling reactions of aryl bromides are less successful than their iodide




proceeds smoothly (entry 22). However, the Cu-catalyzed reactions of other aliphatic alcohols
are more challenging for this catalyst system. An aryl bromide can be successfully cross-
coupled in neat n-hexanol at an elevated temperature (130 'C, entry 23). However, the reactions
of both 20 cyclic and acyclic alcohols do not proceed to full conversion under these and more
rigorous conditions. These data suggest that the efficacy of Cu- catalyzed cross-coupling
reactions of various alcohols with aryl halides follows the trend benzylic 10 alkyl 20 cyclic alkyl
20 acyclic alkyl. We suspect that the efficiency of reactions that employ benzylic alcohols is due,
in large part, to their enhanced acidity relative to other aliphatic alcohols.14
5.3 Conclusion
In summary, we have explored the utility of Me4-Phen as a ligand in the Cu-catalyzed
cross-coupling reactions of aryl iodides and bromides with alcohols. With this protocol, the
cross-coupling reactions of aryl iodides with alcohols can be run under mild conditions without
the required use of excess quantities of nucleophile in the reaction. This catalyst system
complements Pd-based catalyst systems, as well as traditional Williamson reactions, and
nucleophilic substitution reactions of activated aryl halides for the preparation of alkyl aryl
ethers. We believe that chemists in both academic and industrial laboratories will find this
improved catalyst system useful in their work.
5.4 Experimental Procedures
All reactions were carried out in resealable test tubes with teflon septa under a dry argon
or nitrogen atmosphere. Copper(I) iodide (98%) was purchased from Strem. Me4-Phen was
purchased from Acros. The Anhydrous finely powdered Cs2CO3 was a generous gift from
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Chemetall. This base was stored under nitrogen in a Vacuum Atmospheres glovebox. (The base
is hygroscopic and excessive amounts of water lead to the formation of phenol and diaryl ether
byproducts.) Small portions of the base (~5 g) were removed from the glovebox in glass vials,
stored in the air in a desiccator filled with anhydrous calcium sulfate, and weighed in the air.
Alcohols were purchased from commercial sources and used without further purification. Aryl
halides were purchased from commercial sources and, when necessary, filtered through neutral
alumina or distilled. Anhydrous toluene was purchased from J. T. Baker in CYCLE-TRAINER®
solvent delivery kegs and vigorously purged with argon for 2 h. The solvent was further purified
by passing it through two packed columns of neutral alumina under argon. The solvents were
transferred by syringe from the solvent purification system to the reaction flask. Flash column
chromatography was performed using a Biotage SP4 Flash Purification System using KP-Sil
silica cartridges. In all cases, dichloromethane was used to transfer the crude reaction material
onto the silica gel samplet. The samplet was dried in an oven before usage. A gradient elution
using hexane and ethyl acetate was performed, based on the recommendation from the Biotage
TLC Wizard.
Unless specified, yields reported in the publication are of the isolated material and
represent an average of at least two independent runs. Yields reported in the supporting
information refer to a single experiment. Compounds described in the literature were
characterized by comparing their 1H NMR and 13C NMR spectra, and melting points (m.p.) to the
previously reported data; their purity was confirmed by gas chromatography (GC) or elemental
analysis. GC analyses were performed on a Hewlett Packard 6890 instrument with an FID
detector and a Hewlett Packard 10 m x 0.2 mm i.d. HP-1 capillary column using dodecane as an
internal standard. Elemental analyses were performed by Atlantic Microlabs, Inc., Norcross, GA.
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Previously unknown compounds were synthesized, purified and analyzed from a single run and
were then repeated to determine an average yield. They were characterized by 'H NMR, 13C
NMR, m.p., IR and elemental analysis. For those compounds that did not give a satisfactory
elemental analysis, a copy of their 'H NMR spectra is included. 'H NMR and 13C NMR spectra
were recorded on Varian 500 MHz instruments with chemical shifts reported relative to the
deuterated solvent or TMS. IR spectra were recorded on a Perkin-Elmer System 2000 FT-IR
instrument for all previously unknown compounds (KBr disc). Melting points (uncorrected) were
obtained on a Mel-Temp II capillary melting point apparatus.
General procedure for the Cu-catalyzed cross-coupling of alcohols with aryl halides
An oven-dried screw-cap test tube was charged with Cul (9.5 mg, 0.050 mmol), Me4-Phen (24
mg, 0.10 mmol), aryl halide (1.0 mmol, if solid), Cs2 CO3 (490 mg, 1.5 mmol), and a magnetic
stir bar. The reaction vessel was fitted with a rubber septum. The test tube was evacuated and
back-filled with dry argon. Aryl halide (1. 0 mmol, if liquid), and toluene (0.50 mL) were then
added by syringe. The rubber septum was removed and the reaction tube was quickly sealed with
a Teflon-lined septum. The vessel was immersed in a pre-heated oil bath and stirred vigorously
until TLC and/or GC analysis of the crude reaction mixture indicated that the aryl halide had
been completely consumed. The reaction mixture was cooled to room temperature, diluted with
ethyl acetate (15 mL), and filtered through a plug of silica, eluting with additional ethyl acetate
(30 mL). The filtrate was concentrated and the resulting residue was purified by flash
chromatography (hexane/ethyl acetate) to provide the desired product.
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Experimental procedures for compounds in Table 2
MeOI O • M e
4-(hexyloxy)-anisole (Entries 1-3)
The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs2CO3 (391 mg, 1.2 mmol), 4-iodoanisole (234 mg, 1.00 mmol), and n-hexanol (186
[tL, 1.50 mmol) with toluene (0.50 mL) as solvent for 15 h at 80 *C. After cooling to room
temperature, dodecane (225 mL, 1.0 mmol) and ethyl acetate (20 mL) were stirred into the
reaction mixture. The mixture was filtered through a small plug of silica gel, and sampled for GC
analysis. In order to standardize this compound for GC analysis, the product was purified by
flash chromatography (hexane / ethyl acetate 1:0 - 9:1) to afford the title compound as a
colorless oil (162 mg, 78%). ' H NMR (300 MHz, CDCl3) 8 6.85 (4H, s), 3.94-3.89 (3H, t, J =
6.6 Hz), 3.78 (3H, s), 1.79-1.72 (2H, m), 1.49-1.37 (2H, m), 1.36-1.32 (4H, m), 0.94-0.90 (3H, t,
J = 7.0 Hz). 13C NMR (125 MHz, CDCI3) 8 153.9, 153.5, 115.6, 115.0, 68.9, 56.0, 31.9, 29.6,
26.0, 22.9, 14.3. IR (KBr disc, cmn ') 2937, 1510, 1466, 1290, 1235, 1113, 1036, 827,726, 532.
Anal. Calc. for C13H200 2: C 74.96, H 9.68. Found: C 74.78, H 9.74.
CMMe
2-(hexyloxy)-toluene (entry 4)'
The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs2CO3 (490 mg, 1.5 mmol), 2-iodotoluene (127 xiL, 1.00 mmol), and n-hexanol (187
[tL, 1.50 mol) with toluene (0.50 mL) as solvent for 24 h at 110 *C. Chromatographic
purification (hexane / ethyl acetate 1:0 - 9:1) afforded the title compound as a clear oil (159
mg, 83%). 'H NMR (500 MHz, CDCl3) 8 7.16-7.12 (2H, m), 6.85-6.80 (2H, m), 3.96 (2H, t, J =
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6.4 Hz), 2.23 (3H, s), 1.85-1.76 (2H, m), 1.56-1.32 (6H, m), 0.94-0.88 (3H, m). 13C NMR (125
MHz, CDCI3) 157.6, 130.9, 127.1, 127.0, 120.3, 111.1, 68.1, 32.0, 29.7, 26.2, 23.0, 16.6, 14.4.
IR (KBr disc, cm -' ) 2955, 2931, 2860, 1603, 1496, 1463, 1379, 1245, 119, 1122, 1050, 749, 713.
Anal. Calc. for C13H200: C 81.20, H 10.48. Found: C 81.41, H 10.33.
2-(hexyloxy)-anisole (entry 5)15
The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me 4-Phen (24 mg, 0.10
mmol), Cs2CO3 (490 mg, 1.5 mmol), 2-iodoanisole (130 [tL, 1.00 mmol), and n-hexanol (187
[L, 1.50 mol) with toluene (0.50 mL) as solvent for 30 h at 110 *C. Chromatographic
purification (hexane / ethyl acetate 1:0 -) 9:1) afforded the title compound as a clear oil (195
mg, 94%). '1H NMR (500 MHz, CDCl3) 8 6.92-6.90 (4H, m), 4.03 (2H, t, J = 7.0 Hz), 3.88 (3H,
s), 1.86 (2H, m), 7.49-1.34 (8H, m), 0.93-0.90 (3H, m). 13C NMR (125 MHz, CDCl3) 8 149.6,
148.8, 121.0, 121.0, 113.2, 112.0, 69.2, 56.2, 31.9, 29.4, 25.9, 22.8, 14.3. IR (KBr disc, cmn')
2932, 2860, 1593, 1507, 1456, 1253, 1228, 1180, 1125, 1030, 740. Anal. Calc. for Cl3H200 2: C
74.96, H 9.68. Found: C 74.69, H 9.68.
Oc7 Me
1-chloro-2-(hexyloxy)benzene (entry 6)16
The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs2CO3 (490 mg, 1.5 mmol), 1-chloro-2-iodobenzene (122 [tL, 1.00 mmol), and n-
hexanol (187 tL, 1.50 mol) with toluene (0.50 mL) as solvent for 24 h at 110 *C.
Chromatographic purification (hexane / ethyl acetate 1:0 - 1:3) afforded the title compound as a
clear oil (185 mg, 87%). 1H NMR (500 MHz, CDC13) d 7.36 (1H, dd, J = 1.7, 7.9 Hz), 7.20
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(1H, m), 6.94-6.85 (2H, m), 4.03 (2H, t, J = 6.5 Hz), 1.85 (2H, m), 1.54-1.31 (m, 6H), 0.94-0.89
(m, 3H).
1,4-dimethoxybenzene (entry 7)17
The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs 2CO3 (391 mg, 1.2 mmol), 4-iodoanisole (234 mg, 1.00 mmol), and methanol (81 JIL,
2.00 mmol) with toluene (0.50 mL) as solvent for 15 h at 80 *C. Chromatographic purification
(hexane / ethyl acetate 1:0 -- 9:1) afforded the title compound as a colorless oil (108 mg, 78%).
'H NMR (300 MHz, CDCl3) 8 6.84 (4H, s), 3.77 (6H, s). IR (KBr disc, cm'1) 2933, 2860, 1509,




The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs2CO3 (490 mg, 1.5 mmol), 1,bromo-4-iodobenzene (283 mg, 1.00 mmol), and ethanol
(116 [L, 2.0 mol) with toluene (0.50 mL) as solvent for 24 h at 80 *C. Chromatographic
purification (hexane / ethyl acetate 1:0 - 9:1) afforded the title compound as a clear oil (130
mg, 65%). 1H NMR (500 MHz, CDCl3) 6 7.39-7.36 (2H, m), 6.80-6.77 (2H, m), 4.00 (2H, q, J =
7.0 Hz), 1.42 (t, 3H, J = 7.0 Hz). 13C NMR (125 MHz, CDCl3) 8 158.2, 132.4, 116.4, 112.8,
63.9, 14.9. IR (KBr disc, cm -') 2981, 2927, 1592, 1579, 1489, 1475, 1393, 1286, 1245, 1172,
1115, 1072, 1048, 1002, 923, 820, 639, 507. Anal. Calc. for CsHBrO: C 47.79, H 4.51. Found:





The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me 4-Phen (24 mg, 0.10
mmol), Cs2CO 3 (650 mg, 2.0 mmol), 4-chloro-l-iodobenzene (238 mg, 1.00 mmol), and solketal
(249 [tL, 2.00 mmol) with toluene (0.50 mL) as solvent for 15 h at 80 OC. Chromatographic
purification (hexane / ethyl acetate 1:0 -4 9:1) afforded the title compound as a colorless oil (202
mg, 83%). 'H NMR (300 MHz, CDCl3) 8 7.268-7.209 (2H, m), 6.872-6.819 (2H, m), 4.512-
4.434 (1H, m), 4.192-4.143 (1H, dd, J = 6.4, 8.5 Hz), 4.046-3.996 (1H, dd, J = 5.5, 9.5 Hz),
3.938-3.868 (2H, m), 1.465 (3H, s), 1.407 (3H, s). 13C NMR (125 MHz, CDC13) 8 157.3, 129.5,
126.2, 116.0, 110.0, 74.1, 69.2, 66.9, 27.0, 25.5. IR (KBr disc, cm -') 2980, 2932, 1489, 1451,
1371, 1240, 1203, 1169, 1152, 1075, 1051, 1000, 973, 893,831,658. Anal. Calc. for C 12H1 5CIO 3:
C 59.39, H 6.23. Found: C 59.57, H 6.30.
(E)- 1-(but-2-enyloxy)-4-fluorobenzene (entry 10)' 9
The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me 4-Phen (24 mg, 0.10
mmol), Cs2CO3 (490 mg, 1.5 mmol), 1-fluoro-4-iodobenzene (115 tL, 1.00 mmol), and (E)-
crotyl alcohol (127 [tL, 1.50 mol) with toluene (0.50 mL) as solvent for 24 h at 80 OC.
Chromatographic purification (hexane / ethyl acetate 1:0 -- 9:1) afforded the title compound as a
clear oil (117 mg, 70%). 'H NMR (500 MHz, CDCI3) 8 7.00-6.95 (2H, m), 6.89-6.83 (2H, m),
5.90-5.83 (1H, m), 5.75-5.70 (1H, m), 4343 (2H, dd, J = 0.9, 6.2 Hz), 1.77 (3H, d, J = 6.4 Hz).
13C NMR (125 MHz, CDC13) 8 156.4, 155.0, 130.9, 126.1, 116.0, 115.8, 69.5, 18.1. IR (KBr
343
disc, cmn ) 3025, 2941, 2919, 2859, 1506, 1463, 1379, 1293, 1246, 1208, 1097, 1009, 967, 828,
780, 741, 514. Anal. Calc. for C1o0HIFO: C 72.27, H 6.67. Found: C 72.00, H 6.81.
H2Nj 0r
4-(benzyloxy)aniline (entry 11)20
The general procedure was followed using CuI (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs2CO3 (391 mg, 1.2 mmol), 4-iodoaniline (219 mg, 1.00 mmol), and benzyl alcohol
(210 [tL, 2.00 mmol) with toluene (0.50 mL) as solvent for 15 h at 80*C. Chromatographic
purification (hexane / ethyl acetate 1:0 - 9:1) afforded the title compound as a red solid (158
mg, 79%). 'H NMR (300 MHz, CDCl3) 8 7.45-7.32 (5H, m), 6.86-6.80 (2H, m), 6.68-6.63
(2H,m), 3.428 (2H, b s). 13C NMR (125 MHz, CDC13) 6 152.1, 140.4, 137.7, 128.7, 128.0, 127.7,
116.5, 116.2, 70.9. IR (KBr disc, cm-') 2932, 2960, 1585, 1568, 1462, 1382, 1274, 1228, 1127,
1109, 1014, 829, 727, 673, 627,423. m.p. 45-46.5 *C.
1-(4-(pent-2-ynyloxy)phenyl)-1H-pyrrole (entry 12)
The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs2CO3 (391 mg, 1.2 mmol), 1-(4-iodophenyl)pyrrole (269 mg, 1.00 mmol), and 2-
pentyn-1-ol (139 [L, 1.50 mmol) with toluene (0.50 mL) as solvent for 24 h at 80 *C.
Chromatographic purification (hexane / ethyl acetate 1:0 - 9:1) afforded the title compound as a
white solid (209 mg, 92%). 1H NMR (300 MHz, CDC13) 8 7.35-7.30 (2H, m), 7.06-7.01 (4H, m),
6.34-6.33 (2H, t, J = 2.2 Hz), 4.71-4.70 (2H, , J = 2.2 Hz), 2.31-2.22 (2H, m), 1.19-1.14 (3H, t, J
= 7.5 Hz). 13C NMR (125 MHz, CDCl3) 8 156.0, 122.2, 119.9, 115.9, 110.1, 90.0, 74.1, 57.0,
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44.8, 13.8, 12.7. IR (KBr disc, cm -') 3132, 2977, 1522, 1325, 1258, 1243, 1190, 1070, 1018,
1006, 920, 824, 734. m.p. 57.5-59.0 *C.
(E)-2-(hex-2-enyloxy)thiophene (entry 13)
The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs2CO3 (650 mg, 2.0 mmol), 3-iodothiophene (102 [LL, 1.00 mmol), and (E)-hex-2-en-1-
ol (236 iL, 2.00 mmol) with toluene (0.50 mL) as solvent for 15 h at 80 *C. Chromatographic
purification (hexane / ethyl acetate 1:0 4 12.5:1) afforded the title compound as a yellow oil
(125 mg, 69%). 'H NMR (300 MHz, CDCl3) 6 7.191-7.163 (1H, dd, J = 3.1, 5.3 Hz), 6.789-
6.767 (1H, dd, J = 1.6, 5.3 Hz), 6.274-6.258 (1H, q, J = 1.6 Hz), 5.906-5.811 (1H, m), 5.765-
5.666 (1H, m), 4.461-4.438 (2H, dd, J = 1.0, 6.0 Hz), 2.119-2.045 (2H, m), 1.507-1.384 (2H, m),
0.951-0.902 (3H, t, J = 7.3 Hz). 13C NMR (125 MHz, CDC13) 6 157.7, 136.1, 124.9, 124.7,
119.8, 97.6, 71.1, 34.6, 22.3, 13.9. IR (KBr disc, cmm') 3118, 2959, 2929, 2871, 1544, 1421,
1366, 1234, 1177, 1010, 970, 873, 831, 752, 627. Anal. Calc. for CloH 40OS: C 65.89, H 7.74.




tert-butyl 4-(hexyloxy)benzoate (entry 14)
The general procedure was followed using CuI (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs2CO3 (490 mg, 1.5 mmol), tert-butyl-4-iodo benzoate21 (304 mg, 1.00 mmol), and n-
hexanol (187 IAL, 1.50 mol) with toluene (0.50 mL) as solvent for 24 h at 80 *C.
Chromatographic purification (hexane / ethyl acetate 1:0 -> 19:1) afforded a mixture of the title
compound and n-hexyl 4-(hexyloxy)benzoate (7:1 by 'H NMR and GC) as a clear oil (264 mg,
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95%). 'H NMR (500 MHz, CDC13) 8 7.98-7.92 (2H, m), 6.92-6.87 (2H, m), 4.00 (2H, t, J = 6.6
Hz), 1.83-1.76 (2H, m), 1.49-1.44 (2H, m), 1.35-1.30 (2H, m), 0.92 (3H, m). 13C NMR (125
MHz, CDCl3) 8 165.9 ,162.8, 131.5, 124.4, 114.0, 80.6, 68.3, 31.8, 29.3, 28.5, 25.9, 22.8, 14.2.




The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs2CO3 (391 mg, 1.2 mmol), 2-chloro-5-iodopyridine (239 mg, 1.00 mmol), and n-
hexanol (249 RpL, 2.00 mol) with toluene (0.50 mL) as solvent for 15 h at 80 *C.
Chromatographic purification (hexane / ethyl acetate 1:0 - 9:1) afforded the title compound as a
colorless oil (179 mg, 84%). 1H NMR (300 MHz, CDCl3) 6 8.03-8.02 (1H, dd, J = 0.8, 2.9 Hz),
7.22-7.19 (1H, dd, J = 0.8, 8.7 Hz), 7.17-7.14 (1H, dd, J = 2.9, 8.7 Hz), 3.99-3.94 (2H, t, J =
6.4), 1.80-1.73 (2H, m), 1.47-1.30 (6H, m), 0.92-0.87 (3H, m). 13C NMR (125 MHz, CDCl3)6
154.9, 142.6, 137.0, 125.2, 124.7, 69.3, 31.9, 29.4, 26.0, 23.0, 14.4. IR (KBr disc, cm -') 2902,
2863, 1516, 1454, 1245, 1016, 917, 814, 736, 697, 517. Anal. Calc. for C11H16CINO: C 61.82, H
7.55. Found: C 62.02, H 7.65.
3-(2-(naphthalen- 1-yloxy)ethyl)thiophene (entry 16)
The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs 2CO3 (490 mg, 1.5 mmol), 1-iodonaphthalene (175 [iL, 1.00 mmol), and 2-(3-thieno)-
ethanol (168 [tL, 1.50 mol) with toluene (0.50 mL) as solvent for 24 h at 110 *C.
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Chromatographic purification (hexane / ethyl acetate 1:0 - 9:1) afforded the title compound as a
tan oil (252 mg, 99%). 1H NMR (500 MHz, CDCl3) 6 8.31-8.29 (1H, m), 7.82 (1H, dd, J = 2.1,
6.4 Hz), 7.53-7.48 (1H, m), 7.45 (1H, d, J = 8.2 Hz), 7.39 (1H, d, J = 8.0 Hz), 7.31 (1H, dd, J =
2.9, 4.9 Hz), 7.19-7.18 (1H, m), 7.14 (1H, dd, J = 1.2, 4.9 Hz), 6.83 (1H, d, J = 7.5 Hz), 4.38
(2H, d,J = 6.7 Hz), 3.31 (2H, d,J = 6.4 Hz). 13C NMR (125 MHz, CDC13) 8 154.7. 138.9. 134.7.
128.7. 127.7. 126.6. 126.0. 125.9. 125.7. 125.4. 122.2. 121.8. 120.5. 104.8. 68.4. 30.5. IR (KBr
disc, cm-~ ) 3052, 2928, 2873, 1594, 1580, 1508, 1460, 1405, 1269, 1240, 1100, 1071, 1020, 790.
Anal. for C16H140S: C 75.55, H 5.55. Found: C 75.28, H 5.50.
3-(2-(pyridin-3-yl)ethoxy)benzonitrile (entry 17)
The general procedure was followed using CuI (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs2CO3 (490 mg, 1.5 mmol), 3-iodobenzonitrile (229 mg, 1.00 mmol), and 2-(3-
pyridyl)ethanol (172 RL, 1.50 mol) with toluene (0.50 mL) as solvent for 24 h at 80 *C.
Chromatographic purification (hexane / ethyl acetate 1:0 - 3:1) afforded the title compound as a
clear oil (174 mg, 78%). 1H NMR (500 MHz, CDC13) 8 8.56 (1H, d, J = 2.2 Hz), 8.22 (1H, dd, J
= 1.6, 4.7 Hz), 7.65-7.60 (1H, m), 7.40-7.33 (1H, m), 7.29-7.23 (2H, m), 7.13-7.09 (2H, m), 4.20
(2H, t, J = 6.5 Hz), 3.12 (2H, t, J = 6.5 Hz). 13C NMR (125 MHz, CDCl3) 6 158.8, 150.5, 148.5,
136.6, 133.6, 130.6, 125.0, 123.6, 119.9, 118.8, 117.6, 113.4, 68.5, 33.0. IR (KBr disc, cm -1)
3033, 2934, 2878, 2230, 1597, 1578, 1480, 1431, 1328, 1292, 1148, 1033, 971,715, 682. Anal.
Calc. for C14 H12N20: C 74.98, H 5.39.
2-(cyclohexyloxy)pyridine (entry 18)
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The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs2CO3 (490 mg, 1.5 mmol), 4 A molecular sieves (200 mg, flame activated under
vacuum) 2-iodopyridine (106 [IL, 1.00 mmol), and cyclohexanol (158 [LL, 1.50 mmol) with
toluene (0.50 mL) as solvent for 24 h at 110 *C. Chromatographic purification (hexane / ethyl
acetate 1:0 - 9:1) afforded the title compound as a clear oil (164 mg, 93%). 'H NMR (500
MHz, CDC13) 8 8.14 (1H, ddd, J = 0.8, 2.1, 5.0 Hz), 7.54 (1H, ddd, J = 2.0, 7.2, 8.4 Hz), 6.81
(1H, ddd, J = 0.9, 5.0, 7.1 Hz), 6.69 (1H, dt, J = 8.4, 0.8 Hz), 5.06-5.00 (1H, m), 2.05-2.01 (2H,
m), 1.82-1.76 (2H, m), 1.66-1.39 (4H, m), 1.34-1.25 (2H, m). "3C NMR (125 MHz, CDC13) 6
163.7, 147.1, 138.7, 116.4, 111.9, 73.2, 32.1, 25.9, 24.2. IR (KBr disc, cmn ') 3025, 2942, 1614,
1516, 1328, 1249, 1161, 1110, 1061,961, 837, 749. Anal. Calc. for C,,H,5NO: C 74.54, H 8.53.
Found: C 74.50, H 8.63.
1-(cyclopentyloxy)-4-methoxybenzene (entry 19)22
The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me 4-Phen (24 mg, 0.10
mmol), Cs2CO3 (490 mg, 1.5 mmol), 4-iodoanisole (234 mg, 1.00 mmol), and cyclopentanol
(136 yIL, 1.50 mol) with toluene (0.50 mL) as solvent for 24 h at 110 *C. Chromatographic
purification (hexane / ethyl acetate 1:0 - 9:1) afforded the title compound as a clear oil (168 mg
mg, 88%). 'H NMR (500 MHz, CDCl3) 8 6.83 (4H, s), 4.71-4.66 (1H, m), 3.78 (3H, s), 1.90-1.76
(6H, m), 1.65-1.56 (2H, m). 13C NMR (125 MHz, CDCl3) 8 152.3, 116.8, 114.8, 80.0, 55.9, 33.0,
24.2. IR (KBr disc, cm -r ) 2960, 2872, 1833, 1507, 1465, 1441, 1231, 1173, 1106, 1040, 990, 824.




The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs2CO3 (490 mg, 1.5 mmol), 4-iodobenzotrifluoride (147 [LL, 1.00 mmol), and (±)-1-
tetralol (222 mg, 1.50 mol) with toluene (0.50 mL) as solvent for 24 h at 110 *C.
Chromatographic purification (hexane / ethyl acetate 1:0 - 9:1) afforded the title compound as a
clear oil (217 mg, 75%). 'H 4NMR (500 MHz, CDCl3) 6 7.59 (2H, d, J = 8.8 Hz), 7.36-7.19 (4H,
m), 7.10 (d, J = 8.8 Hz), 5.47 (1H, t, J = 4.3 Hz), 2.96-2.91 (1H, m), 2.84-2.78 (1H, m), 2.21-
2.15 (1H, m), 2.09-1.99 (2H, m), 1.87-1.80 (1H, m). 13C NMR (125 MHz, CDC13) 8 138.0,
135.1, 129.6, 129.4, 128.4, 127.3, 127.2, 127.1, 126.4, 116.1, 74.2, 29.2, 28.0, 18.9. IR (KBr
disc, cmn) 3024, 2942, 1614, 1516, 1328, 1250, 1161, 1110, 1061,961,837,749. Anal. Calc. for
C17H_5F3OX: C 69.85, H 5.17. Found: C 69.74, H 5.24.
Me 1  MOH
1-(p-tolyloxy)hexan-5-ol (entry 21)
The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs2CO3 (490 mg, 1.5 mmol), 4-iodotoluene (218 mg, 1.00 mmol), and 1,5-hexanediol
(181 [tL, 1.50 mol) with toluene (0.50 mL) as solvent for 24 h at 80 *C. Chromatographic
purification (hexane / ethyl acetate 1:0 - 4:1) afforded the title compound as a clear oil (156
mg, 75%). 1H NMR (500 MHz, CDCl3) 8 7.09-7.07 (2H, m), 6.82-6.79 (2H, m), 3.95 (2H, t, J =
6.5 Hz), 6.87-3.81 (1H, m), 2.30 (3H, t), 1.83-1.78 (2H, m), 1.61-1.47 (6H, m), 1.22 (3H, dd, J =
0.6, 6.3 Hz). 13C NMR (125 MHz, CDC13) 8 157.1, 130.0, 129.9, 114.5, 68.2, 68.0, 39.2, 29.5,
23.7, 22.6, 20.7. IR (KBr disc, cm 1) 3363 (br), 3031, 2940, 2867, 1614, 1584, 1512, 1474, 1376,




The general procedure was followed using Cul (19 mg, 0.050 mmol), Me4-Phen (48 mg, 0.10
mmol), Cs2CO3 (490 mg, 1.5 mmol), 3-bromoanisole (127 [tL, 1.00 mmol), and benzyl alcohol
(155 [tL, 1.50 mol) with toluene (0.50 mL) as solvent for 24 h at 110 *C. Chromatographic
purification (hexane / ethyl acetate 1:0 - 9:1) afforded the title compound as a clear oil (199
mg, 93%). 'H NMR (500 MHz, CDCl3) 6 7.51-7.36 (5H, m), 7.23 (1H, m), 6.64-6.57 (3H, m),
5.08 (2H, s), 3.82 (3H, s). 13 C NMR (125 MHz, CDCI3) 8 161.0, 160.2, 137.1, 130.1, 128.8,
128.1, 127.7, 107.1, 106.7, 101.5, 70.2, 55.4. IR (KBr disc, cm'- ) 3032, 2939, 2835, 1592, 1492,
1453, 1381, 1288, 1264, 1199, 1151, 1082, 1045, 835, 761, 734, 697. Anal. Calc. for C,4HI40 2: C
78.48, H 6.59. Found: C 78.39, H 6.59.
3-(hexyloxy)-anisole (entry 23)24
The general procedure was followed using Cul (9.5 mg, 0.050 mmol), Me4-Phen (24 mg, 0.10
mmol), Cs2CO3 (490 mg, 1.5 mmol), 3-bromoanisole (127 [IL, 1.00 mmol), and n-hexanol (0.5
pL) as solvent for 24 h at 130 *C. Chromatographic purification (hexane / ethyl acetate 1:0 -
9:1) afforded the title compound as a clear oil (160 mg, 77%). 'H NMR (500 MHz, CDCl3) 6
7.19 (1H, t, J = 4.5 Hz), 6.53-6.48 (3H, m), 3.95 (2H, t, J = 6.7 Hz), 3.79 (3H, s), 1.81-1.76 (2H,
m), 1.49-1.45 (2H, m), 1.38-1.33 (4H, m), 0.94-0.91 (3H, m). 13C NMR (125 MHz, CDCl3) 6
161.0, 160.6, 130.0, 106.8, 106.3, 101.1, 77.0, 55.5, 31.8, 29.5, 26.0, 22.8, 14.3. IR (KBr disc,










































































10 9 8 7 6 5 4 3 2 1 ppm
0.82 1.80 1.85 3.74
0.89 1.90 1.53 2.73
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